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1. Introduction 
 
1.1 Natural products in the bioactive compounds research 
 
According to a study approximately 70% of the world population trust the efficiency of 
natural products when it comes to their health care.[1] The pharmaceutical industry is 
constantly in the search of new natural compounds. Among all the new 
pharmaceuticals we can notice a notable domination of natural products or their 
derivatives as antibacterials or antitumourals.[2] One example of this observation is 
the paclitaxel (1),[3] better known as Taxol®, which is distributed by Brystol-Myers-
Squibb (Figure 1). This substance, isolated from a yew tree of the pacific ocean 
(taxus brevifolia) exhibits biological activity against ovarian and breast cancer and 
has reached sales of billions of dollards.[4] 
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Figure 1: Paclitaxel (1), world-known under the name of Taxol®. 
 
 
Sources of these highly active natural products can be plants (e.g. Taxol®), bacterials 
(e.g. epothilone B (2), isolated from the mycobacterium Sorangium cellulosum and 
possessing similar properties as Taxol®),[5] fungi (e.g. squalestatine 1 (3) from 
Coelomycetes, a cholesterine inhibitor)[6] or marine organisms (e.g. spongistatine 1 
(4) from Spongia sp., which is active against melanoma, lung, intestine and neuron 
cancers) (Figure 2).[7] In parallel to the increasing number of newly described 
bioactive natural substances in the last 30 years, the proportion of fungal or marine 
isolated organisms has been multiplied during the last few years.[8] The exploitation 
of natural products isolated from marine organisms has led to the opinion that there is 
quasi an infinite number of secondary metabolisms, which exhibit high biological 
activities (e.g. spongistatine 1 (4), Figure 2).[9],[10] Derivatives of all these new 
bioactive substances are also interesting for the pharmaceutical industry. Some 
derivatives often become pharmaceutical leads due to their higher activities 
compared to the original natural product.[11] In fact some derivations are conducted 
on basic skeletons of interesting active compounds in order to reach higher activities 
and better properties (less side effects, better absorption). 
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Figure 2: Examples of highly bioactive natural products. 
 
 
1.2 The art and science of constructing the molecules of nature[12] 
 
“The birth of this discipline coincides with the synthesis of urea by Friedrich 
Wöhler from ammonium cyanate in 1828,[13] because this compound is a naturally 
occurring substance. Besides giving birth to organic synthesis, that landmark event 
served to "demystify" nature by burying, once and for all, the myth that the synthesis 
of nature's molecules is her exclusive domain. These days, the discipline of natural 
product synthesis, both total and partial (semisynthesis), is an important field of 
investigation whose dividends stretch from new scientific knowledge to practical 
applications. […] To be sure, this field will continue to excite, enable, and reward as 
we move forward in the 21st century, because a myriad of intriguing molecules from 
nature still remains to be discovered. And, when they are, they will hopefully stimulate 
new campaigns that will inevitably lead to further sharpening of the enabling tool of 
chemical synthesis as we strive to mimic nature in its elegance and efficiency.” 
 
K. C. Nicolaou 
 
In the 20th century a lot of work in the area of the total synthesis of natural products 
has been done.[14] It is particularly important to mention the outstanding work of R. B. 
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Woodward in the middle of the 20th century, who demonstrated the potential of the 
synthetic organic chemistry (1954: strychnine,[15] 1958: reserpine,[16] 1973: vitamin 
B12[17] in collaboration with A. Eschenmoser). The concept of “retrosynthetic analysis” 
of E. J. Corey, which explicits the strategic plan of a synthesis, has been one of the 
most important inventions of this time. The application of this concept has been 
presented through the syntheses of prostaglandin[18] and erythronolide B.[19] R. B. 
Woodward and E. J. Corey have been honoured with the Nobel price for their 
innovative work. 
 
The complexity of the newly synthesised molecules in the area of total synthesis has 
reached an impressive level.[14] Already in 1989 the group of Y. Kishi described the 
synthesis of palytoxine (molecular weight: 2679 g/mol, 64 stereocentres) and holds 
the record of the biggest synthesised asymmetric molecule (with the exception of 
peptides).[20] Often the syntheses of new biologically active substances have become 
a competition between groups to be the first to reach these new structures. The “back 
to back” published syntheses of epothilone by S. J. Danishefsky,[21] K. C. Nicolaou[22] 
or D. Schinzer[23] and the syntheses of the aglycon of vancomycine (5) by D. A. 
Evans,[24] K. C. Nicolaou[25] or D. L. Boger[26] (Figure 3) are a good illustration of this 
competition. 
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Figure 3: Aglycon of the antibiotic vancomycine (5). 
 
 
A lot of biologically active natural products are chiral and this has pushed the 
chemists to elaborate new modern asymmetric reactions in order to reach the desired 
structures.[27] These new methods can be stoichiometric,[28] catalytic[29] or 
enzymatic.[30] The enantiomeric purity of the newly synthesised substances can be 
extremely important for their biological effects. For example the (R,S)-propoxyphene 
(6), better known under the name of Darvon®, is an analgesic substance whereas its 
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enantiomer, (S,R)-propoxyphene (6) known as Novrad®, shows activity against cough 
(Figure 4).[31] 
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analgesic agent
Novrad®
(S,R)-proxyphene (6)
antitussive agent  
 
 
Figure 4: Different enantiomers of propoxyphene (6). 
 
 
Moreover, the well-established synthesis of naturally occurring compounds in solution 
phase is currently being complemented by the development of reactions on solid 
phase.[32] The synthesis of prostaglandin PGF2α of K. D. Janda has shown that some 
very complex structures can be reached using resin-supported chemistry.[33] Thanks 
to this methodology a library of prostaglandin derivatives, possessing the same basic 
skeleton, was prepared and has helped the elucidation of the Structure-Activity 
Relationship (SAR) of this substance. 
 
The success or failure of a total synthesis project seems nowadays to be more a 
question of funding (in the meaning of number of co-workers and cost of chemicals). 
So why is it still interesting to synthesise natural products? 
 
In the academic, as well as in the industrial sectors, natural products synthesis may 
be of interest for a number of reasons:[14a] 
 
a) Although spectroscopic methods have made incredible progresses, there are still 
some structures which can not be identified (especially for very highly complex 
substances). The total synthesis can be in this case really helpful and assist the 
identification or revision of complicated structures (→ structure identification).[34] 
 
b) The total synthesis of natural products may require the discovery of new synthetic 
methods crucial to solve certain strategic problems (→ design of new reactions). 
 
c) A total synthesis does not only allow for biological or medical tests of the newly 
synthesised compounds to be carried out, but also enables the synthesis of analogs 
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or derivatives which can exhibit better properties (higher activity, better compatibility 
with other treatments) and can help to the rationalisation of the Structure-Activity 
Relationship (→ preparation of acceptable quantities of material, synthesis of 
analogs, explanation of Structure-Activity Relationship). 
 
d) A complex natural product represents a difficult challenge, which can attract the 
organic chemists (→ challenge). 
 
 
1.3 Structure-Activity Relationship 
 
A better knowledge about the pharmacophor of a certain substance can help the 
comprehension of the mechanism of the molecular activity. It is possible to identify 
which features of the pharmacophor give increased activity to the molecule in 
comparison to certain derivatives. The basis for the success of this process is in the 
flexibility of the organic synthesis, which has allowed the synthesis of diverse 
analogs. Recently, solid-supported chemistry has had a big impact on the elaboration 
of derivatives thanks to combinatorial chemistry. For example, starting from naturally-
occurring epothilones the group of G. Höfle has synthesised around 100 non-natural 
derivatives via combinatorial chemistry. Similarly, the groups of K. C. Nicolaou and S. 
J. Danishefsky have reached 500 more new non-natural derivatives from their total 
syntheses of epothilone B (2). 
The exploration of the biological activities of all the synthesised derivatives of 
epothilones has contributed to a greater comprehension concerning the important 
structural features for the pharmaceutical properties of a molecule. Moreover, several 
cytotoxic highly active derivatives of epothilones have been prepared and have 
become new basic structures for further studies and potential bioactive candidates for 
the pharmaceutical industry. 
 
 
1.4 Styryllactones and (+)-altholactone 
 
1.4.1 General remarks about the styryllactones and (+)-altholactone 
 
 
1.4.1.1 Introduction 
 
 
The Annonaceae are woody trees, shrubs and vines comprising of about 130 genera 
and 2,300 species. The isoquinoline alkaloids belonging to this family have been 
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reviewed in the literature and more recently a highly active class of natural products, 
the acetogenins, which are inhibitors of the mitochondrial respiratory chain complex I, 
as well.[35] However this family also includes a wide range of compounds belonging to 
various phytochemical groups: e.g. terpenoid compounds co-occur with isoquinoline 
alkaloids in some genera, while a group of secondary metabolites commonly called 
styryllactones has been reported mainly within the genus of Goniothalamus (Figure 
5). 
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Figure 5: Styryllactone skeletons isolated from the genus Goniothalamus. 
 
 
The first isolated styryllactone, the styrylpyrone (R)-goniothalamin (7) (Figure 6), 
found in 1972 within the family Annonaceae, was extracted from several species of 
Goniothalamus.[36] Five years later, a novel furanopyrone derivative, (+)-altholactone 
(8) (Figure 6), was found in the bark of an unnamed Polyalthia species.[37] A large 
number of studies have been carried out to date in order to isolate new 
styryllactones, some of which have cytotoxic activity against tumour cells. 
 
Within the Annonaceae, the high interest concerns the genus Goniothalamus since it 
includes a large number of bioactive styryllactones. These secondary metabolites 
include linear, epoxy and cyclic styryllactone derivatives originating from mixed 
biogenesis involving the shikimic acid and acetate pathways (Scheme 1).  
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Scheme 1: Proposed biogenetic pathways to the styryllactones 
in Goniothalamus.[36] 
 
 
1.4.1.2 Isolation and structural elucidation 
 
 
Plant material such as leaves, stem bark, roots or even the whole plants is typically 
macerated with methanol or ethanol at room temperature. Isolations are performed 
by partitioning the initial extract between hexane, chloroform, dichloromethane and 
ethyl acetate, followed by repeated silica gel chromatographies using flash columns, 
preparative TLC, Chromatotron® separations and/or filtering on gel columns. 
 
The structural elucidation methods most often reported have been one-dimensional 
1H- and 13C-NMR, MS, IR and X-ray crystallography. In addition, two-dimensional 
NMR experiments involving COSY, COSY-45, HMQC, HMBC and NOESY have 
been used. The formation of chemical derivatives has often been used to confirm 
structural data[38] and furthermore, total syntheses have been carried out in order to 
establish or confirm the absolute configurations. 
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1.4.1.3 Classification of styryllactones 
 
 
Thirty-one bioactive styryllactones, with six different basic skeletons, have been 
isolated from Goniothalamus species as shown in Figure 5. The target molecule of 
the work presented herein, (+)-altholactone (8), is a furanopyrone so this class of 
styryllactones will be focused. 
 
The first member of this group, (+)-altholactone (8) also known under the trivial name 
of goniothalenol, was initially identified from Polyalthia[37] and isolated eight years 
later from the bark of Goniothalamus giganteus[39] (Figure 6). (+)-Altholactone (8) and 
furanopyrones in general are biogenetically related to styrylpyrones (Scheme 1).[36], 
[40] 
O
O
O
OH
2
3
3a 7a
OH
OH
OH
;
;
;
Ph
Ph
Ph
: (8)
: (9)
: (10)
(8)      (+)-altholactone ( = goniothalenol)
(9)      (+)-isoaltholactone
(10)    2-epi-altholactone
(11)    3-epi-altholactone
OH; Ph : (11)
2R,3R,3aR,7aS
2S,3S,3aR,7aS
2S,3R,3aR,7aS
2R,3S,3aR,7aS
OO
(R)-goniothalamin (7)
 
 
 
Figure 6: Naturally-occurring furanopyrones from Goniothalamus. 
 
 
The furanopyrone skeleton represents the second most abundant class of 
styryllactones in Goniothalamus. A number of these compounds, including the main 
styryllactone of the genus, are characterised by the presence of an α,β-unsaturated 
δ-lactone moiety. However, there are four different stereoisomers based on the 
relative and absolute configurations at the 2 and 3 positions. The configuration of the 
C-3 stereocentre was initially established from coupling constant values in the 1H-
NMR and crystallographic analysis. The coupling constants between H-3 and H-3a, 
and between H-2 and H-3 in (8) were reported to be 2.5 Hz (trans) and 5.8 Hz 
(trans), respectively, whereas in (9) the corresponding coupling constants were 5.5 
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Hz (cis) and 7.5 Hz (trans); thus, (8) and (9) are diepimers. The existence of 
compound (9) suggested that the different relative configuration at C-2 and C-3 could 
have their origin in an α- or β-epoxidation of the biogenetic intermediary (R)-
goniothalamin (7). Thus β-epoxidation of (7) followed by an intermolecular cyclisation 
may form (+)-altholactone (8), while α-facial formation of the corresponding epoxide 
could give rise to (+)-isoaltholactone (9). 
 
 
1.4.1.4 Bioactivity of styryllactones 
 
 
The styryllactones make up an interesting group from a pharmacological point of 
view. Styryllactones, despite their restricted occurrence in the plant kingdom, are 
reported to possess cytotoxic, anti-tumour, pesticidal, teratogenic and embryotoxic 
activities.[41] Significant anti-tumour and cytotoxic activities associated with 
styryllactones of Goniothalamus have promoted a detailed chemical investigation of 
the different styryllactones. 
 
 
1.4.1.5  (+)-Altholactone (8) 
 
 
(+)-Altholactone (8) was first isolated in 1977 from a Polyalthia species (Annonaceae) 
by J. W. Loder and R. H. Nearn[37] and later, in 1985 from the bark of Goniothalamus 
giganteus by El-Zayat et al.[39] A picture of the Goniothalamus giganteus is shown in 
Figure 7. 
 
 
 
 
Figure 7: Goniothalamus giganteus. 
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The flowers (max: 8 x 17 cm) of this plant undulate like waves and their scent is 
sweet and very strong. This Goniothalamus is found in the forests of Southern 
Thailand, where moisture of the air is high. There, flowering is almost all year long. 
The seeds generally germinate within two months. The trees can be really tall, up to 
20 metres, but one metre high plants can also have flowers although they have fewer 
flowers in northern areas. Propagation is possible by layering or seeds; however 
layering gives very good results and the plants are ready to grow in soil after 3-4 
months. Normally, the organic content of the soil must be high. 
 
(+)-Altholactone (8) (IUPAC name: (2R,3R,3aR,7aS)-3-hydroxy-2-phenyl-(2H,3aH)-
furano-[3,2-b]-pyran-5-one) is a bicyclic compound presenting an α,β-unsatured δ-
lactone (5-oxygenated-5,6-dihydro-2H-pyran-2-one) and a disubstituted furanic motif 
with a bicyclic cis ring junction (Figure 8). This molecule possesses a basic skeleton 
composed of 13 carbons (C13H12O4, molecular weight: Mw = 232) and 4 stereogenic 
centres. 
 
This natural product exhibits a very interesting cytotoxicity to mice during the P388 in 
vivo antileukemic screen (toxic at 45 mg/kg and 118% T/C at 25 mg/kg) and is lethal 
to brine shrimp, Artemia salina (LC50 = 234 µg/mL, 9 KB cytotoxicity ED50 = 2 
µg/mL).[39] 
 
O
O
O
Ph
OH
2
33a
7a
(+)-altholactone (8)
 
 
 
Figure 8: (+)-Altholactone (8). 
 
 
1.4.2 Previous asymmetric syntheses of (+)-altholactone (8) 
 
1.4.2.1 Chiral pool based strategies 
 
 
Due to the wide distribution of the styryllactone class in nature, many synthetic 
methodologies have been employed to synthesise them. Most syntheses use chiral 
pool starting material such as sugars[42] or hydroxy acids[43] and involve 11 to 16 
steps. 
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Due to the unusual structure and biological significance of this class of compounds, 
some groups were interested in designing a concise and flexible stereoselective 
route towards the construction of (+)-altholactone (8) and other styryllactones. Up to 
now three asymmetric total syntheses are reported in the literature and here are 
some summarises of the employed strategies. 
 
 
1.4.2.2 Asymmetric synthesis by Mukai et al. 
 
 
In the course of their program directed towards the stereoselective synthesis of all 
types of antitumour styryllactones, Mukai et al. published in 1996 the synthesis of 
several δ-lactone natural products, such as (+)-altholactone (8)[44c,d] from the (+)-
tricarbonyl(η6-o-(trimethylsilyl)benzaldehyde)-chromium (0) complex 12 via the 
common key intermediate (_)-14.[44a,b] 
 
Preparation of key intermediate 14 starts from 12, generated from o-
trimethylsilylbenzaldehyde (3 steps, 72% overall yield), and its selective aldol 
reaction with an α-benzyloxy thioester. Desilylation and decomplexation of the 
aromatic ring with cerium ammonium trinitrate in methanol gave 13, which was 
further protected with tert-butyldimetylsilyl chloride and reduced with DIBAL-H to the 
corresponding aldehyde in order to perform a selective aldol reaction with 2-
trimethylsilyloxyfuran. Thus the key intermediate (_)-14 has been prepared from the 
chiral benzaldehyde chromium (0) 12 complex in 6 steps (no mentioned yield) 
(Scheme 2). 
 
TBDMSO
OBn
OH
O
O
14
CHO
TMS
Cr(CO)3
StBu
OH
OBn
O
13
1) BnOCH2C(O)StBu
2) TBAF
3) CAN
1) TBDMSCl
2) DIBAL-H
3) 2-trimethylsilyloxyfuran
12
 
 
Scheme 2: Preparation of intermediate 14 from the chiral benzaldehyde 
chromium (0) complex 12. 
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The second concern and most significant requirement for their synthetic plan of the δ-
lactone natural products from intermediate 14 was an efficient transformation of the γ-
lactone moiety of the later to the corresponding δ-lactone derivative. By taking 
advantage of Kitazume’s procedure, they tried to convert 14 into 15.  The secondary 
hydroxy group of 14 was first protected with trimethylsilyl chloride and immediately 
reduced with DIBAL-H to afford the five-membered lactol, which upon exposure to 
potassium tert-butoxide at _70°C underwent a ring transformation accompanied with 
silyl group migration producing the desired six-membered lactol predominantly. 
Oxidation of a mixture of both lactols with pyridinum dichromate was followed by 
hydrolysis with 10% hydrochloric acid to provide the δ-lactone derivative (_)-15 in 
67% overall yield from 14. The allylic alcohol of 15 was tosylated using conventional 
procedures and desilylation with TBAF brought about a spontaneous ring closure to 
provide the dioxabicyclo[4.3.0]nonenone derivative, which was subsequently 
exposed to tin tetrachloride producing (+)-altholactone (8) (8 steps, 56% overall yield 
from 14) (Scheme 3). 
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(+)-altholactone (8)  
 
Scheme 3: Asymmetric total synthesis of (+)-altholactone (8) 
from 14 by Mukai et al. 
 
 
1.4.2.3 Asymmetric synthesis by O’Doherty et al. 
 
 
As a part of their synthetic efforts to enantioselectively synthesise biologically 
important C-arylglycoside natural products from achiral furans, O’Doherty et al. chose 
in 2001 to devise a route to the cytotoxic (+)-altholactone (8).[45b] At the outset, they 
targeted a selective synthesis of four possible C-2/C-3 stereoisomers of altholactone  
(+)-(8) to (11). This approach derives its chirality from a Sharpless catalytic 
asymmetric dihydroxylation of vinylfuran. The resulting diols are produced in high 
enantiomeric excesses and can be stereoselectively transformed into α,β-
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unsaturated δ-lactones via a short and highly diastereoselective oxidation and 
reduction sequence.[45a] Wittig- or Julia-olefination reactions were used to selectively 
introduce the phenyl group side chain with either cis- or trans-stereoselectivity and 
these intermediates were further elaborated into the altholactone isomers via 
selective epoxidation reactions. 
 
The synthesis began with the transformation of furfural 16 into the furyl alcohol 17 by 
employing a 1,2-addition with a Grignard reagent, an elimination under acidic 
conditions and a Sharpless dihydroxylation (3 steps, 75% overall yield). After 
selective protection of the primary alcohol of 17 as the corresponding tert-
butyldimethylsilyl ether, treatment with N-bromosuccinimide in aqueous THF 
produced a hemi-acetal pyranone through an oxidative ring expansion (Achmatowicz 
reaction). Treatment of the crude product with an excess of Jones reagent gave a 
ketolactone intermediate, which was reacted further without purification with a Luche 
reduction to give a δ-lactone (ee > 92%). Protection of the free hydroxyl group of the 
lactone was accomplished with tert-butyldimethylsilyl triflate and the selective 
deprotection of the primary TBS group with hydrogen fluoride gave the corresponding 
free primary alcohol. Dess-Martin oxidation of the primary alcohol gave the 
corresponding aldehyde, which was converted into δ-lactone 18 through a Wittig 
olefination reaction with a diastereoselectivity of 7:1 in favour of the Z-configured 
olefin (Scheme 4). 
16
1) TMSCH2MgCl
2) HCl
3) AD-mix-α
17
O CHO O
OH
OH
1) TBSCl
2) NBS, H2O
3) Jones reagent
4) NaBH4/CeCl3
5) TBSOTf
OO
OTBS
Ph
18
6) HF
7) Dess-Martin
8) Ph3P=CHPh  
 
 
Scheme 4: Synthesis of key intermediate δ-lactone 18. 
 
 
δ-Lactone 18 was treated with meta-chloroperbenzoic acid yielding both epoxides in 
a ~10:1 ratio in favour of the α one. Deprotection of the TBS group was 
accomplished with tetra-n-butylammonium fluoride, followed by acid promoted 
cyclisation to give an inseparable mixture of (+)-isoaltholactone (9) and 3-epi 
altholactone (11). Treatment of this mixture with triflic anhydride and 2,6-lutidine gave 
both of the corresponding triflates, which were separable by silica gel 
chromatography. Displacement of the triflate group in 19 was facile using cesium 
formate giving the ester protected altholactone. Cleavage of the formate group was 
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performed using saturated sodium hydrogen carbonate in THF and methanol to give 
(+)-altholactone (8) (17 steps, 2.5% overall yield from furfural 16) (Scheme 5). 
 
1) m-CPBA
2) TBAF
3) CSA
4) Tf2O
19
1) CsOCOH
2) NaHCO3
OO
OTBS
Ph
18
OO
O
Ph
OTf
(+)-altholactone (8)
 
 
 
Scheme 5: Asymmetric total synthesis of (+)-altholactone (8) 
from 18 by O’Doherty et al. 
 
 
1.4.2.4 Asymmetric synthesis by Yadav et al. 
 
 
Due to the unusual structure and biological significance of the styryllactones, Yadav 
et al. wished in 2003 to design a concise and flexible stereoselective route towards 
the construction of (+)-altholactone (8) and a few stereoisomers from the inexpensive 
and readily available cinnamyl alcohol 20 (Scheme 6).[46] 
 
1) (_)-DET, Ti(OiPr)4
2) Swern
3) Ph3P=CHCO2Et
4) AD-mix α
21
1) CSA
2) 2,2-DMP, p-TsOH
20
Ph OH Ph OEt
O
OOH
OH
O
HO OH
Ph
OEt
O
OPh
OEt
O
OO
+
2322  
 
 
Scheme 6: Asymmetric total synthesis of (+)-altholactone (8) 
by Yadav et al. (part 1). 
 
 
The synthesis began with the Sharpless asymmetric epoxidation of cinnamyl alcohol 
20 to afford the desired epoxide. Oxidation of the alcohol using the Swern protocol 
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gave the corresponding aldehyde, which without purification was subjected to a Wittig 
olefination with the stable ylide (ethoxycarbonyl-methylene)triphenylphosphorane to 
afford the desired epoxi-ester. A Sharpless asymmetric dihydroxylation reaction with 
AD-mix α was performed on this α,β-unsaturated epoxy ester to yield diol 21 in a 
ratio 10:1 with the other diastereoisomer. This inseparable mixture was treated with a 
catalytic amount of chlorosulfonic acid to afford the two corresponding 
tetrahydrofurans by cyclisation. Subsequent treatment with 2,2-dimethoxypropane led 
to acetonide 22 and unreacted diastereoisomer 23 which were readily separated by 
column chromatography. The trans diol 23 was protected with trimethylsilyl chloride 
and reduced with DIBAL-H to afford the corresponding aldehyde, which was 
transformed into the corresponding cis-ester using a Wittig olefination. Finally 
treatment with a catalytic amount of p-toluenesulfonic acid in methanol under 
sonication gave (+)-altholactone (8) (11 steps, 32% overall yield from 20) (Scheme 
7). 
1) TMSCl
2) DIBAL-H
3) Ph3P=CHCO2Et
4) p-TsOH, sonication
(+)-altholactone (8)
O
HO OH
Ph
OEt
O
23  
 
 
Scheme 7: Asymmetric total synthesis of (+)-altholactone (8) 
by Yadav et al. (part 2). 
 
 
1.4.3 Previous work on the synthesis of styryllactones in our group 
 
1.4.3.1 Asymmetric synthesis of (S)-goniothalamin by Enders et al. 
 
 
The asymmetric synthesis of the α,β-unsaturated δ-lactol equivalent 26 as a key 
intermediate towards the total synthesis of a variety of natural products bearing such 
structural motifs was reported by Enders et al. in 2001.[47] An enzymatic approach 
was applied to provide both enantiomers of compound 25 using recLBADH (ee > 
99%) and baker’s yeast (ee = 94%) (Scheme 8). The utility of this intermediate was 
demonstrated in the total synthesis of the non-natural enantiomer of goniothalamin 
(S)-7 (this substance bears the (R)-configuration in the natural form) (Scheme 9). 
 
It was demonstrated that NADP-dependent alcohol dehydrogenase of Lactobacillus 
brevis (recLBADH) can be used for the enantioselective reduction of tert-butyl-6-
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chloro-3,5-dioxohexanoate 24 (ee > 99%). The enantiopure hydroxyl ketoester was 
reduced using Sodium borohydride to obtain the dihydroxy ester, which upon heating 
underwent lactonisation to give the corresponding α,β-unsaturated chloro-lactone 
(S)-25. The later was reduced with DIBAL-H under standard conditions and 
subsequent pyridinium p-toluene sulfonate-catalysed acetalisation with isopropanol 
provided the protected alcohol. Treatment with tetrabutyl ammonium acetate led to 
an acetate protected primary alcohol, which was easily saponified with potassium 
carbonate in methanol giving rise to the key intermediate (S,S)-26 (ee > 99%) 
(Scheme 8). 
 
1) recLBADH
2) NaBH4, then p-TsOH
24
OtBu
O O O
Cl O
O
Cl
(S)-25
1) DIBAL-H
    then iPrOH, PPTS
2) TBAA
3) K2CO3
O
OiPr
OH
(S,S)-26  
 
 
Scheme 8: Synthesis of the key intermediate δ-lactol equivalent (S,S)-26. 
 
 
For the synthesis of (S)-goniothalamin 7, (S,S)-26 was oxidised under Swern 
conditions and directly used in a Wittig reaction under E-selective conditions 
(PhCH2Br, Bu3P and tBuOK) to obtain the corresponding E-configured olefin. Finally, 
PCC-oxidation in the next step provided enantiopure (S)-goniothalamin 7 (8 steps, 
14% overall yield from 24). 
1) Swern
2) Ph3P=CHPh
    then tBuOK
3) PCC
(S)-goniothalamin 7O
OiPr
OH
(S,S)-26  
 
 
Scheme 9: Asymmetric total synthesis of (S)-goniothalamin 7 by Enders et al. 
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1.4.3.2 Attempts towards the synthesis of (+)-goniotriol by Enders et al.[48] 
 
 
In the course of their program directed towards the stereoselective synthesis of all 
types of antitumour styryllactones, Enders et al. tried in 1998-1999 the synthesis of δ-
lactone natural products, such as (+)-goniotriol (27), utilising the well-established 
SAMP/RAMP chemistry. 
 
(+)-Goniotriol (27) was extracted from the bark of Goniothalamus giganteus[49] and 
leaves of Goniothalamus sesquipedalis (Annonaceae)[50] in Thailand. 
 
Due to the structure presenting four vicinal stereocentres and an α,β-unsaturated δ-
lactone, a synthetic plan starting from 2,2-dimethyl-1,3-dioxan-5-one-SAMP-
hydrazone (S)-28 was envisaged (Scheme 10).  
 
The concept is based on an alkylation of hydrazone (S)-28, followed by an aldol 
reaction with benzaldehyde on the corresponding hydrazone-cleaved compound. 
Reduction of the ketone and subsequent oxidation/cyclisation sequence of the 
primary alcohol would provide the δ-lactone motif of the target molecule. Finally 
dehydrogenation of the δ-lactone and acetonide deprotection would lead to (+)-
goniotriol (27). 
 
O
O
Ph
OH
OH OH
O
O
Ph
OH
O O
OH
Ph
OH
O O
OR
O
O
Ph
OH
O O
OR
O
O O
OR
N
O O
N
OCH3
(+)-goniotriol (27)
(S)-28  
 
Scheme 10: Retrosynthetic plan for the total synthesis of (+)-goniotriol (27). 
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The synthesis began with the SAMP-directed alkylation of starting material (S)-28 
(coming from a 1,3-diol building block commonly called dioxanone) with the TBS-
protected 3-bromopropanol (ee = 96%), cleavage of the chiral auxiliary by ozonolysis 
and subsequent aldol reaction with benzaldehyde to afford the aldol product in 
moderate yield but with excellent selectivities (ee, de ≥ 96%). Reduction of the 
ketone moiety with Evans-reagent (tetramethylammonium triacetoxyborohydride) did 
not give the desired anti diol but the corresponding syn one 29, presumably due to 
the chair configuration of the ring formed by the acetonide protecting group of the 
dioxanone. All other attempts to inverse the selectivity of this reduction reaction (Red-
Al®, zincborohydride, catecholborane, L-Selectride®, Super-Hydride®) gave the same 
result (Scheme 11). The syn relative configuration of the diol was demonstrated by 
the synthesis of the corresponding acetonide and NMR study of the two methyl group 
shifts. 
OH
Ph
OH
O O
OTBS
N
O O
1) tBuLi, then
    Br(CH2)3OTBS
2) O3
3) LDA, then PhCHO
4) Me4NBH(OAc)3
(S)-28 29
N
OCH3
 
 
 
Scheme 11: Attempt towards the synthesis of (+)-goniotriol (27) by Enders et al. 
 
 
A possibility to continue this synthetic plan was to inverse this specific stereogenic 
centre through an intramolecular cyclisation to a δ-lactone under Mitsunobu 
conditions[51] (Scheme 12). 
 
OH
Ph
OR
O O
OH
O O
Ph
OR
O O
O
lactonisation under
Mitsunobu conditions
 
 
 
Scheme 12: Principle of the Mitsunobu lactonisation with inversion of configuration. 
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Problems of selectivity in the mono-protection of the benzylic alcohol of 29 forced 
them to give up this strategy and to work on the synthesis of the epi version of the 
molecule. 
 
Simultaneous double protection of both alcohols of 29 to the corresponding acetates 
permitted a regioselective work on the oxidation of the primary alcohol to the desired 
corresponding methyl ester, which was obtained through deprotection of the TBS 
protecting group with triethylamine trihydrogen fluoride and oxidation of the primary 
alcohol to the carboxylic acid with ruthenium trichloride and sodium periodate. 
Saponification with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide chloride, methanol 
and 4-(dimethylamino)pyridine led to the corresponding methyl ester and subsequent 
deprotection of both acetate protecting groups provided 30 without any observed 
cyclisation (Scheme 13). 
 
OH
Ph
OH
O O
OTBS
O
Ph
OH
O O
O
29
1) Ac2O, NEt3, DMAP
2) Et3N.3HF
3) RuCl3, NaIO4
4) EDCL, MeOH, DMAP
5) NaOMe, MeOH
OH
Ph
OH
O O
OCH3
30
O
DBU
THF, reflux
O
Ph
OH
OH OH
O
epi-goniotriol 31  
 
 
Scheme 13: Lactonisation attempt towards epi-goniotriol 31. 
 
 
A last cyclisation attempt to obtain the desired δ-lactone by refluxing 30 in THF in the 
presence of a catalytic amount of 1,8-diazabicyclo[5.4.0]undec-7-ene was performed 
but only led to the recovery of the starting material. 
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Some other additional conditions have been tested to reach this cyclisation but none 
was successful in giving the desired δ-lactone. 
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2 Objectives 
 
As a part of our synthetic efforts to enantioselectively synthesise biologically 
important and antitumour active natural products from 2,2-dimethyl-1,3-dioxan-5-one-
SAMP-hydrazone (or 2,2-dimethyl-1,3-dioxan-5-one-RAMP-hydrazone), a total 
enantio- and diastereoselective synthesis of (+)-altholactone (8) was envisaged. 
 
The core of our approach is to employ an asymmetric alkylation or Michael addition, 
which would introduce the first stereocentre of the molecule. This should induce the 
three other stereocentres to reach the configuration of the target molecule. 
 
O
O
O
Ph
OH
(+)-altholactone (8)  
 
 
Moreover, the strategy should be flexible enough to allow the synthesis of 
enantiomers, diastereoisomers or derivatives and to permit the syntheses of several 
other natural products of the same family. 
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3 Results and discussion 
 
3.1 Asymmetric total synthesis of (+)-altholactone (8) 
 
 
3.1.1 First retrosynthetic concept 
 
 
In continuation of our efforts to enantioselectively synthesise biologically important 
natural products from 2,2-dimethyl-1,3-dioxan-5-one-SAMP-hydrazone (S)-28 (or 2,2-
dimethyl-1,3-dioxan-5-one-RAMP-hydrazone (R)-28) and due to its interesting 
antitumour activities against several sorts of cancer, a total enantio- and 
diastereoselective synthesis of (+)-altholactone (8) has been envisaged. 
 
All total syntheses of furanopyrones, natural or not, involve between 11 and 16 steps 
and very low overall yields. Our strategic plan would involve approximately 15 steps, 
which would make it a competitive enantioselective synthesis of (8) compared to the 
three other reported in the literature. 
 
The synthesis would begin with an asymmetric RAMP-directed alkylation or Michael 
addition using the starting material 2,2-dimethyl-1,3-dioxan-5-one-RAMP-hydrazone 
(R)-28. This would provide the first stereocentre of the molecule, inducer of three 
additional other stereogenic centres of the target molecule. After cleavage of the 
chiral auxiliary, an aldol reaction with benzaldehyde would establish two more 
stereocentres in the molecule and give the complete carbon skeleton of the desired 
natural product (13 carbons). A selective reduction of the ketone moiety would afford 
the fourth and last stereogenic centre and an oxidation/cyclisation sequence would 
led to the δ-lactone motif, representative of the styryllactone class. Deprotection of 
the acetonide protecting group and selective protection of the resulting 1,2-diol motif 
would allow us to transform the free resulting alcohol into a good leaving group. 
Deprotection of the 1,2-diol would afford the desired (+)-altholactone (8) through an 
in situ SN2 ring-closure reaction with inversion of configuration (Scheme 14). 
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Scheme 14: Retrosynthetic plan for the total synthesis of (+)-altholactone (8). 
 
 
3.1.1.1 The 2,2-dimethyl-1,3-dioxan-5-one-SAMP/RAMP-hydrazone method 
 
 
A flexible access to this 1,3-diol building block was developed in our group[52] 
Through condensation of the SAMP, or RAMP, chiral auxiliary[53]  with 2,2-dimethyl-
1,3-dioxan-5-one 34, it is possible to generate chiral dihydroxyacetone equivalents 
which are appropriate for the synthesis of carbohydrates[54] for example. After 
metalation the aza-enolate can be reacted with various electrophiles.[55] This 
methodology has enabled the synthesis of α-alkylated[56] or α,α’-dialkylated[56e],[57] 
dioxanones, as well as aldol[58] or Michael[59] reactions. It is notable that dialkylations 
lead to anti-substituted products. Through one more alkylation, quaternary 
stereocentres can be reached. After cleavage of the chiral auxiliary, the 
corresponding substituted dioxanone can be recovered. Then, there are several 
possibilities to functionalise the carbonyl function. For example, it is possible to obtain 
1,2,3-triols by reducing the carbonyl group (Scheme 15). 
 
As part of our continuous synthetic efforts to enantioselectively synthesise 
biologically active natural products, dioxanone 34 was, and still is, a very interesting 
and useful 1,3-diol building block.[60], [61] 
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34
O
O O
O
O O
O
O O
O O
O
O O
O
O O
O
O O
O
O O
H3C R
CH3 R2 R1
CO2R2
R1
R R2 R1 R
OBn
OTBS
R
OHOH
α-alkylations aldol reactions
quaternarisation deoxygenation
Michael additions  
 
Scheme 15: Several methods based on the 2,2-dimethyl-1,3-dioxan-5-one-
SAMP/RAMP-hydrazone developed by Enders et al. 
 
 
 
Preparation of the starting material 
 
2,2-Dimethyl-1,3-dioxan-5-one 34 was synthesised using a modification of the 
method of Woodward and Vorbrüggen reported by Hoppe et al. using a two-step 
sequence (Scheme 16).[56a],[62] 
 
O
O O
34
OH OH
NH2.HClHO
O O
NH2HO
1) 2,2-DMP, CSA
     DMF, RT, 3 d
2) Et3N, EtOAc
NaIO4, H2O
0°C to RT
60%
over two steps
32 33  
 
Scheme 16: Synthesis of 2,2-dimethyl-1,3-dioxan-5-one 34 by Hoppe et al. 
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Thus, the aminotriol hydrochloride 32 was converted into the corresponding 
acetonide protected 1,3-diol 33 with 2,2-DMP and a catalytic amount of 
camphorsulfonic acid in DMF. In the second step, the synthesis of 2,2-dimethyl-1,3-
dioxan-5-one 34 was reached through an oxidative cleavage of 33 with NaIO4 in 
aqueous solution. 
 
It is then possible to convert 2,2-dimethyl-1,3-dioxan-5-one 34 into the corresponding 
hydrazones through condensation of N,N-dimethylhydrazine, SAMP ((S)-1-amino-2-
methoxymethylpyrrolidine) or RAMP ((R)-1-amino-2-methoxymethylpyrrolidine). In 
the case of N,N-dimethylhydrazone, dioxanone 34 and an excess of hydrazine were 
refluxed in benzene. After work-up and distillation, the product 35 was isolated in 
88% yield. But in the case of the chiral SAMP- or RAMP-hydrazones, no excess of 
hydrazine was used and the reaction was performed with a Dean-Stark trap. In this 
case as well, after work-up and purification by distillation, the corresponding 
hydrazones were obtained in 88% yield for the SAMP-hydrazone (S)-28 and 90% 
yield for the RAMP-hydrazone (R)-28 (Scheme 17). 
 
O
O O
34
N
O O
(R)-28
N
OCH3
N
O O
(S)-28
N
OCH3
N
O O
35
N
CH3
CH3
N,N-dimethylhydrazine
cyclohexane, ∆, 4 h
SAMP, benzene
∆, overnight
RAMP, benzene
∆, overnight
88% 90%
88%
 
 
Scheme 17: Synthesis of SAMP/RAMP hydrazones 28 and 
N,N-dimethylhydrazone 35 
 
 
The employed SAMP and RAMP chiral auxiliaries were synthesised using a six-step 
method starting from the amino acid (S)- or (R)-proline.[63] 
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3.1.1.2 Alkylation and Michael addition on RAMP-hydrazone (R)-28 
 
 
One of the key steps of our strategy is the establishment of the first stereocentre of 
the molecule through an asymmetric RAMP-directed α-alkylation of the dioxanone 
34. This alkylation was accomplished by applying an α-substitution with a halide or 
with a Michael acceptor through a SE2’ mechanism (Scheme 18). 
After alkylation, cleavage of the chiral auxiliary has to be controlled in order to afford 
the α-monoalkylated dioxanone without racemisation of the new stereogenic centre. 
 
N
O O
(S)-28
N
OCH3
N
O O
N
OCH3RR
O
O
CH3
H3C
N
O O
N
OCH3R
O
O
CH3
CH3
N
N
N
N
H3CO
OCH3
Li
Li
RX
RX
R
 
 
 
Scheme 18: Proposed mechanism for the α- and α,α’-alkylations. 
 
 
For this reaction, we followed the general protocol developed in our group.[56e] 
 
The RAMP-hydrazone (R)-28 was deprotonated at the α-position with tert-BuLi in 
THF at _78°C and was alkylated using the desired electrophile or Michael acceptor at 
a lower reaction temperature of _100°C. Then, after work-up but without any further 
purification, the chiral auxiliary was cleaved following well-known protocols reported 
in the literature (ozonolysis, aqueous acid biphasic solution, CuCl2).[53a],[56a,c,e],[64] Here 
only two of these methods were tested to recover the dioxanone without 
racemisation: an ozonolysis (oxidative method) and a hydrolysis with an aqueous 
acid solution (hydrolytic method). For the first one, the crude monoalkylated RAMP-
hydrazone, dissolved in CH2Cl2, was subjected to an ozonolysis reaction with ozone 
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O3 at _78°C until completion of the reaction (red Sudan was used as a coloured 
indicator to control the reaction advancement: the initial red colour changed to yellow 
and then to blue upon completion of the reaction). For the later one method, the 
crude monoalkylated RAMP-hydrazone, dissolved in Et2O, was subjected to an 
aqueous saturated solution of oxalic acid (CO2H)2. This biphasic reaction was 
vigorously stirred overnight. After work-up and purification, the monoalkylated 
dioxanones were isolated in moderate to good yields and excellent enantiomeric 
excesses. 
 
The determination of the diastereoisomeric excess of the monoalkylated hydrazone 
was possible by analysing the 1H- and 13C-NMR data. After cleavage of the 
hydrazone, the assignement of the enantiomeric excess of the monoalkylated 
dioxanone was carried out with the help of a chiral stationary phase gas 
chromatography. As a reference substance, a racemic sample of all monoalkylated 
compound was synthesised through alkylation of 2,2-dimethyl-1,3-dioxan-5-one-N,N-
dimethylhydrazone 35. 
 
We initially envisaged to alkylate RAMP-hydrazone (R)-28 with ethyl acrylate 
CH2=CHCO2Et using a Michael addition. The reaction was successful in affording the 
desired compound (R)-36, but the low yield (8% over 2 steps) was not acceptable for 
the first key step of our strategy although the enantioselectivity of the reaction was 
good (ee = 86%). 
 
We tried to reach the same product (R)-36 through an alkylation with ethyl-3-
bromopropionate Br(CH2)2CO2Et, but similar results were obtained in terms of yield 
(17%). In contrast, the enantioselectivity of the reaction was considerably better (ee = 
95%) (Scheme 19). 
 
 
N
O O
(R)-28
N
OCH3
1) tBuli, THF, -78°C
2) RH or RX, THF, -100°C
3) O3, CH2Cl2, -78°C
O
O O
(R)-36
OEt
O
RH = CH2=CHCO2Et, 8%, ee = 86%
RX = Br(CH2)2CO2Et, 17%, ee = 95%  
 
Scheme 19: Michael addition and α-alkylation on hydrazone (R)-28. 
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Alkylation with an electrophile containing a carbon at a higher oxidation state or with 
a Michael acceptor was not possible in good yield. So we had to think about an 
alternative route, such as an alkylation with an electrophile which would be 
transformed into the corresponding methyl or ethyl ester later. 
 
Thus we tried to achieve this with the alkylation of (R)-28 employing 4-bromobut-1-
ene Br(CH2)2CH=CH2. We wanted to perform simultaneously the cleavage of the 
chiral auxiliary and an ozonolysis reaction on the terminal olefin to reach the 
corresponding aldehyde, which would be later oxidised to the corresponding 
methylester. Although this alkylation succeeded in giving the desired product (R,R)-
37, the ozonolysis did not perform the two expected and simultaneous reactions and 
resulted only in decomposition of (R,R)-37. Ozonolysis reaction of the terminal olefin 
was tested again on compound (R)-38, obtained after cleavage of the chiral auxiliary 
with oxalic acid (64% over 2 steps, ee = 94%), but the reaction only afforded a 
complex and inseparable mixture of compounds (Scheme 20). 
 
N
O O
(R)-28
N
OCH3
1) tBuli, THF, -78°C
2) BrCH2CH2CH=CH2
    THF, -100°C
N
O O
(R,R)-37
64% from (R)-28, ee = 94%
N
OCH3
N
O O
(R,R)-37
N
OCH3
O3, CH2Cl2, -78°C
O
O O
H
O
O O
(R)-38
(CO2H)2
Et2O, RT
O
O3
CH2Cl2, -78°C
 
 
 
Scheme 20: α-Alkylation with 4-bromobut-1-ene on hydrazone (R)-28 
and attempts of different ozonolysis reaction. 
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T. Hundertmark, a co-worker in the Enders group, who was working on the total 
synthesis of (+)-goniotriol, tried to reach the corresponding methylester of (S)-38 by 
applying an oxidation developed by Marshall et al.[65] Unfortunately the reaction did 
not give any identifiable product (Scheme 21). 
 
 
O
O O
(S)-38
O3, NaOH, MeOH
CH2Cl2, -78°C
O
O O
OMe
O
Marshall-oxidation
 
 
 Scheme 21: Attempt of Marshall-oxidation of (S)-38. 
 
 
In conclusion, none of these reactions were successful in affording the desired 
compounds in good yields and enantioselectivities. An alternative could be an 
alkylation of hydrazone (R)-28 with the TBS-protected 3-bromopropanol 39, which 
had already been used as an electrophile for this kind of alkylation, followed by 
oxidation of this side chain at a later stage of the synthesis. 
 
First we had to synthesise this non-commercially available electrophile from 3-
bromopropanol. The tert-butyldimethylsilyl (TBS) protecting group was chosen due to 
its stability under basic conditions and its ability to be selectively removed. 
 
The TBS-protected 3-bromopropanol 39 was obtained through TBS-silylation of 3-
bromopropanol with tert-butyldimethylsilyl chloride, Et3N and DMAP in CH2Cl2 in 92% 
(Scheme 22). 
 
TBSCl, Et3N, DMAP
CH2Cl2, RT
Br OH Br O
Si
C(CH3)3
CH3
H3C
92%
39  
 
Scheme 22: Synthesis of the TBS-protected electrophile 39. 
 
 
Alkylation of RAMP-hydrazone (R)-28 with the TBS-protected 3-bromopropanol 39, 
followed by cleavage of the chiral auxiliary of (R,R)-40 with oxalic acid, respecting the 
general protocol described before, led to the desired monoalkylated dioxanone (R)-
41 in 81% over 2 steps and with a excellent enantioselectivity (ee > 98%) (Scheme 
23). 
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OCH3
1) tBuLi, THF, -78°C
2) 39, THF, -100°C
3) (CO2H)2, Et2O, RT
81%, ee > 98%
O
O O
(R)-41
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Scheme 23: Alkylation of (R)-28 with electrophile 39. 
 
 
3.1.1.3 Aldol reaction with benzaldehyde 
 
 
In order to reach the basic carbon skeleton of (+)-altholactone (8) (13 carbons), we 
envisaged an aldol reaction of the monoalkylated dioxanone (R)-41, which would 
introduce two new stereogenic centres at the same time. This kind of reaction was 
already well-known in our group and even organocatalytic versions, employing 
proline, were studied with success.[66] 
 
Due to the simplicity of the protocol and the excellent results obtained in our group,[67] 
we envisaged an organocatalysed aldol reaction of the monoalkylated dioxanone (R)-
41 with benzaldehyde. Two attempts were performed with (R)- and (S)-proline 
(30mol%, in DMF, RT, 3 days) but unfortunately, these reactions only led to the 
recovery of the starting material without racemisation (Scheme 24). 
 
(R)- or (S)-proline
(30mol%), PhCHO
DMF, RT, 3 d
O
O O
(R)-41
OTBS
O
O O
OTBSPh
OH
 
 
 
Scheme 24: Proline-catalysed aldol reaction of (R)-41 with benzaldehyde. 
 
 
Faced with these first results, we decided to abandon the idea of an organocatalysed 
aldol reaction and to find other pathways of induction. 
 
A first idea was to try to use the same chiral auxiliary for the aldol reaction as for the 
asymmetric alkylation, which means trying to reach good selectivity carrying out the 
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aldol reaction with the RAMP-hydrazone (R,R)-40. We tried this reaction following a 
protocol known within the group, and we decided to conduct the cleavage of the 
chiral auxiliary in order to simplify the identification of the different aldol products. 
This two-step sequence gave all the four possible aldol products 42 to 45 in 10, 61 
and 3% yield, respectively (aldol products 44 and 45 are inseparable by 
chromatography on silica gel) (Scheme 25). 
 
 
1) tBuLi, THF, -78°C
2) PhCHO, THF, -100°C
3) O3, CH2Cl2, -78°C
N
O O
(R,R)-40
OTBS
O
O O
OTBSPh
OH
N
OCH3
10%
42 +  43 (61%)  +  44/45 (3%)
O
O O
OTBSPh
OH
43
O
O O
OTBSPh
OH
44
O
O O
OTBSPh
OH
45
 
 
Scheme 25: RAMP-catalysed aldol reaction betwen (R,R)-40 and benzaldehyde. 
 
 
Although the reaction gave the expected aldol products in good yield (aldolisation of 
74% of the starting material (R,R)-40), selectivity was not very high and not in favour 
of the desired product 42. 
 
Aldol reactions of monoalkylated dioxanones have been previously studied and used 
in our group, notably by O. F. Prokopenko[58a] and S. J. Ince.[58b,c] The latter 
developed a protocol to perform boron-mediated aldol reactions of dioxanone 34 and 
monoalkylated dioxanone derivatives. Aldol reaction of (R)-41 with benzaldehyde in 
the presence of Cy2BCl and Et3N afforded exclusively the desired aldol product 42 in 
64% yield, possessing the expected trans relative configuration between C-6 and C-7 
(see numbering below) (de > 98%, relative configuration confirmed by NOE). 
Moreover, this reaction introduced the chirality on carbon C-6 to yield exclusively the 
anti-acetal protected 1,3-diol. This anti relative configuration of the six-membered 
acetonide was easily assigned by 13C NMR analysis of the acetonide methyl group 
chemical shifts (δ = 23.6 and 23.7 ppm).[68] It was our aim that the centre established 
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via the RAMP methodology would direct the creation of the remaining ones (Scheme 
26). 
 
1) Cy2BCl, Et3N, Et2O
2) PhCHO, Et2O
O
O O
(R)-41
OTBS
O
O O
OTBSPh
OH
42
64%, de > 98%
5
67
 
 
 
Scheme 26: Boron-mediated aldol reaction of (R)-41 with benzaldehyde. 
 
 
It is important to note the relativily low stability of aldol products 42, 43, 44 and 45 
obtained through the different aldol reactions that we performed. In fact, these 
compounds can decompose through a retro-aldol reaction during purification by flash 
chromatography on silica gel as well as during the TLC controls. Some attempts of 
purification by Et3N-deactivated silica gel chromatography were performed but led to 
epimerisation of the aldol products. 
 
 
3.1.1.4 Reduction of the aldol product 
 
 
It was now time to introduce the fourth and last stereogenic centre of our target 
molecule. It was to be established through a stereoselective reduction of the carbonyl 
moiety of β-hydroxy ketone 42. In order to reach the desired trans relative 
configuration between C-5 and C-7, we thought of using 
tetramethylammoniumtriacetoxyborhydride (Me4NBH(OAc)3), widely developed by D. 
A. Evans,[69] which is in general successful for acyclic cases. Unfortunately, the 
reaction failed to afford the desired stereoselectivity for the reduction of aldol 42. The 
reaction only led to product 46, possessing a syn relative configuration (corroborated 
by NOE-measurements), in 39% yield (Scheme 27). 
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Me4NBH(OAc)3
THF/CH3CN (9:1)
-30°C to RT
O
O O
OTBSPh
OH
42
OH
O O
OTBSPh
OH
46
39%, de > 98%
O
O
H
HO
CH3
CH3
O
PhHB
(OAc)2
H H
OTBS
 
 
 
Scheme 27: Stereoselective reduction of 42 with Me4NBH(OAc)3. 
 
 
The syn-selectivity may be explained by an intramolecular hydride transfer where the 
dioxanone unit exists predominantly in a twisted boat conformation and the side 
chain is located in a pseudo-equatorial position. The hydride attacks the carbonyl 
function selectively from the Re-face to generate the syn-1,3-diol (Scheme 27). 
 
 
3.1.1.5 Deprotection of the acetonide protected 1,3-diol 
 
 
Seeing that the cycle formed by the acetonide protecting group caused problems for 
the reduction of the carbonyl moiety of aldol product 42, the easiest solution was to 
cleave it before performing the reduction. This meant that we had to arrange 
differently our 1,3-diol motif protecting groups. 
 
There are a lot of methods and conditions to cleave an acetonide protecting group. 
Acid-catalysed hydrolysis is the most widespread method for deprotecting 
isopropylidene derivatives and the acid strength and, as well as reaction times can 
vary widely. In most cases aqueous acid or an ion exchange resin will remove them 
rapidly and we tested a few of them in order to obtain the corresponding triol 
(Scheme 28). 
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O
O O
42
See table below
OTBSPh
OH O
OH OH
OTBSPh
OH
 
 
Entry Acid source Solvent Temp. Time Results 
1 p-TsOH (1.0 equiv) Acetone RT 48 h Complete decomposition of 42
a
2 p-TsOH (1.0 equiv) 
2,2-DMP/ 
H2O (55:1) 
RT 3 h No reaction (recovery of 42 without racemisation) 
3 PPTS (1.0 equiv) CH2Cl2 RT 24 h 
No reaction (recovery of 42 
without racemisation) 
4 PPTS (1.0 equiv) MeOH reflux 4 d 
Deprotection of the acetonide 
and the TBS protecting group 
5 
Acetic 
acid/H2O 
(3:1) 
- 70°C 1.5 h Complete decomposition of 42a
6 DOWEX 50W MeOH RT 4 h Complete decomposition of 42
a
a “complete decomposition of 42” we mean a simultaneous cleavage of the acetonide and TBS 
protecting groups and a retro-aldol reaction, which affords the corresponding triol. 
 
 
Scheme 28: Attempts of deprotection of aldol product 42. 
 
 
None of these conditions allowed to afford the desired triol. All conditions are too 
acidic for the aldol function (β-hydroxy ketone) or for the acid-sensitive TBS 
protecting group. Only the fourth entry (PPTS (1.0 equiv), MeOH, reflux, 4 d) afforded 
the expected acetonide deprotection without performing a simultaneous retro-aldol 
reaction. Unfortunately, this reaction also led to deprotection of the TBS-protected 
primary alcohol and there is no efficient solution to continue with our synthesis with 
this totally deprotected tetraol. 
 
There also exist non-aqueous acidic conditions to deprotect an acetonide. One 
example comes from William’s synthesis of phyllanthocin in which a dioxolane had to 
be hydrolysed without affecting a TBS ether group.[70] The deprotection was 
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accomplished by treatment of the acetal with ethanedithiol and acid. In the absence 
of an oxygen nucleophile, the TBS ether was stable under these conditions. 
Following the same protocol, we tried to remove the acetal of 42 but it only led to 
decomposition of the aldol product (Scheme 29). 
 
 
O
O O
42
HS(CH2)2SH (7 equiv)
p-TsOH (0.05 mol%)
CHCl3, reflux
OTBSPh
OH O
OH OH
OTBSPh
OH
 
 
Scheme 29: Attempt of deprotection of aldol product 42 with ethanedithiol. 
 
 
A last attempt for the acetal removal was tested using propanedithiol and boron 
trifluoride etherate (BF3.OEt2) in CH2Cl2.[71] These conditions are also known to be 
efficient in removing acetonide groups in the presence of TBS-protected alcohols, but 
this trial led to decomposition of the aldol product as well and recovery of 23% of the 
starting material (Scheme 30). 
 
O
O O
42
HS(CH2)3SH (2.6 equiv)
BF3.Et2O (7.3 mol%)
CH2Cl2, 0°C
OTBSPh
OH O
OH OH
OTBSPh
OH
 
 
Scheme 30: Attempt of deprotection of aldol product 42 with propanedithiol. 
 
 
This reaction is also possible under the following conditions: HS(CH2)3SH, MeSO3H 
(cat.), CH2Cl2, 0°C[72] but we have not try these knowing that our aldol product 42 is 
very sensitive under acidic conditions. 
 
 
3.1.1.6 Choice of a new primary alcohol protecting group 
 
 
Faced with these problems, we had to search for another protecting group for the 
side chain introduced through the asymmetric alkylation. We chose the benzyl 
protecting group due to its known stability under basic and acidic conditions and its 
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facility to be removed under standard hydrogenation conditions. It was, thus, hoped 
that this protecting group would be stable enough to permit the work on other parts of 
the molecule and would be removed without altering the previous steps of synthesis. 
 
The first step was to synthesise the electrophile we needed for the asymmetric 
RAMP-directed alkylation. For this, we tried several standard conditions which are 
summarised in the next table (Scheme 31). 
 
 
See table below
Br OH Br O
47  
 
Entry Base BnBr Solvent Temp. Time Yielda
1 NaH  (2.0 equiv) 1.05 equiv 
DMF 
(c = 0.2) RT 15 h 50% 
2 NaH  (1.2 equiv) 1.05 equiv 
DMF 
(c = 0.2) 
_78°C to 0°C 3 d 63% 
3 NaH  (1.2 equiv) 1.05 equiv 
DMF 
(c = 0.2) 
_78°C to RT 26 h 66% 
4 NaH  (1.1 equiv) 1.05 equiv
DMF 
(c = 0.5) 
_80°C to RT 20 h 76% 
5 Et3N  (1.2 equiv) 1.25 equiv 
CH2Cl2 
(c = 0.3) RT 22 h - 
           a Isolated yields of purified products. 
 
 
Scheme 31: Synthesis of the benzyl-protected electrophile 47. 
 
 
In summary, we found suitable conditions to synthesise the desired electrophile 47 in 
big scale and quite easily. The problem was to control the SN2 side reaction of 3-
bromopropanol on the starting material (dimerisation through Williamson reaction). 
This was possible with the help of a slow addition of the base to a mixture of 3-
bromopropanol and benzyl bromide and with a very slow increase of the temperature 
during overnight. 
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In the literature, we found one other possibility to synthesise the desired electrophile 
and this was through a two-step sequence developed by Jiang et al.[73] First, 3-
bromopropanol was deprotonated and silylated with diisopropylsilyl chloride 
((iPr)2SiCl) to afford the corresponding alkoxydialkylsilane, which was directly 
subjected to a reductive etherification with benzaldehyde and a catalytic amount of 
diisopropylsilyl chloride (0.1 equiv) in the presence of bismuth bromide. This 
sequence gave the desired product 47 in 95% yield over 2 steps but there remained 
always some traces of benzaldehyde and diisopropylsilyl chloride even after repeated 
chromatographies on silica gel (Scheme 32). 
 
(iPr)2SiHCl, Et3N
DMAP, THF
Br OH Br O
Si
H
95% over two steps BiBr3,(
iPr)2SiHCl
PhCHO, CH3CN
Br O
47  
 
Scheme 32: Synthesis of the benzyl-protected electrophile 47 through a new two-
step sequence of etherification. 
 
 
3.1.1.7 RAMP-directed alkylation and aldol reaction with benzaldehyde 
 
 
With our new electrophile in hand, we could try the same alkylation/aldol reaction 
sequence as before to obtain the basic carbon skeleton of our target molecule. 
 
The asymmetric RAMP-directed alkylation was performed following the same 
protocol as the first time (synthesis of (R)-41 in scheme 23). The expected 
monoalkylated dioxanone (R)-49 was obtained in 82% over 2 steps and with 
excellent selectivity (ee > 98%) (Scheme 33). 
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(R)-28
N
OCH3
1) tBuLi, THF, -78°C
2) 47, THF, -100°C
3) (CO2H)2, Et2O, RT
82%, ee > 98%
O
O O
(R)-49
OBn
 
 
 
Scheme 33: Alkylation of (R)-28 with electrophile 47. 
 
 
The monoalkylated dioxanone (R)-49 was subjected to the same boron-mediated 
aldol reaction as (R)-41 and led to the expected aldol product 50 in 68% yield 
possessing a trans relative configuration between C-6 and C-7 (see numbering below 
in scheme 34) (de > 98%, relative configuration confirmed by NOE). Similarly to the 
first time with the TBS-protected compound (R)-41, this reaction introduced the 
chirality on carbon C-6 to yield exclusively the anti-acetal protected 1,3-diol. The anti 
relative configuration of the six-membered acetonide was easily assigned by 13C 
NMR[68] analysis of the acetonide methyl group chemical shifts (δ = 23.5 and 23.6 
ppm). 
 
1) Cy2BCl, Et3N, Et2O
2) PhCHO, Et2O
O
O O
(R)-49
OBn
O
O O
OBnPh
OH
50
68%, de > 98%
5
67
 
 
 
Scheme 34: Boron-mediated aldol reaction of (R)-49 with benzaldehyde. 
 
 
3.1.1.8 New attempts of deprotection of the acetonide protected 1,3-diol 
 
 
Similarly to aldol product 42, we tried to remove the acetonide protecting group of the 
new benzyl-protected compound 50 through an acid-catalysed hydrolysis (Scheme 
35). 
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O
O O
50
See table below
OBnPh
OH O
OH OH
OBnPh
OH
 
 
Entry Acid source Solvent Temp. Time Results 
1 p-TsOH (1.0 equiv) Acetone RT 19 h 
Cleavage of the acetonide and 
simultaneous retro-aldol reaction 
2 p-TsOH (1.0 equiv) MeOH RT 19 h 
Cleavage of the acetonide and 
simultaneous retro-aldol reaction 
3 HCl (3N) (1.0 equiv) MeOH RT 48 h 
Cleavage of the acetonide and 
simultaneous retro-aldol reaction 
4 TFA (1.0 equiv) 
THF/H2O 
(2:1) RT 3 d 
Cleavage of the acetonide and 
simultaneous retro-aldol reaction 
5 
TFA 
(0.25 
equiv) 
MeOH RT 3 d Cleavage of the acetonide and simultaneous retro-aldol reaction 
6 PPTS (1.0 equiv) CH2Cl2 RT 24 h 
No reaction (recovery of 50 
without racemisation) 
7 PPTS (1.0 equiv) MeOH reflux 3 d 
Cleavage of the acetonide 
(decomposition of the product 
during purification) 
8 Amberlyst
® 
15 MeOH RT 9 h 
Cleavage of the acetonide and 
simultaneous retro-aldol reaction 
 
 
Scheme 35: Deprotection attempts of aldol product 50. 
 
 
None of these conditions were suitable to afford the desired triol. All conditions are 
too acidic for the aldol function (β-hydroxy ketone) except for the seventh entry 
(PPTS (1.0 equiv), MeOH, reflux, 3 d) which effected the expected acetonide 
deprotection without a simultaneous retro-aldol reaction. Unfortunately, the triol 
product was not stable enough during chromatography on silica gel and no products 
have been recovered from this purification. 
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3.1.1.9 Study of the reduction of the aldol product carbonyl moiety 
 
 
Following the unexpected results obtained from the reduction of β-hydroxy ketone 42 
with tetramethylammoniumtriacetoxyborhydride (Me4NBH(OAc)3) (1,3-diol syn 
relative configuration between C-5 and C-7), two different options were opened to us 
to try to invert the selectivity of this reduction step. 
 
The first one was to cleave the acetonide protecting group, originating from the 
dioxanone starting material, in order to perform the carbonyl reduction reaction on an 
acyclic compound, after, of course, rearrangement of the protecting groups. 
Unfortunately, it was impossible to reach the desired deprotected product because of 
the relativily low stability of the resulting aldol-products. 
 
The second possibility was to test new reagents and condition for the reduction of β-
hydroxy ketone 50. Through this screening, we hoped to reach the desired selectivity 
due to the different mechanisms of action of the various reductive agents and the fact 
that the cyclic β-hydroxy ketone 50 does not possess a regular chair conformation as 
a result of the anti-acetal protected 1,3-diol motif (pseudo-chair conformation). 
 
We, thus, initially tested several boron-mediated reductions under standard 
conditions and results are summarised in the next table (Scheme 36). 
 
See table below
O
O O
OBnPh
OH
50
OH
*
O O
OBnPh
OH
 
 
Entry Reductive agent Solvent Temp. Time Yield
a (anti / syn)
b
51  /  52 
1 NaBH4  (2.0 equiv) MeOH 
_78°C 2 h 74% 48 / 52 
2 catecholborane (5.0 equiv) THF 
_10°C 3 h 91% > 98 / 2 
3 L-Selectride
® 
(1.5 equiv) THF 
_78°C 3 h 97% > 98 / 2 
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4 Me4NBH(OAc)3 (5.0 equiv) 
Acetic 
acid/CH3CN 
(1:1) 
_20°C 
(freezer) 24 h 63% > 1 / 99 
a Isolated yields of purified products. 
b Ratios were measured by HPLC and 1H-NMR. 
 
 
Scheme 36: Attempts of stereoselective reduction of 50 with several 
boron reducing agents. 
 
 
The first entry illustrates a test of reduction of the carbonyl moiety with the non-
hindered boron reductive agent NaBH4. The aim of this trial was not to reach any 
selectivity but to check that it was possible to obtain the anti 1,3-diol product. And 
fortunately, this reaction conducted almost to a racemic mixture of both syn and anti 
1,3-diols in a good yield. It proved that the acetonide protecting group, forming a 
cyclic β-hydroxy ketone, does not block the reduction of the carbonyl function in 
giving only the syn 1,3-diol. 
 
This first interesting result encouraged us to test some other more-hindered boron 
reductive agents as L-Selectride® or catecholborane.[74] Both led to the reduction of 
the carbonyl moiety in good yields, 97% and 91% respectively, and with good 
selectivities in favour of the desired anti 1,3-diol 51 (de > 96%). 
 
A test of reduction with Me4NBH(OAc)3[69] was also performed and afforded, as for 
the first trial on 42, the non-desired syn 1,3-diol 52. The reaction yield was moderate 
(only 63%), but the selectivity was excellent (de > 98%). 
This inversion of selectivity between entries 3 (and 2 as well) and 4 can be explained 
by the different mechanisms of action of the reductive agents. In fact, L-Selectride® 
and catecholborane perform their reductions through an intermolecular mechanism 
instead of tetramethylammoniumtriacetoxyborhydride (Me4NBH(OAc)3), which occurs 
an intramolecular mechanism (chair-like transition state).[69] 
 
 
3.1.1.10 Improvement of the reduction reaction 
 
 
The reduction of β-hydroxy ketone 50 using L-Selectride® succeeded in giving the 
desired anti 1,3-diol 51 but we obtained a 1,3-diol with two free indiscriminated 
alcohols and that could cause regioselectivity problems in the next steps of the 
strategy. 
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Due to some interesting reduction examples of 2-alkyl-3-hydroxy ketones via their 
corresponding silyl ethers in the literature,[75],[76] we decided to try to reduce the 
carbonyl function of 50 and to discriminate between our two alcohols simultaneously 
through a protection/boron-mediated reduction sequence. 
 
The first step was to protect β-hydroxy ketone 50 and, for this, we first thought 
considered an acetate protecting group due to its stability under acidic conditions. We 
would, thus, be able to deprotect selectively the acetonide or the acetate protecting 
group under acidic or basic conditions, respectively. 
 
We tried to protect 50 under standard acetylation conditions (Scheme 37). 
 
O
O O
50
See table below
OBnPh
OH O
O O
53
OBnPh
O
O
O
O O
54
OBnPh
+     54
Elimination product:
 
 
Entry Conditions Solvent Temp. Time Yield
a 
53 / 54 
1 
Et3N (2.0 equiv) 
DMAP (0.05 equiv) 
Ac2O (1.1 equiv) 
CH2Cl2 RT 2 h 43% / 18% 
2 
Et3N (2.0 equiv) 
DMAP (0.05 equiv) 
Ac2O (1.1 equiv) 
CH2Cl2 0°C 1 h 50% / 15% 
3 
Py (2.0 equiv) 
DMAP (0.05 equiv) 
Ac2O (1.1 equiv) 
CH2Cl2 0°C to RT 4 h 66% / 10% 
a Isolated yields of purified products. 
 
 
Scheme 37: Protection of β-hydroxy ketone 50 with an acetate protecting group. 
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The reaction resulted in the expected acetate protection of β-hydroxy ketone 50 but it 
was not possible to avoid the elimination side reaction. The acetoxy group is too 
good a leaving group and facilitates the elimination reaction to afford compound 54. 
 
We, thus, returned to our first idea which was to perform the reduction of 50 via the 
corresponding silyl ether and we protected the former with TBSOTf an 2,6-lutidine 
under standard conditions.[58b] The reaction gave the TBS-protected product 55 in 
90% yield without observed epimerisation of the alcohol function or elimination of the 
newly protected alkoxy group (Scheme 38). 
O
O O
50
TBSOTf (1.5 equiv)
2,6-lutidine (3.0 equiv)
CH2Cl2, RT
OBnPh
OH O
O O
55
OBnPh
O
Si
90%
 
 
 
Scheme 38: Protection of β-hydroxy ketone 50 as the corresponding silyl ether. 
 
 
With silyl ether 55 in hands, we could try to reduce the carbonyl moiety with a boron 
reductive agent as we did for 50 (Scheme 39). 
 
See table below
O
O O
OBnPh
TBSO
55
OH
*
O O
OBnPh
TBSO
 
 
Entry Reductive agent Solvent Temp. Time Yield
a (anti / syn)
b 
56  /  57 
1 NaBH4  (2.0 equiv) MeOH 
_78°C to RT 3 h 100% 66 / 34 
2 L-Selectride
® 
(1.5 equiv) THF 
_78°C 5 h 88% > 98 / 2 
a Isolated yields of purified products. 
b Ratios were measured by HPLC and 1H-NMR. 
 
 
Scheme 39: Stereoselective reduction of 55 with boron reductive agents. 
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The reduction of silyl ether 55 with L-Selectride® led to the desired TBS-protected anti 
1,3-diol 56 in 88% yield and with an excellent diastereoisomeric excess (de > 96%). 
 
All four stereogenic centres of our target molecule were established and, at this point, 
we had to work on the oxidation/cyclisation sequence to obtain the important δ-
lactone motif. 
 
 
3.1.1.11 Oxidation/cyclisation sequence 
 
 
The δ-lactone motif is representative of the styryllactone class and in our strategy, we 
wanted to synthesise this motif through an oxidation/cyclisation sequence. In fact, 
oxidation of the primary alcohol of the side chain would afford the corresponding 
lactol, in equilibrium with the open-chain form, or the corresponding lactone directly. It 
was, thus, envisaged that the expected δ-lactone motif would be obtained through a 
short sequence (3 or 4 steps). 
 
Deprotection of the benzyl protecting group in 56 was possible using standard 
conditions of hydrogenation. Thus, hydrogenation of 56 with 10% palladium on 
carbon gave alcohol 58 in 89% yield (Scheme 40). 
 
 
OH
O O
56
H2, 10% Pd/C
EtOAc, RT
OBnPh
TBSO OH
O O
58
OHPh
TBSO
89%
 
 
 
Scheme 40: Hydrogenation of 56 with palladium on carbon. 
 
 
Oxidation of 58 to the corresponding carboxylic acid 
 
It was hoped that a direct “one-step” transformation of primary alcohol 58 into the 
corresponding carboxylic acid, without oxidation of the free secondary alcohol, would 
lead to an in situ cyclisation to the desired δ-lactone. Several conditions have been 
tested in order to carry out this sequence and are reported in the following table 
(Scheme 41). 
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See table below
OH
O O
OHPh
TBSO
58
OH
O O
OHPh
TBSO O
O
O O
Ph
TBSO
O
OH
O O
HPh
TBSO
59
O
Corresponding aldehyde:
 
 
 
Entry Oxidative agent Solvent Temp. Time Yielda 
1 RuCl3 (3% in weight)  NaIO4 (1.5 equiv) 
CCl4/CH3CN/H2O 
(1:1:1.6) RT 3 h 27% of 59
2 TPAP (5 mol%) NMO (1.5 equiv) CH2Cl2 RT 3 h 66% of 59
a Isolated yields of purified products. 
 
 
Scheme 41: Attempts of oxidation of 58 to the corresponding carboxylic acid. 
 
 
Both attempts with RuCl3/NaIO4[77] and TPAP (tetra-n-propylammonium 
perruthenate)/NMO (N-methylmorpholine N-oxide)[78] afforded aldehyde 59 as the 
sole product and no further oxidation was observed. 
 
Because of these results, we decided to consider a two-step sequence in order to 
transform alcohol 58 into the corresponding carboxylic acid. 
 
 
Oxidation of 58 to the corresponding aldehyde 59 
 
In order to improve the yield of aldehyde 59 a number of more standard oxidative 
agents and conditions to oxidise a primary alcohol into the corresponding aldehyde 
(Scheme 42). 
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See table below
OH
O O
OHPh
TBSO
58
OH
O O
HPh
TBSO O
O
O O
Ph
TBSO
OH
59
O
O O
HPh
TBSO O
60
Product of the double oxidation:
+   60
 
 
Entry Oxidative agent Solvent Temp. Time Yielda 
1 
(COCl)2 (3.0 equiv) 
 DMSO (6.0 equiv) 
Et3N (9.0 equiv) 
CH2Cl2 _78°C to 0°C 1.5 h 71% of 60
2 
(COCl)2 (1.1 equiv) 
 DMSO (2.2 equiv) 
Et3N (5.0 equiv) 
CH2Cl2 _78°C to _20°C 1 h 
39% of 60
30% of 58
3 IBX (2.2 equiv) DMSO (c = 0.05) RT 3 h 64% of 59
a Isolated yields of purified products. 
 
 
Scheme 42: Oxidation of 58 to the corresponding aldehyde 59. 
 
 
Standard oxidation conditions such as Swern conditions ((COCl)2, DMSO, Et3N)[79] 
and IBX (o-iodoxybenzoic acid in DMSO)[80] were not more efficient than TPAP/NMO 
in furnishing aldehyde 59. Moreover, we could notice that Swern conditions were, in 
our case, not regioselective. This reaction also led to compound 60 arising from 
simultaneous oxidation of both free alcohols. In contrast, oxidation of 58 with 
TPAP/NMO and IBX led to the desired aldehyde 59 in good yields (66% and 64% 
respectively) without detectable formation of the doubly oxidised product 60. 
 
It was also interesting to note that we have managed to synthesise aldehyde 59, but 
we have not observed any in situ cyclisation of 59 to the corresponding lactol. 
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Oxidation of 59 to the corresponding carboxylic acid 
 
The newly synthesised aldehyde 59 had to be oxidised to the corresponding 
carboxylic acid in order to reach the desired δ-lactone. This was possible by 
subjecting aldehyde 59 to treatment with sodium chlorite (NaOCl2) in conjunction with 
a chlorine scavenger[81] and gave the corresponding carboxylic acid 61 in 86% yield 
(Scheme 43). 
 
OH
O O
59
NaOCl2 (2.5 equiv)
2-methyl-2-butene (18 equiv)
NaH2PO4.2H2O (2.0 equiv)
acetone/H2O (1:1), RT
HPh
TBSO OH
O O
61
OHPh
TBSO
86%
O O
 
 
 
Scheme 43: Oxidation of 59 with sodium chlorite. 
 
 
As in the case of aldehyde 59, we have not observed any in situ cyclisation of 61 to 
the corresponding δ-lactone. 
 
 
Saponification of 61 into the corresponding methyl ester 
 
We, subsequently, considered transforming carboxylic acid 61 into the corresponding 
methyl ester 62. For this, 61 was, thus subjected to 1-((3-dimethylamino)-propyl)-3-
ethylcarbodiimide hydrochloride (EDCL) and 4-dimethylaminopyridine (DMAP).[48] 
The reaction afforded the corresponding methyl ester 62 in 63% yield (Scheme 44). 
 
OH
O O
61
EDCL (1.1 equiv)
DMAP (0.1 equiv)
MeOH (15.0 equiv)
CH2Cl2, RT
OHPh
TBSO OH
O O
62
OCH3Ph
TBSO
63%
O O
 
 
 
Scheme 44: Esterification of 61 with EDCL/DMAP. 
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Once again, we have not observed any in situ cyclisation of 62 to the corresponding 
δ-lactone. 
 
 
Cyclisation attempts of methyl ester 62 
 
With carboxylic acid 61 and the corresponding methyl ester 62 in hand, we have two 
molecules which could afford the desired δ-lactone through a cyclisation reaction. 
 
Shing et al. published in 1992 and 1995[42f],[82] the synthesis of several styryllactones. 
In their synthesis of (_)-goniotriol (27), (+)-goniotriol (27), (+)-goniopypyrone and (+)-
altholactone (8), they performed a reaction of lactonisation with a catalytic amount of 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in boiling THF (Scheme 45). 
 
OH
O O
DBU (cat.)
THF, reflux
Ph
OH O
O O
Ph
OH
83%
CO2Me
O
OH
O O
DBU (cat.)
THF, reflux
Ph
OH O
O O
Ph
OH
70%
CO2Me
O
(_)-goniotriol (27)
(+)-altholactone (8)
 
 
Scheme 45: DBU-catalysed cyclisations performed by Shing et al. 
 
 
T. Hundertmark tried in 1999 to apply the same conditions of cyclisation in his 
attempt of a total synthesis of (+)-goniotriol (27),[48] but these conditions were 
unsuccessful in affording the desired product (Scheme 46). 
 
OH
O O
DBU (cat.)
THF, reflux
Ph
OH O
O O
Ph
OH
O
(+)-goniotriol (27)CO2Me
29
 
Scheme 46: Attempt of DBU-catalysed cyclisation by T. Hundertmark. 
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In our group, a similar kind of cyclisation of a monoalkylated dioxanone was 
performed to synthesise a number of azasugars (Scheme 47).[83] 
 
 
O
O O
H2, Pd/C
MeOH, RT
R
HN
O O
R azasugarsN3
 
 
 
Scheme 47: Synthesis of azasugars by Enders et al. 
 
 
We tried the same conditions as Shing et al. to perform a DBU-catalysed cyclisation 
of methyl ester 62. Unfortunately, these conditions did not lead to the desired δ-
lactone (Scheme 48), but only to the recovery of starting material 62 without any 
epimerisation. 
OH
O O
DBU (cat.)
THF, reflux
Ph
TBSO O
O O
Ph
TBSO
O
(+)-altholactone (8)CO2Me
62
 
 
Scheme 48: Attempt of DBU-catalysed cyclisation of 62. 
 
 
To conclude, it has not been possible to carry out the envisaged cyclisation of 62, 
presumably due to the resulting trans bicyclic ring junction and the large ring strain 
involved with the latter. In fact, using the same cyclisation conditions, Shing et al. 
performed the synthesis of two δ-lactones possessing a cis bicyclic ring junction 
instead, whereas our group has not managed to synthesise related δ-lactones 
possessing a trans bicyclic ring junction. All these points towards the probability that, 
in our case, a trans bicyclic ring junction is not a favoured configuration cause of the 
ring strain of the bicyclic system. 
The non-regular chair conformation of the dioxanone ring, due to the anti-acetal 
protected 1,3-diol motif, could also explain the unfavourable conformation of methyl 
ester 62. 
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3.1.2 New retrosynthetic concept 
 
 
A new strategy would have to make the most of the initial good results concerning the 
establishment of the four stereogenic centres of the target molecule and to take into 
account the difficulty of performing the lactonisation of the side chain in the presence 
of the six-membered acetonide originating from the dioxanone 34. As a result, we 
had to keep the beginning of the previous strategy until compound 56 the same and 
to reconsider carrying out our oxidation/cyclisation sequence on an acyclic 1,5-diol. 
 
Starting back from 56, the new strategy would begin with the protection of the free 
secondary alcohol as the corresponding benzyl ether in order to perform a 
simultaneous debenzylation after rearrangement of the 1,3-acetal diol to the 1,2-
acetal diol. Rearrangement of the six-membered acetonide to the five-membered 
one, followed by protection of the resulting free alcohol, would afford the new acyclic 
starting material for our sequence oxidation/cyclisation. The sequence would lead to 
the δ-lactone motif representative of the styryllactone class. The unsaturation of the 
lactone would be introduced by dehydrogenation of the α and β positions. 
Deprotection and transformation of the cyclic alcohol into a good leaving group would 
afford the desired (+)-altholactone (8) through an in situ SN2 ring-closure reaction 
with inversion of configuration after deprotection of the 1,2-diol under acidic 
conditions (Scheme 49). 
 
O
O
O
O
OH
OBn
Ph
TBSO
O O
OBn
O
O O
OBn
N
O O
N
OCH3
(+)-altholactone (8)
(R)-28
OBnPh
OGP
O
O
Ph
O
HO
Ph
O
O
OBn
 
 
 
Scheme 49: New strategy for the total synthesis of (+)-altholactone (8). 
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3.1.2.1 Protection of the secondary alcohol as its benzyl ether 
 
 
In order to work on the acetonide rearrangement, we first had to protect the free 
secondary alcohol 56. We considered a transformation into the corresponding benzyl 
ether in order to be able to perform a simultaneous double debenzylation of both 
alcohols that required for the oxidation/cyclisation sequence (Scheme 50). Moreover, 
benzyl ethers are known to be relatively stable under acidic conditions which we 
would need for the acetonide rearrangement. 
OH
O O
56
See table below
OBnPh
TBSO O
O O
63
OBnPh
TBSO
 
 
Entry Reagents Solvent Temp. Time Yielda 
1[84] NaH (1.1 equiv)  BnBr (1.1 equiv) 
DMF 
(c = 0.1) RT 20 h 16% 
2[85] 
KH (3.0 equiv) 
 BnBr (3.0 equiv) 
(n-Bu)4NI (cat.) 
THF 
(c = 0.1) RT 24 h 
Recovery of 
56 
3[86] KH (1.5 equiv)  BnBr (2.0 equiv) 
THF 
(c = 0.1) 0°C to RT 2.5 h 53% 
4[86] KH (1.2 equiv)  BnBr (2.0 equiv) 
THF 
(c = 0.1) 0°C to RT 22 h 90% 
a Isolated yields of purified products. 
 
 
Scheme 50: Protection of alcohol 56 as the corresponding benzyl ether 63. 
 
 
The desired benzyl ether 63 was synthesised in 90% yield using potassium hydride 
KH as the base, because the corresponding sodium alkoxide seemed not to be 
nucleophilic enough to perform the substitution of benzyl bromide. 
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3.1.2.2 Cleavage of the acetonide and TBS protecting groups 
 
 
The displacement of the six-membered acetonide to the five-membered one is an 
equilibrium displacement reaction between acetals. To be able to check this 
equilibrium between the two acetals, we needed to remove the acetonide and TBS 
protecting groups to obtain the corresponding triol 65, which would be subjected to 
acetalisation conditions (Scheme 51). 
 
 
OBn
O O
63
Amberlyst® 15
MeOH, RT
OBnPh
TBSO OBn
OH OH
64
OBnPh
TBSO
92% over two steps
OBn
OH OH
65
OBnPh
OH
TBAF
THF, RT
 
 
Scheme 51: Double deprotection of acetal and TBS protecting groups of 63. 
 
 
This short sequence afforded the desired triol 65 in 92% yield over 2 steps. We 
noticed during the first step of acetonide cleavage with Amberlyst® 15[87] that the 
deprotection of the TBS protecting group was partially occurring. These conditions 
were acidic enough to remove the silyl protecting group, but more slowly than the 
acetonide cleavage. After complete cleavage of the acetal (TLC control) we needed 
to complete the TBS deprotection with tetra-n-butylammonium fluoride (TBAF) to 
obtain triol 65. 
 
 
3.1.2.3 Acetal protection of triol 65 
 
 
The aim of subjection of triol 65 to acetalisation conditions was to check what kind of 
equilibrium we could get. In other words, what kind of mixture between both acetals 
we could obtain. Of course, we expected a ratio in favour of the five-membered 
dioxolane, but we could not predict at all the results of the reaction. 
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It is known that dioxolanes are preferred to dioxanes and cis-fused dioxolanes are 
thermodynamically favoured over trans-fused systems (Scheme 52), but 
isopropylidene acetal formation is a thermodynamically driven process; Hence, in 
cases where two (or more) acetals are possible, the more stable diastereoisomer will 
prevail. Secondary alcohols have a greater tendency to form isopropylidene 
derivatives than primary ones. 
 
OH OH
acetone, p-TsOH
CuSO4, RTOH
OH O O
OH
O
O
1,2,4-butanetriol
+
(95 : 5)
O
O
OH acetone
Amberlyst® 15
RT, 30 min
OH
O
O
85%
 
 
 
Scheme 52: 1,3-Dioxolane vs. 1,3-dioxane formation and 
cis-fused dioxolanes vs. trans-fused systems. 
 
 
In our case, triol 65 possessed three free secondary alcohols which could form a 
trans dioxane and a cis dioxolane. As a result, no prediction about the nature of the 
acetal mixture we would get was possible. Then, we just had to try the reaction and 
hope that the desired dioxolane would be the thermodynamically favoured acetal 
during the reaction (Scheme 53). 
 
See table below
OBn
O O
66
OBnPh
OHOBn
OH OH
65
OBnPh
OH
OBn
OH
67
OBnO
O
Ph
+
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Entry Conditions Solvent Temp. Time Yielda Ratio
b 
66:67 
1[88] 2,2-DMP (5.0 equiv) PPTS (cat.) CH2Cl2 RT 20 h 93% 2.0 / 1 
2 2,2-DMP (5.0 equiv) PPTS (cat.) CH2Cl2 RT 14 h 97% 2.2 / 1 
3 2,2-DMP (5.0 equiv) PPTS (cat.) CH2Cl2 
_10°C→10°C 24 h 94% 3.0 / 1 
4 2,2-DMP (5.0 equiv) PPTS (cat.) CH2Cl2 0°C 24 h 85% 3.0 / 1 
5 2,2-DMP (1.5 equiv) PPTS (cat.) CH2Cl2 RT 26 h 97% 2.2 / 1 
6 2,2-DMP (1.5 equiv) PPTS (10 mol%) CH2Cl2 RT 24 h 92% 1.9 / 1 
7 2,2-DMP (1.2 equiv) PPTS (cat.) CH2Cl2 RT 24 h 100% 2.4 / 1 
a Isolated yields of purified products. 
b Ratios were measured from the isolated separable acetals. 
 
 
Scheme 53: Isopropylidene acetal formation starting from 65. 
 
 
As expected, we obtained the formation of both acetals 66 and 67 as a readily 
separable mixture by chromatography on silica gel. Variation of the reaction 
conditions, like excess of 2,2-dimethoxypropane (2,2-DMP) or reaction temperature, 
did not lead to an improvement and the best result we could get was a 2:1 ratio in 
favour of the six-membered acetal 66. 
 
Steric effects can be used to influence the proportion of dioxane and dioxolane 
isomers obtained from a 1,2,4-triol system. For example triol 68 gave a 9:1 mixture of 
dioxolane and dioxane products, respectively, when acetone was used as the 
acetalisation reagent. But when 3-pentanone was employed under essentially the 
same conditions, the dioxolane product was formed exclusively (Scheme 54). 
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OH OH
acetone, p-TsOH, RTOH
OH O O
OH
O
O
68
+
(9  : 1)
OH O
O
Et2CO, p-TsOH
THF, RT
quant.
90%
 
 
 
Scheme 54: 1,3-Dioxolane vs. 1,3-dioxane formation. 
 
 
The protocol using 3,3-dimethoxypentane[89],[90] (3,3-DMP) instead of 3-pentanone[91] 
has become one of the most popular methods because it generally gives high yields 
and is compatible with acid-sensitive protecting groups such as the TBS group. 
 
An attempt of acetalisation of triol 65 led to a (1.4:1) ratio in favour of the six-
membered acetal 69 in quantitative yield (Scheme 55). 
 
 
Et2CO, PPTS (cat.)
CH2Cl2, RT
OBn
O O
69
OBnPh
OHOBn
OH OH
65
OBnPh
OH
OBn
OH
70
OBnO
O
Ph
+
quant.
Separable mixture 69:70 (1.4:1)
 
 
Scheme 55: Acetal formation starting from 65 with 3,3-dimethoxypentane. 
 
 
The mixture ratio was a little bit better than with 2,2-DMP (1.4:1 instead of 2:1 for the 
same range of yields) but not enough to make this sequence feasible for our 
synthesis. Even efficient recycling of dioxane 66 back to triol 65, with Amberlyst® 15 
in methanol,[87] did not improve the prospects of this sequence (Scheme 56). 
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Amberlyst® 15
MeOH, RT
OBn
O O
66
OBnPh
OH
OBn
OH OH
65
OBnPh
OH
99%
 
 
 
Scheme 56: Recycling of dioxane 66 back to triol 65. 
 
 
A solution could be a direct acetonide rearrangement of dioxane 66 to dioxolane 67, 
which would be more elegant and make our strategy shorter by one step. 
 
 
3.1.2.4 Acetonide displacement 
 
 
A direct acetonide rearrangement of dioxane 66 to dioxolane 67 would also be 
possible in our strategy. It would consist on an acid-catalysed isomerisation (Scheme 
57) of the six-membered acetal to the five-membered one. We knew already that this 
reaction had a very low chance to give a better acetals mixture quality than the one 
we got with the acetalisation reaction of triol 65, but this reaction would afford the 
desired dioxolane 67 in a shorter (one step less) and more elegant sequence. 
 
p-TsOH
(1:10)
O
O
OH
HO O
O
 
 
 
Scheme 57: Isomerisation of acetonide under acidic conditions. 
 
 
First we had to prepare dioxane 66 circumventing triol 65. This was possible through 
a simple deprotection of the silyl protecting group of compound 63. This reaction was 
conducted with TBAF in THF and provided the desired TBS-deprotected product 66 
in 95% yield (Scheme 58). 
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OBn
O O
63
OBnPh
TBSO TBAF
THF, RT
OBn
O O
66
OBnPh
OH
95%
 
 
 
Scheme 58: Deprotection of the TBS protecting group of 63. 
 
 
With dioxane 66 in hand, we could attempt an acid-catalysed isomerisation of 66 into 
67 (Scheme 59). 
 
 
See table below
OBn
O O
66
OBnPh
OH
OBn
OH
67
OBnO
O
Ph
 
 
Entry Conditions Solvent Temp. Time Yielda Ratio
b 
66:67 
Yield
65a 
1 p-TsOH (cat.) Acetone (c = 0.04) RT 70 h 82% 1.6 / 1 15%
2 p-TsOH (cat.) Acetone (c = 0.04) reflux 25 h 59% 3.0 / 1 9% 
3 
p-TsOH (cat.) 
2,2-DMP (0.25 equiv) 
PPTS (cat.) 
Acetone 
(c = 0.1) RT 24 h 94% 1.6 / 1 - 
4 
p-TsOH (cat.) 
2,2-DMP (1.1 equiv) 
PPTS (cat.) 
Acetone 
(c = 0.1) RT 27 h 100% 3.3 / 1 - 
a Isolated yields of purified products. 
b Ratios were measured from the isolated separable acetals. 
 
 
Scheme 59: Acid-catalysed isomerisation of dioxane 66 into dioxolane 67. 
 
 
The isomerisation of dioxane 66 into dioxolane 67 worked better than expected and 
afforded a better ratio (1.6 to 1 in favour of the six-membered acetal) in excellent 
yield (94%). 
Results and discussion 
 
58 
Having established a better way to synthesise dioxolane 67, we could at this point 
work further on our strategy of the synthesis of (+)-altholactone (8). 
 
 
3.1.2.5 Arrangements for the oxidation/cyclisation sequence 
 
 
For our oxidation/in situ cyclisation sequence, we needed to protect the resulting free 
alcohol of 67 and, subsequently to deprotect both benzyl-protected alcohols to 
provide the expected free acyclic 1,5-diol for the cyclisation. 
 
Protection of alcohol 67 was performed with TBSOTf and 2,6-lutidine and led to the 
corresponding silyl ether 71 in 99% yield, which following double debenzylation under 
standard hydrogenation conditions gave the desired free diol 72 in 99% yield 
(Scheme 60). 
 
OBn
OH
67
OBnO
O
Ph OBn
OTBS
71
OBnO
O
Ph
OH
OTBS
72
OHO
O
Ph
TBSOTf (1.5 equiv)
2,6-lutidine (3.0 equiv)
CH2Cl2, RT
99%
H2, 10% Pd/C
EtOAc, RT
99%
 
 
Scheme 60: Arrangement of 67 for the oxidation/cyclisation sequence. 
 
 
3.1.2.6 Oxidation/in situ cyclisation sequence 
 
 
With the new acyclic 1,5-diol 72, we had a new starting material for our oxidation/in 
situ cyclisation sequence and another occasion to proof that the six-membered acetal 
of 58 was the cause of the non-cyclisation. 
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Our initial studies on the oxidation of 58 helped us to find suitable conditions for the 
cyclisation. More specifically, a sequence using IBX in DMSO followed by 
TPAP/NMO provided the expected formation of the δ-lactone. In fact, selective 
oxidation of the primary alcohol of 72 led to the corresponding aldehyde which 
cyclised in situ to provide the corresponding lactol 73. Subsequently, oxidation with 
TPAP/NMO led to the desired lactone 74. This two-step sequence afforded δ-lactone 
74 starting from diol 72 in 77% yield over 2 steps (Scheme 61). 
 
OH
OTBS
72
OHO
O
Ph IBX (2.2 equiv)
DMSO, RT
TPAP (5 mol%)
NMO (1.5 equiv)
CH2Cl2, RT
77% over two steps
O
OTBS
73
O
O
Ph
OH
O
OTBS
74
O
O
Ph
O
 
 
Scheme 61: Oxidation/in situ cyclisation sequence on diol 72. 
 
 
3.1.2.7 Dehydrogenation of δ-lactone 74 
 
 
The α,β-unsaturated δ-lactone is representative of the styryllactone class of natural 
products. In all syntheses of styryllactone natural products, only two principal ways of 
synthesis of this motif are employed. The first one is an intramolecular cyclisation of 
an enoate which provided directly the desired α,β-unsaturated δ-lactone moiety. The 
second consists of initial obtention of the δ-lactone, through different ways, and then, 
subsequent establishment of the unsaturation through a dehydrogenation reaction. 
In our synthesis, we opted for the second strategy and we had to perform a 
dehydrogenation reaction of δ-lactone 74. 
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The transformation of ketones to enones by selenenylation followed by selenoxide 
elimination was developed by Sharpless et al.,[92] Reich et al. [93] and Grieco et al.[94] 
during the seventies and provided some excellent results in giving a wide range of 
enones including α,β-unsaturated δ-lactones. 
 
We explored this reaction and different conditions for the selenenylation and 
elimination steps in order to obtain the desired α,β-unsaturated δ-lactone (Scheme 
62). 
See table below
O
OTBS
75
O
O
Ph
O
O
OTBS
74
O
O
Ph
O
 
 
Entry Conditions Solvent Temp. Time Yield 75a 
Yield
74a 
LDA (3.0 equiv) 
PhSeCl (3.0 equiv) THF 
_78°C 1+1 h 
1 
30 %H2O2 (5.0 equiv) CH2Cl2 0°C 30 min
37% 6% 
LDA (3.0 equiv) 
PhSeCl (3.0 equiv) THF 
_78°C 1+1 h 
2 
30% H2O2 (5.0 equiv) 
Py (2.2 equiv) CH2Cl2 0°C 30 min
50% 26% 
LDA (4.0 equiv) 
PhSeCl (3.0 equiv) THF 
_78°C 1+1 h 
3 30% H2O2/H2O (1:1) 
(10.0 equiv) 
Py (2.2 equiv) 
CH2Cl2 0°C 30 min
60% 31% 
a Isolated yields of purified products. 
 
 
Scheme 62: Selenenylation/elimination reaction of δ-lactone 74. 
 
 
The two-step selenenylation/elimination sequence afforded the desired α,β-
unsaturated δ-lactone 75 in 60% yield (86% corrected yield) accompanied by the 
recovery of 31% of the starting material. 
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3.1.2.8 Arrangements for the SN2 ring-closure 
 
 
In order to finish the synthesis of (+)-altholactone (8), we had to perform a SN2 ring-
closure, which would lead to the tetrahydrofurane ring. Therefore, we needed to 
transform the TBS-protected alcohol of 75 into a better leaving group and we chose 
to tosylate this alcohol in order to perform the SN2 ring-closure (Scheme 63). 
 
TBAF
THF, RT
O
OH
76
O
O
Ph
O
O
OTBS
75
O
O
Ph
O
O
OTs
77
O
O
Ph
O
74%
TsCl, DMAP
CH2Cl2, RT
95%
 
 
Scheme 63: Arrangements of the α,β-unsaturated δ-lactone 75. 
 
 
Deprotection of silyl ether 75 with TBAF led to alcohol 76 in 74% followed by 
tosylation of the new free alcohol with TsCl and DMAP[44d],[95] to give the desired 
tosylate 77 in 95% yield. 
 
 
3.1.2.9 SN2 ring-closure and synthesis of (+)-altholactone (8) 
 
 
The total synthesis of (+)-altholactone (8) would be reached through a SN2 ring-
closure reaction as the last step of the synthesis. In order to perform the nucleophilic 
substitution, we had to remove the acetonide protecting group of 77 to free the 
alcohol on C-7, which would direct the ring-closure (Scheme 64). 
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O
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93% O
Ph
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Scheme 64: Acetal cleavage and ring-closure to yield (+)-altholactone (8). 
 
 
The acetonide cleavage with Amberlyst® 15 in methanol[87] led to the desired 
styryllactone (+)-altholactone (8) in 93% yield. Removal of the acetal allowed an in 
situ SN2 ring-closure[44d] reaction, which resulted in formation of the tetrahydrofurane 
ring. 
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3.2 Asymmetric total synthesis of (+)-goniodiol (78) 
 
 
3.2.1 Presentation of the target molecule 
 
 
Studies on natural products isolated from Asian trees of the genus Goniothalamus 
have led to the discovery of several classes of compounds with interesting biological 
properties, including acetogins, alkaloids and styryllactones. For example, (+)-
goniodiol (78) (Figure 9) was isolated from petroleum ether extracts of the leaves and 
twigs of Goniothalamus sesquipedalis (Figure 9),[96] and shown to have potent and 
selective cytotoxic activity against A-549 human lung carcinoma.[97] Closely related 
derivatives have since been found in a number of other Goniothalamus species.[98] 
These interesting cytotoxic properties have encouraged several groups to synthesise 
(+)-goniodiol (78) [42j],[99] and its derivatives.[100] 
 
(+)-goniodiol (78)
O
O
Ph
OH
OH
    
 
 
Figure 9: (+)-Goniodiol (78) isolated from Goniothalamus sesquipedalis (picture). 
 
 
3.2.2 Retrosynthetic concept 
 
 
The total enantio- and diastereoselective synthesis of (+)-goniodiol (78) could be 
feasible, in a short two-step sequence, using tosylate intermediate 77 in a 
deoxygenation reaction by displacement of the tosylate group. Subsequent acetal 
removal under acidic conditions would provide the desired (+)-goniodiol (78) 
(Scheme 65). 
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Scheme 65: Strategic concept for the synthesis of (+)-goniodiol (78). 
 
 
3.2.3 Deoxygenation of the δ-lactone 77 
 
 
Therefore, we tried to deoxygenate compound 77 through displacement of its 
tosylate group using a hydride source, such as lithium triethylborohydride LiBHEt3 
(also named Super-Hydride® or Calselect®)[101] (Scheme 66). 
 
LiBHEt3
THF, 0°C
O
OTs
77
O
O
Ph
O
26%
O
OTs
79
O
O
Ph
OH
 
 
 
Scheme 66: Deoxygenation by displacement of a tosylate group. 
 
 
Displacement of the tosylate group of compound 77 was not possible due to the fact 
that our hydride source, lithium triethylborohydride LiBHEt3, was not regioselective 
enough. In fact, simultaneous reduction of the lactone moiety to the corresponding 
lactol and a hydrogenation of the lactone unsaturation occurred to provide lactol 79 in 
26% yield. The tosylate group was left untouched during the transformation of 77 into 
79. That proved that we needed another hydride source or another leaving group, 
than a tosylate group, to reach the desired deoxygenation of compound 77.
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4. Research summary 
 
In the context of this work, we studied alkylation, aldol, reduction and cyclisation 
reactions of the 1,3-diol building block named dioxanone 34. We developed an 
enantio- and diastereoselective way to the styryllactone (+)-altholactone (8) and we 
attempted to reach some other styryllactones such as (+)-goniodiol (78). 
Here follow summaries of this work. 
 
 
4.1 Asymmetric total synthesis of (+)-altholactone (8) 
 
 
4.1.1 Alkylation and aldol reaction of the RAMP-dioxanone hydrazone 
 
 
Towards the total synthesis of (+)-altholactone (8), we performed an alkylation/aldol 
reaction sequence on the RAMP-dioxanone hydrazone (R)-28 to afford the basic 
carbon skeleton of our target molecule. We tried two different protecting groups for 
the alkylation electrophile and we subjected the resulting monoalkylated dioxanone to 
a boron-mediated aldol reaction with benzaldehyde (Scheme 67). 
 
 
N
O O
(R)-28
N
OCH3
1) tBuLi, THF, -78°C
    then Br(CH2)3OR
    THF, -100°C
2) (CO2H)2, Et2O, RT
3) Cy2BCl, Et3N, Et2O
    then PhCHO, Et2O
O
O O
ORPh
OH
42 R = TBS, 52%, ee > 98%, de > 98%
50 R = Bn, 56%, ee > 98%, de > 98%
5
67
"Three-step sequence"
 
 
 
Scheme 67: Alkylation/aldol reaction sequence on RAMP-hydrazone (R)-28. 
 
 
This three-step sequence led to the expected aldol products 42 and 50 in good yields 
(52% and 56% respectively). These aldol products possess a trans acetal-protected 
1,3-diol and a trans configuration between C-6 and C-7 (see numbering above). Both 
products were obtained with excellent selectivities (ee, de > 98%, relative 
configuration confirmed by NOE and by 13C NMR assignment).[68] 
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4.1.2 Reduction of the carbonyl moiety of the aldol product 
 
 
We also conducted a study concerning the reduction of the carbonyl moiety of the 
previously synthesised aldol products 50 and 55 and it was hoped that we could 
reach a total and high control on this reduction reaction (Scheme 68). 
 
 
See table below
O
O O
OBnPh
OR OH
*
O O
OBnPh
OR
50 R = H
55 R = TBS  
 
Entry Reductive agent Solvent Temp. Time Yield
a 
 (anti : 
syn)b 
51 / 52 
1 
(R = H) 
NaBH4 
 (2.0 equiv) MeOH 
_78°C 2 h 74% 48 / 52 
2 
(R = H) 
catecholborane 
(5.0 equiv) THF 
_10°C 3 h 91% > 98 / 2 
3 
(R = H) 
L-Selectride® 
(1.5 equiv) THF 
_78°C 3 h 97% > 98 / 2 
4 
(R = H) 
Me4NBH(OAc)3 
(5.0 equiv) 
Acetic 
acid/CH3CN 
(1:1) 
_20°C 
(freezer) 24 h 63% > 1 / 99 
a Isolated yields of purified products. 
b Ratios were measured by HPLC and 1H-NMR. 
 
Entry Reductive agent Solvent Temp. Time Yield
a 
 (anti : 
syn)b 
56 / 57 
5 
(R = TBS) 
NaBH4 
 (2.0 equiv) MeOH 
_78°C → RT 3 h 100% 66 / 34 
6 
(R = TBS) 
L-Selectride® 
(1.5 equiv) THF 
_78°C 5 h 88% > 98 / 2 
a Isolated yields of purified products. 
b Ratios were measured by HPLC and 1H-NMR. 
 
 
Scheme 68: Stereoselective reduction of the aldol products 50 and 55. 
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Thus, reduction of the carbonyl moiety of the dioxanone aldol products 50 and 55 has 
been performed with very high diastereoselectivities (de > 96% confirmed by NOE, 
NMR and HPLC). For the free aldol product 50, we have now access to both cis and 
trans 1,3-diols in high selectivities. Concerning the protected aldol product 55, it 
appears more difficult to reach both 1,3-diols due to the conformation of the molecule 
but, at least, the trans 1,3-diol is reachable in high yield and with high selectivity. 
 
 
4.1.3 Oxidation/in situ cyclisation sequence 
 
 
Shing et al. performed an intramolecular DBU-catalysed cyclisation of 5-
hydroxymethyl ester compounds, which provided α,β-unsaturated δ-lactones 
containing a cis bicyclic ring junction. Unfortunately in our case, these conditions did 
not lead to the desired δ-lactone (Scheme 69), but only to the recovery of starting 
material 62 without any epimerisation. 
 
OH
O O
DBU (cat.)
THF, reflux
Ph
TBSO O
O O
Ph
TBSO
O
(+)-altholactone (8)CO2Me
62
 
 
Scheme 69: Attempt of DBU-catalysed cyclisation of 62. 
 
 
The non-regular chair conformation of the six-membered ring due to the anti-acetal 
protected 1,3-diol motif and the increased ring strain of the trans bicyclic ring junction 
may explain the failure of methyl ester 62 to provide the expected product. 
 
In fact, we tried to perform the same sequence on an acyclic 1,5-diol and the results 
were really impressive. The double oxidation sequence led directly to the 
corresponding δ-lactone 74 from the diol 72 (Scheme 70). 
 
Research summary 
 
68 
OH
OTBS
72
OHO
O
Ph
1) IBX (2.2 equiv)
    DMSO, RT
2) TPAP (5 mol%)
    NMO (1.5 equiv)
    CH2Cl2, RT
77% over two steps
O
OTBS
74
O
O
Ph
O
 
 
 
Scheme 70: Oxidation/in situ cyclisation sequence of diol 72. 
 
 
4.1.4 Stereoselective total synthesis of (+)-altholactone (8) 
 
 
(+)-Altholactone (8) is a styryllactone isolated from the Goniothalamus sp. (see 
picture, page 9) of the Annonaceae family and possesses antitumour, antibacterial 
and antifungal properties. Several total syntheses of (+)-altholactone (8) utilising the 
existing chiral pool, as well as employing stereoselective methodologies have been 
reported. The key steps that we have envisaged for our synthetic approach are 
illustrated in scheme 71. 
 
 
O
O
O
Ph
HO
(+)-altholactone (8)
lactonisation
SN2 ring-closure
aldol reaction
 
 
 
Scheme 71: Retrosynthetic plan for the total synthesis of (+)-altholactone (8). 
 
 
 
Starting from the previously reported dioxanone 34, the well-established RAMP 
auxiliary was employed to effect an asymmetric alkylation which proceeded with 
excellent stereocontrol (ee > 98%) and was subsequently removed using oxalic acid. 
A diastereoselective aldol reaction with benzaldehyde afforded 50 with excellent 
selectivity (ee > 98%, de > 98%). Protection of the secondary alcohol as the 
corresponding TBS ether, followed by diastereoselective reduction using L-
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Selectride® (de > 96%), protection of the resulting alcohol as the benzyl ether and 
deprotection of TBS protecting group yielded 66 (Scheme 72). 
 
 
O
O O
34
O
O O
50
OBnPh
OH
OBn
O O
66
OBnPh
OH O
O
O
O
OTBS
Ph
OO
O
Ph
OH
(+)-altholactone (8)
74
1) RAMP
2) Br(CH2)3OBn
3) Oxalic acid
4) Cy2BCl, Et3N
     PhCHO
50% over 4 steps
ee > 98%, de > 98%
1) TBSOTf
2) (L)-Selectride®
3) KH, BnBr
4) TBAF
68% over 4 steps
de > 96%
1) 2,2-DMP
2) TBSOTf
3) H2, Pd/C
4) IBX, DMSO
5) TPAP/NMO
72% over 5 steps
1) LDA, PhSeCl
2) H2O2, CH2Cl2
3) TBAF
4) TsCl, DMAP
5) Amb.® 15, MeOH
56% over 5 steps
 
 
 
Scheme 72: Total synthesis of (+)-altholactone (8). 
 
 
For the conversion of 66 to 67, a sequence involving a 1,2-diol selective protection 
under equilibrating conditions, TBS ether protection and simultaneous double alcohol 
deprotection under standard hydrogenation conditions was developed. The resulting 
diol was used in an oxidation/in situ cyclisation reaction using IBX. The oxidation of 
the resulting lactol with a combination of TPAP and NMO led to lactone 74. 
 
The generation of the double bond was performed with an α-selenylation/elimination 
sequence and the TBS protecting group was removed with TBAF. In order to reach 
our target molecule via an SN2 ring-closure, the free alcohol was transformed into the 
corresponding tosylate and the acetonide was removed under acidic conditions with 
Amberlyst® 15 to afford (+)-altholactone (8). 
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The furanopyrone, (+)-altholactone (8), has, thus, been reached in 18 steps (13.7% 
overall yield) from dioxanone 34 with excellent selectivities (ee > 98%, de > 98%) 
using diastereoselective alkylation and aldol chemistry, an oxidation/in situ cyclisation 
sequence, as well as an SN2 ring-closure for the key steps. 
 
 
4.2 Asymmetric total synthesis of (+)-goniodiol (78) 
 
 
(+)-Goniodiol (78) was isolated from petroleum ether extracts of the leaves and twigs 
of Goniothalamus sesquipedalis (see picture, page 63) and shown to have potent 
and selective cytotoxic activity against A-549 human lung carcinoma. 
 
It was envisaged that the total enantio- and diastereoselective synthesis of (+)-
goniodiol (78) could be achieved, in a short two-step sequence, using a 
deoxygenation reaction of the tosylate intermediate 77 by displacement of the 
tosylate group. Acetal removal under acidic conditions would provide the desired (+)-
goniodiol (78) (Scheme 73). 
 
Amberlyst® 15
MeOH, RT
(+)-goniodiol (78)
O
O
O
Ph
O
O
O
Ph
OH
OH
LiBHEt3
THF, 0°CO
OTs
77
O
O
Ph
O
 
 
 
Scheme 73: Strategic concept for the synthesis of (+)-goniodiol (78). 
 
 
The tosylate displacement on compound 77 was not possible due to the fact that our 
hydride source, namely lithium triethylborohydride LiBHEt3, was not regioselective 
enough. In fact, simultaneous reduction of the lactone moiety to the corresponding 
lactol and hydrogenation of the unsaturation of the lactone occured to provide the 
corresponding saturated lactol in 26% yield. 
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5. Outlook 
 
In the context of the total and stereoselective synthesis of other natural products from 
the styryllactone class, a lot of future work is possible in order to explore all the 
possibilities offered by the strategies developed in this report. 
 
 
5.1 Asymmetric total synthesis of (_)-altholactone (8) 
 
 
For the synthesis of (+)-altholactone (8), it was our aim to establish all stereogenic 
centres of the molecule from the first one to be created. In fact, the stereocentre 
established via the RAMP methodology, which was the second step in our strategy, 
directed the creation of the three remaining ones. 
 
So, theoretically, it would be possible to provide (_)-altholactone (8) by using the 
enantiomer of the chiral auxiliary used for the asymmetric alkylation of our synthesis. 
A simple use of the SAMP chiral auxiliary, instead of its enantiomer RAMP, would 
lead to (_)-altholactone (8) because all other stereogenic centres would be created by 
the chirality of the molecule itself (Scheme 74). 
 
 
O
O O
34
OH
O O
80
OBnPh
TBSO
OO
O
Ph
OH
(_)-altholactone (8)
1) SAMP
2) Br(CH2)3OBn
3) Oxalic acid
4) Cy2BCl, Et3N
     PhCHO
5) TBSOTf
6) (L)-Selectride®
 
 
Scheme 74: Hypothetical synthesis of (_)-altholactone (8). 
 
. 
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5.2 Asymmetric total synthesis of (+)-goniodiol (78) 
 
 
5.2.1 Strategy using a tosylate group 
 
 
The total enantio- and diastereoselective synthesis of (+)-goniodiol (78) could be 
possible, in a short 2 step sequence using a deoxygenation reaction of the tosylate 
intermediate 77 by displacement of the tosylate group. Following acetal removal 
under acidic conditions would provide the desired (+)-goniodiol (78) (Scheme 75). 
 
Amberlyst® 15
MeOH, RT
(+)-goniodiol (78)
O
O
O
Ph
O
O
O
Ph
OH
OH
LiBHEt3
THF, 0°CO
OTs
77
O
O
Ph
O
 
 
 
Scheme 75: Strategic concept for the synthesis of (+)-goniodiol (78). 
 
 
Tosylate displacement was not possible due to the fact that our hydride source, 
namely lithium triethylborohydride LiBHEt3, was not regioselective enough. In fact, 
simultaneous reduction of the lactone moiety to the corresponding lactol and 
hydrogenation of the unsaturation of the lactone occurred to provide the 
corresponding saturated lactol. 
 
A study of this displacement reaction and an investigation of a different and more 
regioselective hydride source could be conducted and lead to the total 
stereoselective of (+)-goniodiol (78). 
 
 
5.2.2 Strategy using an acetate group 
 
 
Otherwise, the synthesis of (+)-goniodiol (78) could be possible, in a short three-step 
sequence using a deacetoxylation reaction of the alcohol intermediate 76 like the one 
that Honda et al. used in their total synthesis of this natural product (Scheme 76).[102] 
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(+)-goniodiol (78)
O
O
O
O
O
O
Ph
OH
1) Ac2O, Py, DMAP
2) Zn, CuSO4.5H2O
    AcONa, AcOH
3) DBU (cat.), THF
O
OH
O
O
O
OH
90% over three steps
 
 
Scheme 76: Deacetoxylation of an α,β-unsaturated δ-lactone by Honda et al. 
 
 
Acetal removal under acidic conditions would provide the desired (+)-goniodiol (78) 
(Scheme 77). 
 
Amberlyst® 15
MeOH, RT
(+)-goniodiol (78)
O
O
O
Ph
O
O
O
Ph
OH
OHO
OH
76
O
O
Ph
O
1) Ac2O, Py, DMAP
2) Zn, CuSO4.5H2O
    AcONa, AcOH
3) DBU (cat.), THF
 
 
Scheme 77: New strategic concept for the synthesis of (+)-goniodiol (78). 
 
 
The three-step deacetoxylation sequence used by Honda et al. was really successful 
in affording the desired deoxygenated α,β-unsaturated δ-lactone (90% over 3 steps). 
Moreover their starting material for this reaction is really close to our alcohol 
intermediate 76. So, it would be highly pausible that this reaction also works well on 
alcohol 76 and provide with an efficient stereoselective pathway to (+)-goniodiol (78). 
 
 
5.3 Asymmetric total synthesis of (+)-goniotriol (27) 
 
 
A pathway to another natural product of the styryllactone class can be envisaged 
from the alcohol intermediate 76 synthesised during our synthesis of (+)-altholactone 
(8). In fact, alcohol 76 is already an acetal protected epimer of (+)-goniotriol (27). An 
inversion of the configuration of the free hydroxyl group of 76, through a Mitsunobu 
reaction, would lead to the right configuration of (+)-goniotriol (27). Acetal cleavage 
under acidic conditions would provide the desired natural product (+)-goniotriol (27). 
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For example, Vatèle et al. performed a Mitsunobu reaction in the presence of 4-
nitrobenzoic acid which provided inversion of the configuration of an hydroxyl group 
without any racemisation.[103] This reaction would fit perfectly in our strategy and give 
access to (+)-goniotriol (27) (Scheme 78). 
 
 
Amberlyst® 15
MeOH, RT
(+)-goniotriol (27)
O
O
O
Ph
O
O
O
Ph
OH
OHO
OH
76
O
O
Ph
O
1) DEAD, PPh3
    4-NO2PhCO2H
2) K2CO3
    EtOH/CH2Cl2
OH OH
81
 
 
Scheme 78: Strategic concept for the synthesis of (+)-goniotriol (27). 
 
 
General notification 
 
Naturally, both enantiomers of (+)-goniodiol (78) and (+)-goniotriol (27) could be 
available through the same synthetic strategies using the enantiomers of 
intermediates 76 and 77, which could be synthesised via the same way by use of the 
SAMP chiral auxiliary, instead of RAMP, for the asymmetric alkylation of dioxanone 
34.
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6. Experimental part 
 
6.1 General remarks about preparative work 
 
Reaction application general remarks 
 
All moisture-sensitive reactions were carried out using standard Schlenk techniques 
and under argon unless stated otherwise. For the non moisture-sensitive reactions 
the mention “no Ar” is explicitly mentioned. Except special mention, all reactions have 
been conducted on PTFE-coated magnetic stirrers. 
Used organic solvents were dried and purified by conventional methods prior to use. 
Absolute THF and Et2O were freshly distilled over sodium-lead alloy/benzophenone 
under argon. Absolute CH2Cl2 was washed with conc. H2SO4, NaHCO3, dried with 
MgSO4 and freshly distilled over calcium hydride under argon. Absolute CH3CN was 
distilled over calcium hydride under argon. Absolute methanol was distilled over 
magnesium whereas absolute ethanol was purchased from Merck. Absolute DMF 
was purchased from Acros. 
 
Reaction control 
 
Advancement of reactions was followed by glass-backed TLC plates (silica gel 60 
F254, d = 0.25 mm) with fluorescent indicator from Merck-Schuchardt. The detection 
of UV-active substances was performed under an UV-light (λ = 254 nm). All 
substances revealed spots on TLC plates by diving in a “mostain” solution (for 100 
mL of “mostain” solution: 10% H2SO4 (100 mL), Ce(IV)SO4 (30 mg), 
(NH4)6Mo7O24.4H2O (5 g)), or in a solution of molybdatophosphoric acid (5% in 
ethanol), and following heating with an heating gun. 
 
Reaction work-up general remarks 
 
Except special mention, work-up of reaction followed always the same protocol: after 
the “quench” (neutralisation) of the reaction with an aqueous reagent (generally pH 7 
buffer solution, saturated NaHCO3 solution or H2O), the reaction mixture was 
decanted in a separatory funnel in order to separate the organic layer from the 
aqueous one. The aqueous phase was extracted several times with an appropriate 
organic solvent (EtOAc, Et2O or CH2Cl2) and the organic phase was dried over a 
solid drying agent (generally MgSO4 or Na2SO4). After filtration of the dried organic 
phase through cotton (in a funnel), the liquid filtrate was concentrated under reduced 
pressure on a rotary evaporator. Finally, the crude product was directly used in the 
next step or purified through a column chromatography on silica gel or by distillation. 
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Every work-up is reaction specific, so more informations are added in each reaction 
protocol. 
 
Column chromatography 
 
Due to the specific purification problems, different glass-columns with appropriate 
diameters and lengths, with or without fritted disc, were used. In order to reach a 
good separation, a really low air overpression (max. 0.3 bar) was used to push the 
eluting solvent. For all chromatographies, silica gel 60 (particle size range 0.040-
0.063 mm) from Merck-Schuchardt was used. After isolation and purification, the 
substances were concentrated with a rotary evaporator prior to their stability under 
reduced pressure. 
 
Distillations 
 
Distillations were performed with a short-path or a kugelrohr distillation, with or 
without use of a vigreux column and reduced pressure prior to the nature and the 
quantity of substance to distillate. Boiling points were measured with a mercury filled 
thermometer adapted on the distillation apparatus and are uncorrected. 
 
Storage of the synthesised compounds 
 
All synthesised compounds were sealed under argon and stored at _24°C in a 
freezer. 
 
Special apparatus 
 
Syringe pump:  Bioblock Scientific, model A-99 
Ozone generator:  Fischer, Meckenheim, model 502 
Kugelrohr distillation: Büchi, model GKR-50 
 
Literature known substances 
 
SAMP ((S)-1-Amino-2-methoxymethylpyrrolidine) 
RAMP ((R)-1-Amino-2-methoxymethylpyrrolidine) 
Dioxanone (2,2-Dimethyl-1,3-dioxan-5-one) 34 
2,2-Dimethyl-1,3-dioxan-5-one-SAMP-hydrazone (S)-28 
2,2-Dimethyl-1,3-dioxan-5-one-RAMP-hydrazone (R)-28 
IBX (o-iodoxybenzoic acid) 
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Commercially available reagents 
 
Reagents of commercial quality were used from freshly opened containers or purified 
by common methods. n-BuLi and tert-BuLi (1.6M in hexane) were purchased from 
Merck-Schuchardt. 3-Bromopropanol was purchased from Aldrich. All other used 
reagents were commercially available or already available in the laboratories of the 
group. 
 
 
6.2 General remarks about analyses 
  
Yields 
 
Yields were calculated based on the purified products. 
 
Gas chromatography 
 
Achiral 
Apparatus: Varian CP 3800 
Column:  CP-SIL 8 (fused silica, 30 m x 0.32 mm ID) 
Mobile phase: nitrogen (0.8 bar) 
Injector temperature: 280°C 
Detector temperature: 300°C 
 
Chiral 
Apparatus:  Siemens Sichromat 3 
Column:  Lipodex G (25 m x 0.25 mm ID) 
   Mobile phase: oxygen (0.8 bar) 
Injector temperature: 220°C 
Detector temperature: 280°C 
 
The retention time of each not decomposed product will be given. To simplify, the 
result of the measurement will be presented following this form: type of column, start 
temperature, temperature gradient and final temperature (respectively in °C). 
 
HPLC 
 
Analytic 
Apparatus:  Helwett-Packard 1050 and 1100 with DAD 
Column (achiral): LiChrosorb Si 60 (7 µm) (250 mm x 4.6 mm) 
   Kromasil 100 Sil (5 µm) (250 mm x 4.6 mm) 
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Column (chiral) : Chiralpak AS (10 µm) (250 mm x 4.6 mm) 
Chiralpak OD (10 µm) (250 mm x 4.6 mm) 
Chiralpak AD (10 µm) (250 mm x 4.6 mm) 
 
Preparative 
Apparatus:  Gilson Abimed with UV (IR detector) 
Column (achiral): LiChrosorb Si 60 (7 µm) (250 mm x 25 mm) 
 
Melting points 
 
Apparatus:  Tottoli-melting point apparatus Büchi 510 
 
Melting points were determined in an opened capillary tube with a mercury filled 
thermometer adapted on the apparatus and are uncorrected. 
 
Polarimetry 
 
Apparatus:  Perkin-Elmer P241 
 
Sample concentrations are reported in g/dL. 
 
NMR spectroscopy 
 
1H NMR spectroscopy 
Apparatus: Varian Gemini 300 (300 MHz), Mercury 300 (300 MHz), Varian 
Inova 400 (400 MHz), Varian Unity 500 (500 MHz) 
 
13C NMR spectroscopy 
Apparatus: Varian Gemini 300 (75 MHz), Mercury 300 (75 MHz), Varian 
Inova 400 (100 MHz), Varian Unity 500 (125 MHz) 
 
Special techniques: 1H broad-band decoupled; J-modulated spin-echo (Waltz-16 
decoupler sequence) 
 
Spectrums have been acquired with tetramethylsilane (TMS) as internal standard. 
The coupling constants J are reported in Hertz (Hz). The signal multiplicity is reported 
as the following scheme: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet 
(not trivial signal but symmetric to the middle point). To simplify the lecture of the 
NMR spectra, the concerned H or C atom is written in italics and identified with 
neighbouring atoms. A special attention to the writing and the utilisation of brackets 
has to be observed: C(CH2)2 means the same as CH2-C-CH2 and not C-CH2-CH2 
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(which would be symbolise CCH2CH2). Except special mention, all measurements 
have been performed at room temperature. 
 
Mass spectroscopy 
 
Apparatus: MS: Varian MAT 212, Finnigan SSQ 7000 (Standard conditions: 
EI, 70 eV; CI, 100 eV) 
   HR-MS: Finnigan MAT 95 
 
Results are reported by presenting the mass of the fragments (m/z) as a proportion of 
intensity compared to the base pick (100%) in percentage. Only signals presenting a 
high intensity (≥ 10%) or characteristic signals (generally M+) are reported. 
 
IR spectroscopy 
 
Apparatus:  Perkin-Elmer 1760 FT 
 
Measurements have been performed as films (in CHCl3) or as KBr pressed pallets. 
Sample infrared absorption bands are reported in cm-1. The form and intensity of the 
bands are reported following the abbreviations: vw = very wide (0-10% 
Transmission), w = wide (11-40% T), m = medium (41-70% T), s = small (71-90% T); 
Moreover, br = broadly based. 
 
Elemental analyses 
 
Apparatus:  Heraeus CHN-O-Rapid 
 
To be accurate, a sample has to fit with a precision of ∆C,H,N ≤ 0.5%. 
 
 
6.3 Description of the experiments  
 
 
2,2-Dimethyl-5-amino-5-hydroxymethyl-1,3-dioxane (33) 
C7H15O3N, Mw = 161.20 
 
O O
H3C CH3
NH2HO
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“no Ar” 
A 2 L round-bottom flask, equipped with a magnetic stirring bar, was filled with 2-
amino-2-hydroxymethyl-1,3-propandiol hydrochloride 32 (78.0 g, 500.0 mmol, 1.0 
equiv), DMF (170 mL), 2,2-dimethoxypropane (CH3)2C(OCH3)2 (2,2-DMP) (63.8 g, 
600.0 mmol, 1.2 equiv) and camphorsulfonic acid (CSA) (4.10 g, 25.0 mmol, 0.05 
equiv). The mixture was stirred at RT for 48 h. Triethylamine Et3N (4.2 mL) was 
added followed by removal of the solvent under reduced pressure. The residue was 
dissolved in EtOAc (1.2 L) and triethylamine Et3N (67 mL) and stirred at RT for 15 
min. The precipitate (ammonium salts) was filtered and washed with EtOAc. The 
solvent was removed under reduced pressure to give 2,2-dimethyl-5-amino-5-
hydroxymethyl-1,3-dioxane 33 as a colourless solid. 
 
Yield:   m = 73.900 g 0.46 mol, 92% (from GC) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 3.82 (d, 3J(H,H) = 11.8 Hz, 2H, CHHOC(CH3)2), 3.62 (d, 3J(H,H) = 11.8 Hz, 2H, 
CHHOC(CH3)2), 3.56 (s, 2H, CH2OH), 3.48 (s, 3H, OH, NH2), 1.45 (s, 3H, C(CH3)), 
1.42 (s, 3H, C(CH3)) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 98.4 (C(CH3)2), 66.7 (2C, CH2OC(CH3)), 64.2 (CH2OH), 50.6 (CCH2), 25.0 
(C(CH3)), 22.1 (C(CH3)) ppm. 
 
All other analytical data correspond to those described in the literature.[62] 
 
 
 
2,2-Dimethyl-1,3-dioxan-5-one [dioxanone] (34) 
C6H10O3, Mw = 130.14 
 
O O
H3C CH3
O
 
 
“no Ar” 
A 2 L three necked round-bottom flask, equipped with an overhead stirrer, dropping 
funnel and thermometer was filled with 2,2-dimethyl-5-amino-5-hydroxymethyl-1,3-
dioxane 33 (50.0 g, 310.0 mmol, 1.0 equiv), H2O (450 mL). 
Monopotassiumdihydrogenophosphate KH2PO4 (42.4 g, 310.0 mmol, 1.0 equiv) was 
added and the solution was cooled to 5°C. Then, an aqueous sodium periodate 
NaIO4 solution (924 mL, 0.5 M, 1.5 equiv) was added dropwise over 3 h while the 
temperature was maintained at 5-10°C. The cooling bath was removed and the 
mixture was stirred at RT for 15 h. The aqueous solution was extracted with CH2Cl2 
(15x 70 mL). The combinated organic layers were washed with brine (70 mL), dried 
(MgSO4) and concentrated under reduced pressure. The brown crude product was 
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purified by distillation using a vigreux column to afford 2,2-dimethyl-1,3-dioxan-5-one 
34 as a colourless oil. 
 
Yield:   m = 25.300 g 0.19 mol, 63% 
 
GC:   Rf = 3.5 min  CP-Sil-8, 40-10-300 
Boiling point: 50-54°C  15 mbar 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 4.16 (s, 4H, CH2)), 1.46 (s, 6H, C(CH3)2) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 208.0 (CO), 100.1 (C(CH3)2), 66.8 (2C, CH2), 23.5 (2C, C(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 2990 (w), 2941 (m), 2891 (m), 1752 (vw), 1679 (m), 1426 (m), 1379 (w), 1326 (s), 
1235 (vw), 1153 (w), 1092 (vw), 1052 (w), 832 (w), 733 (s), 572 (s), 516 (s), 477 (m) 
cm-1. 
 
MS (EI, 70 eV): 
 
m/z [%] = 130 (63) [M+], 115 (65), 10 (67), 72 (100), 59 (17), 58 (18). 
 
Elemental Analysis: 
 
C6H10O3 (130.14): calcd C 55.37, H 7.74; found C 55.14, H 7.71. 
 
 
 
(R)-1-Amino-2-methoxymethylpyrrolidine [RAMP] 
C6H14ON2, Mw = 130.19 
 
N
NH2
OCH3
 
 
GC:   Rf = 5.1 min  CP-Sil-8, 80-4iso-10-300 
Boiling point: 62-67°C  10 mbar 
Optical rotation: αD25 = - 71.00° to -73.50° (neat) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 3.48 (d, 3J(H,H) = 5.2 Hz, 2H; CH2OCH3), 3.37 (s, 3H; OCH3), 3.26 (td, 3J(H,H) = 
6.3, 2.8 Hz, 1H; NCHH), 3.17 (s, 2H; NH2), 2.40-2.46 (m, 1H; NCH), 2.35 (q, 3J(H,H) 
= 8.8 Hz, 1H; NCHH), 1.89-1.98 (m, 1H; NCHCHHCH2), 1.71-1.80 (m, 2H; 
NCHCHHCH2, NCH2CHH), 1.51-1.60 (m, 1H; NCH2CHH) ppm. 
Experimental part 
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13C NMR (100 MHz, CDCl3): 
 
δ = 75.7 (CH2OCH3), 68.2 (NCH), 60.1 (NCH2), 59.1 (OCH3), 26.3 (NCHCH2CH2), 
20.9 (NCH2CH2) ppm. 
 
All other analytical data correspond to those described in the literature.[104] 
 
 
 
(R)-(_)-1-(2,2-Dimethyl-1,3-dioxan-5-ylidenamino)-2-methoxy-methylpyrrolidine 
(28) 
C12H22O3N2, Mw = 242.31 
 
O O
H3C CH3
NN
OCH3
 
 
“no Ar” 
In a flask equipped with a Dean-Stark trap (for azeotropic removal of H2O) and a 
reflux condenser, dioxanone 34 (8.452 g, 65.0 mmol, 1.0 equiv) and (R)-1-amino-2-
methoxymethylpyrrolidine (RAMP) (8.480 g, 65.0 mmol, 1.0 equiv) in benzene (80 
mL) were refluxed for 20 h. After cooling, Et2O (200 mL) was added and the mixture 
was washed with H2O (2x 10 mL). The organic layer was dried (MgSO4) and the 
solvent was removed under reduced pressure. The crude hydrazone was purified by 
distillation under reduced pressure to give (R)-28 as a yellow oil. 
 
Yield:   m = 14.163 g 58.60 mmol, 90% 
 
GC:   Rf = 8.1 min  CP-Sil-8, 100-10-300 
Boiling point: 106-109 °C  1 mbar 
Optical rotation: αD23 = - 230.00° (neat) and [α]D23 = - 307.74 (c = 1.01 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 4.21-4.58 (m, 4H; CH2CN), 3.35 (s, 3H; OCH3), 3.04-3.46 (m, 4H; NCHH, NCH, 
CH2OCH3), 2.50 (q, 3J(H,H) = 8.5 Hz, 1H; NCHH), 1.93-2.06 (m, 1H; NCHCHHCH2), 
1.80-1.89 (m, 2H; NCH2CHH, NCHCHHCH2), 1.60-1.71 (m, 1H; NCH2CHH), 1.43 (s, 
3H; C(CH3)), 1.40 (s, 3H; C(CH3)) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 160.0 (CN), 99.9 (C(CH3)2), 75.4 (CH2OCH3), 66.6 (NCH), 62.6, 60.3, (2C, 
CH2CN), 59.2 (OCH3), 55.4 (NCH2), 26.7 (NHCHCH2CH2), 24.5 (C(CH3)), 23.2 
(C(CH3)), 22.7 (NCH2CH2) ppm. 
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IR (CHCl3): 
 
ν = 2982 (w), 2937 (w), 2874 (w), 1668 (s), 1451 (w), 1376 (w), 1341 (s), 1221 (vw), 
1150 (w), 1094 (vw), 1068 (vw), 971 (s), 912 (s), 836 (w), 516 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 244 (15), 243 (100) [M++H], 242 (19), 211 (8), 197 (19), 185 (52). 
 
MS (EI, 70 eV): 
 
m/z [%] = 242 (1.5) [M+], 139 (43), 98 (60), 70 (100), 43 (30). 
 
Elemental Analysis: 
 
C12H22N2O3 (242.31): calcd C 59.48, H 9.15, N 11.56; found C 59.47, H 9.36, N 
11.34. 
 
 
 
2,2-Dimethyl-1,3-dioxan-5-on-N,N-dimethyl-hydrazone (35) 
C8H16O2N2, Mw = 172.22 
 
O O
H3C CH3
NN
CH3
H3C
 
 
“no Ar” 
In a flask equipped with a Dean-Stark trap (for azeotropic removal of H2O) and a 
reflux condenser, dioxanone 34 (4.80 g, 36.5 mmol, 1.0 equiv) and N,N-
dimethylhydrazine NH2N(CH3)2 (6.0 mL, 70.0 mmol, 2.0 equiv) in benzene (70 mL) 
were refluxed for 5 h. After cooling, the solvent was removed under reduced 
pressure. The remaining brown oil was dissolved in Et2O, dried (MgSO4) and 
concentrated under reduced pressure. The crude hydrazone was purified by 
distillation under reduced pressure to give 35 as a yellow oil. 
 
Yield:   m = 5.520 g  32.00 mmol, 88% 
 
GC:   Rf = 4.4 min  CP-Sil-8, 80-10-300 
Boiling point: 63-65°C  4 mbar 
 
1H NMR (300 MHz, CDCl3): 
δ = 4.53 (t, 3J(H,H) = 0.8 Hz, 2H; CH2), 4.28 (t, 3J(H,H) = 0.8 Hz,  2H; CH2), 2.44 (s, 
6H; N(CH3)2), 1.42 (s, 6H; C(CH3)2) ppm. 
 
 
Experimental part 
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13C NMR (75 MHz, CDCl3): 
 
δ = 165.3 (C=N), 100.2 (C(CH3)2), 62.4 (CH2), 59.4 (CH2), 47.5 (2C, N(CH3)2), 23.8 
(2C, C(CH3)2) ppm. 
 
All other analytical data correspond to those described in the literature.[105] 
 
 
 
(R)-(+)-Ethyl-3-(2,2-dimethyl-5-oxo-1,3-dioxan-4-yl)propanoate (36) 
C11H18O5, Mw = 230.26 
 
O O
H3C CH3
O
O
O
 
 
Michael addition procedure: 
 
A dry, argon flushed, 100 mL Schlenk round-bottom flask, equipped with a magnetic 
stirring bar, was filled with RAMP-hydrazone (R)-28 (731 mg, 3.0 mmol, 1.0 equiv) 
and anhydrous Et2O (15 mL). Then, tBuLi (2.1 mL, 15% in n-pentane, 3.3 mmol, 1.1 
equiv) was added dropwise by syringe at _78°C. After stirring for 2 h at this 
temperature, the mixture was cooled to _100°C and ethyl acrylate CH2=CHCO2Et 
(0.43 mL, 3.9 mmol, 1.3 equiv) was added slowly. After further stirring for 2 h at 
_100°C, the mixture was allowed to warm up to RT over 15 h. The mixture was 
quenched with pH 7 buffer solution (3 mL) and diluted with Et2O (15 mL). The organic 
layer was washed with pH 7 buffer solution (10 mL) and brine (2x 10 mL). The 
combinated organic layers were dried (MgSO4) and concentrated under reduced 
pressure. A solution of the resulting crude hydrazone and Sudan red in CH2Cl2 (15 
mL) was ozonolysed at _78°C until an excess of ozone as a decolouration from red to 
blue was observed. This excess of ozone was removed by bubbling the solution with 
argon and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography on silica gel (n-pentane/Et2O 80:20) to afford (R)-36 
as a colourless liquid. 
 
Yield:   m = 55 mg  0.20 mmol, 8% (over 2 steps) 
ee:   86% (GC on chiral stationary phase) 
 
Alkylation procedure: 
 
A dry, argon flushed, 100 mL Schlenk round-bottom flask, equipped with a magnetic 
stirring bar, was filled with RAMP-hydrazone (R)-28 (2.421 g, 10.0 mmol, 1.0 equiv) 
and anhydrous THF (40 mL). Then, tBuLi (7.5 mL, 15% in n-pentane, 11.0 mmol, 1.1 
equiv) was added dropwise by syringe at _78°C. After stirring for 2 h at this 
temperature, the mixture was cooled to _100°C and freshly distilled ethyl-3-
bromopropionate Br(CH2)2CO2Et (1.4 mL, 11.0 mmol, 1.1 equiv), dissolved in 
anhydrous THF (2 mL) was added slowly. After further stirring for 2 h at _100°C, the 
mixture was allowed to warm up to RT over 15 h. The mixture was quenched with pH 
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7 buffer solution (3 mL) and diluted with Et2O (80 mL). The organic layer was washed 
with pH 7 buffer solution (10 mL) and brine (2x 10 mL). The combinated organic 
layers were dried (MgSO4) and concentrated under reduced pressure. A solution of 
the resulting crude hydrazone and Sudan red in CH2Cl2 (50 mL) was ozonolysed at 
_78°C until an excess of ozone as a decolouration from red to blue was observed. 
This excess of ozone was removed by bubbling the solution with argon and the 
solvent was removed under reduced pressure. The crude product was purified by 
flash chromatography on silica gel (n-pentane/Et2O 80:20) to afford (R)-36 as a 
colourless liquid. 
 
Yield:   m = 399 mg  1.70 mmol, 17% (over 2 steps) 
ee:   95% (GC on chiral stationary phase) 
 
GC:   Rf = 8.5 min  CP-Sil-8, 80-10-300 
Optical rotation: [α]D25 = + 208.76 (c = 1.13 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 4.32 (ddd, 3J(H,H) = 8.7, 4.0, 1.5 Hz, 1H; CH), 4.26 (dd, 3J(H,H) = 17.1, 1.5 Hz, 
1H; OCHH), 4.13 (q, 3J(H,H) = 7.2 Hz, 2H; OCH2CH3), 4.00 (d, 3J(H,H) = 17.1, 1H; 
OCHH),  2.44 (t, 3J(H,H) = 7.3 Hz, 2H; CHCH2CH2), 2.17-2.28 (m, 1H; CHCHHCH2), 
1.80-1.92 (m, 1H; CHCHHCH2), 1.44 (s, 3H; C(CH3)), 1.42 (s, 3H; C(CH3)), 1.26 (t, 
3J(H,H) = 7.2 Hz, 3H; OCH2CH3) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 209.1 (CO), 173.0 (C(O)OCH2CH3), 100.9 (C(CH3)2), 73.3 (CH), 66.6 (OCH2), 
60.5 (OCH2CH3), 29.6 (CHCH2CH2), 23.8 (2C, C(CH3)2), 23.6 (CHCH2CH2), 14.3 
(OCH2CH3) ppm. 
 
IR (CHCl3): 
 
ν = 3781 (s), 3475 (w), 2983 (m), 2939 (m), 2392 (m), 2289 (m), 1728 (vw), 1418 (m), 
1381 (m), 1176 (w), 1092 (m), 1028 (m), 860 (s), 626 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 231 (2) [M++H], 229 (5), 213 (21), 185 (11), 173 (91), 172 (13), 155 (19), 
145 (82), 129 (16), 127 (100), 101 (17). 
 
MS (EI, 70 eV): 
 
m/z [%] = 215 (2) [M+-CH3], 185 (23), 172 (30), 145 (20), 131 (31), 129 (53), 127 
(22), 126 (22), 114 (21), 102 (31), 101 (85), 99 (11), 86 (12), 85 (100), 74 (14), 73 
(25), 72 (59), 59 (12), 57 (17), 55 (24). 
 
Elemental Analysis: 
 
C11H18O5 (230.26): calcd C 57.38, H 7.88; found C 57.79, H 7.92. 
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(R,R)-4-(3-Butenyl)-2,2-dimethyl-1,3-dioxan-5-on-RAMP-hydrazone (37) 
C16H28O3N2, Mw = 296.41 
 
O O
H3C CH3
NN
OCH3
 
 
Yield:   Not measured (crude product directly used in the next step) 
de:   > 98% (1H NMR, 13C NMR, GC) 
 
GC:   Rf = 7.5 min  CP-Sil-8, 140-10-300 
Optical rotation: [α]D25 = - 122.70 (c = 6.60 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 5.77-5.92 (m, 1H; CH2CH2CH=CH2), 4.93-5.10 (m, 2H; CH2CH2CH=CH2), 4.52 
(d, 3J(H,H) = 7.7 Hz, 1H; CH), 4.44 (d, 3J(H,H) = 12.6 Hz, 1H; CHHO), 3.93 (d, 
3J(H,H) = 12.6 Hz, 1H; CHHO), 3.15-3.50 (m, 4H; NCH, NCHH, CH2OCH3), 3.31 (s, 
3H; OCH3), 2.48 (m, 1H; NCHH), 1.60-2.20 (m, 8H; CH2CH2CH=CH2, 
CH2CH2CH=CH2, NCH2CH2, NCH2CH2CH2), 1.39 (s, 3H; C(CH3)), 1.36 (s, 3H; 
C(CH3))  ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 160.8 (C=N), 138.1 (CH2CH=CH2), 114.9 (CH2CH=CH2), 99.7 (C(CH3)2), 75.8 
(CH2OCH3), 70.4 (CH), 66.6 (CHCH2OCH3), 63.8 (CH2O), 59.0 (OCH3), 53.4 (NCH2), 
29.2 (CH2CH=CH2), 27.3 (CHCH2CH2), 26.9 (NCH2CH2CH2), 26.7 (C(CH3)), 24.2 
(C(CH3)), 22.8 (NCH2CH2) ppm. 
 
IR (CHCl3): 
 
ν = 3076 (m), 2982 (w), 2925 (w), 2879 (vw), 2830 (w), 1641 (m), 1449 (w), 1380 (w), 
1372 (w), 1338 (w), 1280 (m), 1227 (w), 1158 (w), 1098 (w), 1057 (w), 1026 (w), 996 
(m), 972 (m), 913 (m) cm-1. 
 
MS (CI, isobutane): 
 
m/z [%] = 297 (100) [M++H], 296 (3), 239 (4), 114 (5). 
 
Elemental Analysis: 
 
C16H28N2O3 (296.40): calcd C 64.83, H 9.52, N 9.45; found C 64.50, H 9.64, N 9.91. 
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(R)-(+)-4-(3-Butenyl)-2,2-dimethyl-1,3-dioxan-5-one (38) 
C10H16O3, Mw = 184.23 
 
O O
H3C CH3
O
 
 
A dry, argon flushed, 100 mL Schlenk round-bottom flask, equipped with a magnetic 
stirring bar, was filled with RAMP-hydrazone (R)-28 (1.294 g, 5.3 mmol, 1.0 equiv) 
and anhydrous THF (20 mL). Then, tBuLi (4.0 mL, 15% in n-pentane, 5.9 mmol, 1.1 
equiv) was added dropwise by syringe at _78°C. After stirring for 2 h at this 
temperature, the mixture was cooled to _100°C and 4-bromobut-1-ene 
Br(CH2)2CH=CH2 (0.7 mL, 6.9 mmol, 1.3 equiv), dissolved in anhydrous THF (2 mL) 
was added slowly. After further stirring for 2 h at _100°C, the mixture was allowed to 
warm up to RT over 15 h. The mixture was quenched with pH 7 buffer solution (2 mL) 
and diluted with Et2O (20 mL). The organic layer was washed with pH 7 buffer 
solution (10 mL) and brine (2x 10 mL). The combinated organic layers were dried 
(MgSO4) and concentrated under reduced pressure. A solution of the resulting crude 
hydrazone in Et2O (50 mL) was vigorously stirred at RT with a saturated aqueous 
solution of oxalic acid (CO2H)2 (20 mL) over 6 h (TLC control). The aqueous layer 
was separated, extracted with Et2O and the organic extracts were combined, washed 
with brine (10 mL), dried (MgSO4) and concentrated under reduced pressure. The 
crude product was purified by flash chromatography on silica gel (n-pentane/Et2O 
90:10) to afford (R)-38 as a colourless liquid. 
 
Yield:   m = 633 mg  3.40 mmol, 64% (over 2 steps) 
ee:   94% (GC on chiral stationary phase) 
 
GC:   Rf = 4.8 min  CP-Sil-8, 80-10-300 
Optical rotation: [α]D25 = + 257.18 (c = 1.02 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 5.73-5.84 (m, 1H; CH2CH2CH=CH2), 5.06 (dq, 3J(H,H) = 17.3, 1.7 Hz, 1H; 
CH2CH2CH=CHH), 5.00 (m, 1H; CH2CH2CH=CHH), 4.26 (dd, 3J(H,H) = 16.9, 1.4 Hz, 
1H; CHHO), 4.24 (m, 1H; CH), 3.98 (d, 3J(H,H) = 16.9 Hz, 1H; CHHO), 2.10-2.28 (m, 
2H; CH2CH2CH=CH2), 1.92-2.02 (m, 1H; CHHCH2CH=CH2), 1.59-1.69 (m, 1H; 
CHHCH2CH=CH2), 1.45 (s, 3H; C(CH3)), 1.44 (s, 3H; C(CH3))  ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 209.5 (CO), 137.3 (CH2CH=CH2), 115.4 (CH2CH=CH2), 100.7 (C(CH3)2), 73.5 
(CH), 66.5 (CH2O), 29.0 (CH2CH=CH2), 27.4 (CHCH2CH2), 23.9 (C(CH3)), 23.7 
(C(CH3)) ppm. 
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IR (CHCl3): 
 
ν = 3078 (s), 2988 (w), 2937 (m), 2884 (m), 1748 (vw), 1641 (m), 1433 (m), 1377 (w), 
1327 (s), 1250 (w), 1225 (vw), 1175 (w), 1103 (w), 1072 (m), 1017 (s), 995 (m), 916 
(w), 864 (w), 781 (s), 637 (s), 603 (s), 538 (m) cm-1. 
 
MS (CI, isobutane): 
 
m/z [%] = 185 (32) [M++H], 128 (6), 127 (100), 109 (5), 82 (3). 
 
MS (EI, 70 eV): 
 
m/z [%] = 184 (7) [M+], 98 (24), 83 (11), 74 (19), 73 (12), 72 (100), 67 (20), 59 (60), 
55 (32), 45 (23). 
 
Elemental Analysis: 
 
C10H16O3 (184.23): calcd C 65.19, H 8.75; found C 65.45, H 8.86. 
 
 
 
3-Bromo-1-tert-butyldimethylsilyloxypropane (39) 
C9H21OSiBr, Mw = 253.25 
 
Br O Si
 
 
“no Ar” 
To a stirred solution of 3-bromopropanol Br(CH2)3OH (10.005 g, 72.0 mmol, 1.0 
equiv) and a catalytic amount of 4-dimethylaminopyridine (DMAP) in CH2Cl2 (250 
mL) at RT was added triethylamine Et3N (8.597 g, 85.0 mmol, 1.2 equiv) and tert-
butyldimethylsilylchloride TBSCl (13.897 g, 105.9 mmol, 1.5 equiv). Stirring was 
continued for 18 h at RT before the mixture was quenched with aqueous NH4Cl 
solution (160 mL) and extracted with CH2Cl2 (200 mL). The aqueous portion was 
diluted with H2O (100 mL) and extracted with Et2O (3x 100 mL). The combined 
organic extracts were washed with brine (100 mL), dried (MgSO4), filtered and 
concentrated under reduced pressure to give the crude product as a yellow liquid. 
The crude electrophile was purified by distillation under reduced pressure to give the 
TBS-protected 39 as a colourless oil. 
 
Yield:   m = 16.818 g 66.41 mmol, 92% 
 
GC:   Rf = 5.3 min  CP-Sil-8, 80-10-300 
Boiling point: 63°C   5 mbar 
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1H NMR (300 MHz, CDCl3): 
 
δ = 3.74 (t, 3J(H,H) = 5.8 Hz, 2H; CH2O), 3.52 (t, 3J(H,H) = 6.3 Hz, 2H; CH2Br), 2.03 
(tt, 3J(H,H) = 6.3, 5.8 Hz, 2H; CH2CH2CH2), 0.90 (s, 9H; C(CH3)3), 0.07 (s, 6H; 
Si(CH3)2)ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 60.4 (CH2O), 35.5 (CH2Br), 30.7 (CH2CH2CH2), 25.9 (3C, C(CH3)3), 18.3 
(C(CH3)3), -5.4 (2C, Si(CH3)2) ppm. 
 
All other analytical data correspond to those described in the literature.[106] 
 
 
 
(R,R)-4-[3-(tert-Butyldimethylsilyloxy)propyl]-2,2-dimethyl-1,3-dioxan-5-on-
RAMP-hydrazone (40) 
C21H42O4N2Si, Mw = 214.65 
 
NN
OCH3
O O
H3C CH3
O Si
 
 
Yield:   Not measured (crude product directly used in the next step) 
de:   > 96% (1H NMR, 13C NMR, GC) 
 
GC:   Rf = 16.1 min  CP-Sil-8, 100-10-300 
Optical rotation: [α]D25 = - 98.80 (c = 2.50 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 4.49 (d, 3J(H,H) = 15.4 Hz, 1H; OCHH), 4.34 (m, 1H; CH), 4.12 (dd, 3J(H,H) = 
15.4, 2.0 Hz, 1H; OCHH),  3.64 (t, 3J(H,H) = 6.7 Hz, 2H; CH2OSi), 3.42 (dd, 3J(H,H) = 
8.7, 3.7 Hz, 1H; CHHOCH3), 3.35 (s, 3H; OCH3), 3.22-3.35 (m, 1H; NCH), 3.21 (dd, 
3J(H,H) = 8.7, 7.1 Hz, 1H; CHHOCH3), 3.05 (m, 1H; NCHH), 2.40 (d, 3J(H,H) = 8.5 
Hz, 1H; NCHH), 1.40-2.02 (m, 8H; CHCH2CH2, CHCH2CH2, NCH2CH2, 
NCH2CH2CH2), 1.39 (s, 6H; C(CH3)2), 0.89 (s, 9H; SiC(CH3)3), 0.05 (s, 6H; Si(CH3)2) 
ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 162.4 (C=N), 100.2 (C(CH3)2), 75.7 (CH2OCH3), 70.7 (CH), 66.8 (CHCH2OCH3), 
63.4 (OCH2), 59.9 (CH2OSi), 59.3 (OCH3), 55.6 (NCH2), 28.7 (CHCH2CH2), 28.4 
(CHCH2CH2), 26.9 (NCH2CH2CH2), 26.1 (3C, SiC(CH3)3), 24.4 (C(CH3)), 24.1 
(C(CH3)), 22.9 (NCH2CH2), 18.5 (SiC(CH3)3), -5.1 (2C, Si(CH3)2) ppm. 
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IR (CHCl3): 
 
ν = 2983 (w), 2955 (w), 2857 (w), 1472 (m), 1462 (m), 1447 (m), 1380 (w), 1372 (w), 
1255 (w), 1226 (w), 1200 (m), 1162 (m), 1101 (w), 1069 (w), 1015 (m), 836 (w) cm-1. 
 
MS (EI, 70 eV): 
 
m/z [%] = 414 (5) [M+], 361 (55), 356 (44), 311 (70), 178 (19), 154 (14), 144 (19), 128 
(8), 114 (17), 98 (11), 75 (33), 70 (62), 59 (6), 57 (7), 56 (6). 
 
Elemental Analysis: 
 
C21H42N2O4Si (414.66): calcd C 60.82, H 10.21, N 6.75; found C 60.82, H 9.73, N 
6.43. 
 
 
 
(R)-(+)-4-[3-(tert-Butyldimethylsilyloxy)propyl]-2,2-dimethyl-1,3-dioxan-5-one 
(41) 
C15H30O4Si, Mw = 302.48 
 
O O
H3C CH3
O
O Si
 
 
A dry, argon flushed, 250 mL Schlenk round-bottom flask, equipped with a magnetic 
stirring bar, was filled with RAMP-hydrazone (R)-28 (3.244 g, 13.4 mmol, 1.0 equiv) 
and anhydrous THF (54 mL). Then, tBuLi (10.0 mL, 15% in n-pentane, 14.7 mmol, 
1.1 equiv) was added dropwise by syringe at _78°C. After stirring for 2 h at this 
temperature, the mixture was cooled to _100°C and 3-bromo-1-
butyldimethylsilyloxypropane 39 (3.730 g, 14.7 mmol, 1.1 equiv), dissolved in 
anhydrous THF (5 mL) was added slowly. After further stirring for 2 h at _100°C, the 
mixture was allowed to warm up to RT over 15 h. The mixture was quenched with pH 
7 buffer solution (3 mL) and diluted with Et2O (100 mL). The organic layer was 
washed with pH 7 buffer solution (15 mL) and brine (2x 15 mL). The combinated 
organic layers were dried (MgSO4) and concentrated under reduced pressure. A 
solution of the resulting crude hydrazone in Et2O (130 mL) was vigorously stirred at 
RT with a saturated aqueous solution of oxalic acid (CO2H)2 (100 mL) over 15 h (TLC 
control). The aqueous layer was separated, extracted with Et2O and the organic 
extracts were combined, washed with brine (40 mL), dried (MgSO4) and concentrated 
under reduced pressure. The crude product was purified by flash chromatography on 
silica gel (n-pentane/Et2O 90:10) to afford (R)-41 as a colourless liquid. 
 
Yield:   m = 3.277 g  10.80 mmol, 81% (over 2 steps) 
ee:   > 98% (GC on chiral stationary phase) 
 
GC:   Rf = 11.0 min CP-Sil-8, 80-10-300 
Optical rotation: [α]D25 = + 127.40 (c = 2.10 in CHCl3) 
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1H NMR (400 MHz, CDCl3): 
 
δ = 4.23-4.28 (m, 1H; CH), 4.25 (d, 3J(H,H) = 17.3 Hz, 1H; OCHH), 3.98 (d, 3J(H,H) = 
17.3, 1H; OCHH),  3.61-3.66 (td, 3J(H,H) = 6.3, 2.2 Hz, 2H; CH2OSi), 1.91-1.98 (m, 
1H; CHCHHCH2), 1.52-1.71 (m, 3H; CHCHHCH2, CHCH2CH2), 1.46 (s, 3H; C(CH3)), 
1.43 (s, 3H; C(CH3)), 0.89 (s, 9H; SiC(CH3)3), 0.00 (s, 6H; Si(CH3)2) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 209.2 (CO), 100.6 (C(CH3)2), 74.4 (CH), 66.5 (OCH2), 62.7 (CH2OSi), 28.3 
(CHCH2CH2), 25.9 (3C, SiC(CH3)3), 25.0 (CHCH2CH2), 24.0 (C(CH3)), 23.6 (C(CH3)), 
18.3 (SiC(CH3)3), -5.3 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 2988 (w), 2955 (w), 2931 (vw), 2866 (w), 2858 (w), 1804 (m), 1748 (m), 1715 
(vw), 1472 (m), 1464 (m), 1445 (m), 1383 (m), 1362 (m), 1256 (vw), 1225 (w), 1102 
(vw), 837 (vw), 778 (w) cm-1. 
 
MS (EI, 70 eV): 
 
m/z [%] = 245 (3) [M+-(CH3)2CO], 187 (30), 145 (25), 143 (10), 103 (11), 101 (28), 75 
(100), 59 (15). 
 
Elemental Analysis: 
 
C15H30O4Si (302.49): calcd C 59.56, H 9.99; found C 59.59, H 10.10. 
 
 
 
(4R,6R)-(+)-4-[3-(tert-Butyldimethylsilyloxy)propyl]-6-[(R)-
hydroxy(phenyl)methyl]-2,2-dimethyl-1,3-dioxan-5-one (42) 
C22H36O5Si, Mw = 408.60 
 
O O
H3C CH3
O
O Si
OH
 
 
To a stirred solution of dicyclopentylborane chloride Cy2BCl (16.0 mL, 15.9 mmol, 1.5 
equiv) in Et2O (212 mL), at _78°C, was added triethylamine Et3N (2.5 mL, 18.0 mmol, 
1.7 equiv) via syringe followed, 10 min later, by a solution of ketone 41 (3.208 g, 3.2 
mmol, 1.0 equiv) in Et2O (25 mL), via syringe. Stirring was continued for a further 30 
min at _78°C, before the mixture was warmed up to 0°C for 1 h. The resulting 
suspension was recooled to _78°C before a solution of freshly distilled benzaldehyde 
PhCHO (1.62 mL, 15.9 mmol, 1.5 equiv) in Et2O (35 mL) was added dropwise via 
syringe. The stirring was continued for 1 h at _78°C before the flask was sealed and 
placed in a freezer (_24°C) for 20 h. The mixture was quenched with pH 7 buffer 
solution (80 mL) and extracted with Et2O (140 mL). The combined organic extracts 
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were concentrated under reduced pressure, taken up in pH 7 buffer solution (81 mL) 
and MeOH (64 mL) and cooled to 0°C before aqueous hydrogen peroxide H2O2 (32 
mL, 30%, 0.03 equiv) was added dropwise. The mixture was warmed up to RT for 2 
h, poured into pH 7 buffer solution (70 mL) and extracted with CH2Cl2 (300 mL). The 
combined organic extracts were dried (Na2SO4), filtered and concentrated under 
reduced pressure. The crude product was purified by flash chromatography on silica 
gel (n-pentane/Et2O 70:30) to afford aldol product 42 as a pale yellow oil 
contaminated by a trace of benzaldehyde. 
 
Yield:   m = 2.771 g  6.78 mmol, 64% 
de:   > 98% (1H NMR, 13C NMR) 
 
GC:   Decomposition 
Optical rotation: [α]D24 = + 35.18 (c = 1.00 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 7.26-7.40 (m, 5H; Ar-H), 4.88 (dd, 3J(H,H) = 7.4, 2.7 Hz, 1H; PhCH(OH)), 4.29 
(dd, 3J(H,H) = 7.4, 1.5 Hz, 1H; C(O)CHCH(OH)), 4.15 (ddd, 3J(H,H) = 7.9, 4.0, 1.5 
Hz, 1H; CHCH2), 3.65 (d, 3J(H,H) = 3.0 Hz, 1H; OH), 3.50 (td, 3J(H,H) = 6.4, 1.5 Hz, 
2H; CH2OSi), 1.88-1.98 (m, 1H; CHCHHCH2), 1.54-1.68 (m, 3H; CHCHHCH2, 
CHCH2CH2), 1.36 (s, 3H; C(CH3)), 1.23 (s, 3H; C(CH3)), 0.89 (s, 9H; SiC(CH3)3), 0.04 
(s, 6H; Si(CH3)2) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 212.9 (CO), 139.5 (Ar-C), 128.0, 128.0, 127.1 (5C, Ar-CH), 101.4 (C(CH3)2), 75.8 
(PhCH(OH)), 74.5 (CHCH2), 72.8 (C(O)CHCH(OH)), 62.7 (CH2CH2CH2), 28.3 
(CHCH2), 26.0 (3C, SiC(CH3)3), 25.4 (CH2CH2CH2), 23.7 (C(CH3)), 23.6 (C(CH3)), 
18.4 (SiC(CH3)3), -5.3 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3440 (m), 3065 (m), 2954 (vw), 2932 (vw), 2888 (w), 2858 (vw), 1793 (m), 1459 
(w), 1383 (w), 1255 (vw), 1203 (w), 1101 (vw), 1053 (w), 837 (vw) cm-1. 
 
MS (EI, 70 eV): 
 
m/z [%] = 390 (0.1) [M+-H2O], 281 (10), 187 (100) [M+-PhCHO -TBS], 169 (20), 143 
(25), 75 (41). 
 
Elemental Analysis: 
 
C22H36O5Si (408.60): calcd C 64.66, H 8.88; found C 65.16, H 8.88. 
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(4R,6R)-(+)-4-[3-(tert-Butyldimethylsilyloxy)propyl]-6-[(S)-
hydroxy(phenyl)methyl]-2,2-dimethyl-1,3-dioxan-5-one (43) 
C22H36O5Si, Mw = 408.60 
 
O O
H3C CH3
O
O Si
OH
 
 
A dry, argon flushed, 100 mL Schlenk round-bottom flask, equipped with a magnetic 
stirring bar, was filled with RAMP-hydrazone 40 (325 mg, 0.78 mmol, 1.0 equiv) and 
anhydrous THF (20 mL). Then, tBuLi (580 µL, 15% in n-pentane, 0.86 mmol, 1.1 
equiv) was added dropwise by syringe at _78°C. After stirring for 2 h at this 
temperature, the mixture was cooled to _100°C and freshly distilled benzaldehyde 
PhCHO (120 µL, 1.18 mmol, 1.5 equiv), dissolved in anhydrous THF (4 mL) was 
added slowly. After further stirring for 2 h at _100°C, the mixture was allowed to warm 
up to RT for 15 h. The mixture was quenched with pH 7 buffer solution (6 mL) and 
diluted with Et2O (10 mL). The organic layer was washed with pH 7 buffer solution 
(10 mL) and brine (2x 10 mL). The combinated organic layers were dried (MgSO4) 
and concentrated under reduced pressure. A solution of the resulting crude 
hydrazone and Sudan red in CH2Cl2 (25 mL) was ozonolysed at _78°C until an 
excess of ozone as a decolouration from red to blue was observed. This excess of 
ozone was removed by bubbling the solution with argon and the solvent was under 
reduced pressure. The crude product was purified by flash chromatography on silica 
gel (n-pentane/Et2O 70:30) to afford aldol product 43 as a pale yellow oil. 
 
Yield:   m = 175 mg  0.43 mmol, 61% 
de:   > 98% (1H NMR, 13C NMR) 
 
GC:   Decomposition 
Optical rotation: [α]D24 = + 169.86 (c = 1.25 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 7.27-7.42 (m, 5H; Ar-H), 5.21 (dd, 3J(H,H) = 8.2, 2.7 Hz, 1H; PhCH(OH)), 4.40 
(dd, 3J(H,H) = 2.7, 1.2 Hz, 1H; C(O)CHCH(OH)), 4.19 (ddd, 3J(H,H) = 8.4, 4.1, 1.2 
Hz, 1H; CHCH2), 2.90 (d, 3J(H,H) = 7.9 Hz, 1H; OH), 3.62 (td, 3J(H,H) = 6.4, 1.5 Hz, 
2H; CH2OSi), 1.90-1.99 (m, 1H; CHCHHCH2), 1.50-1.72 (m, 3H; CHCHHCH2, 
CHCH2CH2), 1.47 (s, 3H; C(CH3)), 1.32 (s, 3H; C(CH3)), 0.89 (s, 9H; SiC(CH3)3), 0.04 
(s, 6H; Si(CH3)2) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 209.2 (CO), 140.5 (Ar-C), 128.2, 127.7, 126.4 (5C, Ar-CH), 101.4 (C(CH3)2), 77.5 
(PhCH(OH)), 74.6 (CHCH2), 71.4 (C(O)CHCH(OH)), 62.8 (CH2CH2CH2), 28.3 
(CHCH2), 26.0 (3C, SiC(CH3)3), 24.9 (CH2CH2CH2), 24.0 (C(CH3)), 23.9 (C(CH3)), 
18.3 (SiC(CH3)3), -5.3 (2C, Si(CH3)2) ppm. 
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IR (CHCl3): 
 
ν = 3990 (s), 3471 (m), 3065 (s), 2989 (w), 2933 (vw), 2859 (vw), 1746 (vw), 1497 
(s), 1466 (m), 1382 (w), 1253 (w), 1225 (w), 1171 (w), 1099 (vw), 1053 (w), 1005 (s), 
973 (s), 946 (s), 902 (s), 838 (vw), 759 (vw), 701 (w), 666 (m), 591 (m) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 409 (0.4) [M++H], 391 (8) [M++H -H2O], 303 (33), 285 (30), 246 (11), 245 
(69), 171 (12), 187 (6) [M++H -PhCHO -TBS], 107 (100). 
 
MS (EI, 70 eV): 
 
m/z [%] = 390 (1) [M+-H2O], 293 (12), 275 (15), 207 (18), 201 (11), 188 (14), 187 
(100) [M+-PhCHO -TBS], 169 (13), 157 (12), 145 (20), 143 (21), 106 (13), 105 (18), 
101 (18), 75 (19). 
 
Elemental Analysis: 
 
C22H36O5Si (408.60): calcd C 64.66, H 8.88; found C 64.92, H 8.93. 
 
 
 
(4R,5S,6R)-(+)-4-[3-(tert-Butyldimethylsilyloxy)propyl]-6-[(R)-
hydroxy(phenyl)methyl]-2,2-dimethyl-1,3-dioxan-5-ol (46) 
C22H38O5Si, Mw = 410.62 
 
O O
H3C CH3
OH
O Si
OH
 
 
To a stirred solution of aldol product 42 (1.128 g, 2.76 mmol, 1.0 equiv) in a mixture 
THF (45 mL)/CH3CN (5 mL) at _30°C was added 
tetramethylammoniumtriacetoxyborhydride Me4NBH(OAc)3 (2.207 g, 8.28 mmol, 3.0 
equiv) in one portion. Stirring was continued for a further 30 min at _30°C, before the 
mixture was warmed to RT for 24 h. The mixture was quenched with sodium 
hydrocarbonate NaHCO3 (10%, 30 mL) and diluted with CH2Cl2 (20 mL). The 
aqueous layer was separated, extracted with CH2Cl2 (3 x 30 mL) and the organic 
extracts were combined, washed with brine (20 mL), dried (MgSO4) and concentrated 
under reduced pressure. The crude product was purified by flash chromatography on 
silica gel (n-pentane/Et2O 95:5) to afford diol 46 as a colourless oil. 
 
Yield:   m = 440 mg  1.07 mmol, 39% 
de:   > 98% (1H NMR, 13C NMR) 
 
GC:   Rf = 19.3 min CP-Sil-8, 80-10-300 
Optical rotation: [α]D24 = - 30.87 (c = 1.10 in CHCl3) 
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1H NMR (300 MHz, CDCl3): 
δ = 7.25-7.43 (m, 5H; Ar-H), 4.83 (d, 3J(H,H) = 5.7 Hz, 1H; PhCH(OH)), 3.92 (dd, 
3J(H,H) = 7.4, 1.5 Hz, 1H; CH(OH)CHCH(OH)), 3.68-3.74 (m, 2H; CHCH2, 
PhCH(OH)CH), 3.62 (t, 3J(H,H) = 5.8 Hz, 2H; CH2OSi), 2.90 (s, 1H; OH), 1.95 (s, 1H; 
OH), 1.54-1.61 (m, 4H; CHCH2CH2, CHCH2CH2), 1.30 (s, 3H; C(CH3)), 1.28 (s, 3H; 
C(CH3)), 0.88 (s, 9H; SiC(CH3)3), 0.04 (s, 6H; Si(CH3)2) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 139.9 (Ar-C), 128.3, 127.8, 126.5 (5C, Ar-CH), 101.1 (C(CH3)2), 77.6 
(CHCH(OH)CH), 74.7 (PhCH(OH)), 71.3 (CH(OH)CHCH(OH)), 70.3 (CHCH2), 63.2 
(CH2CH2CH2), 28.8 (CHCH2), 26.0 (3C, SiC(CH3)3), 24.8 (CH2CH2CH2), 24.4 
(C(CH3)), 23.9 (C(CH3)), 18.4 (SiC(CH3)3), -5.3 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3426 (w), 3064 (s), 3033 (s), 2931 (vw), 2858 (vw), 1716 (s), 1497 (s), 1464 (m), 
1380 (w), 1252 (w), 1229 (w), 1169 (m), 1097 (vw), 1057 (w), 939 (s), 900 (m), 838 
(vw), 776 (w), 701 (w), 662 (s), 620 (s), 573 (s), 518 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 411 (7.9) [M++H], 393 (12), 354 (11), 353 (49), 335 (10), 319 (21), 317 (35), 
277 (31), 261 (15), 249 (12), 247 (23), 233 (19), 231 (15), 217 (20), 215 (38), 207 
(12), 204 (13), 203 (100), 185 (14), 175 (16), 161 (30), 115 (17), 101 (16), 71 (19). 
 
MS (EI, 70 eV): 
 
m/z [%] = 303 (14) [M+-PhCH2O], 285 (13), 277 (30), 259 (11), 245 (17), 207 (27), 
204 (15), 203 (100), 185 (13), 175 (30), 171 (14), 161 (14), 159 (22), 157 (37), 150 
(18), 145 (39), 132 (30), 131 (23), 131 (10), 113 (10), 107 (11), 105 (18), 75 (24), 73 
(10), 71 (28). 
 
Elemental Analysis: 
 
C22H38O5Si (410.62): calcd C 64.35, H 9.32; found C 64.19, H 9.47. 
 
 
 
3-(Benzyloxy)-1-bromopropane (47) 
C10H13OBr, Mw = 229.11 
 
OBr
 
 
“no Ar” 
To a stirred solution of 3-bromopropanol Br(CH2)3OH (34.348 g, 247.1 mmol, 1.0 
equiv) and benzyl bromide BnBr (44.384 g, 259.5 mmol, 1.05 equiv) in DMF (300 mL) 
at _90°C was added sodium hydride NaH (11.862 g, 296.6 mmol, 1.2 equiv) in 
portions of 1 to 2 g. Stirring was continued for a further 30 min at _90°C, before the 
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mixture was warmed up to RT in 18 h (the reaction was let in the dry ice/acetone bath 
overnight). The mixture was quenched with aqueous NH4Cl solution (400 mL) and 
extracted with Et2O (300 mL). The aqueous portion was diluted with H2O (300 mL) 
and extracted with Et2O (3x 100 mL). The combined organic extracts were washed 
with brine (100 mL), dried (MgSO4), filtered and concentrated under reduced 
pressure to give the crude product as a yellow liquid. Purification by flash 
chromatography on silica gel (n-pentane/Et2O 95:15) gave the Bn-protected product 
47 as a pale yellow liquid. 
 
Yield:   m = 42.614 g 186.00 mmol, 76% 
 
GC:   Rf = 8.3 min  CP-Sil-8, 80-10-300 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.26-7.37 (m, 5H; Ar-H), 4.52 (s, 2H; CH2Ph), 3.60 (t, 3J(H,H) = 6.0 Hz, 2H; 
CH2OCH2), 3.53 (t, 3J(H,H) = 6.6 Hz, 2H; CH2Br),  2.14 (tt, 3J(H,H) = 6.6, 6.0 Hz, 2H; 
CH2CH2CH2) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 138.0 (Ar-C), 128.2, 127.5, 127.4 (5C, Ar-CH), 73.0 (OCH2Ph), 67.6 (CH2OCH2), 
32.9 (CH2CH2CH2), 30.6 (CH2Br) ppm. 
 
IR (CHCl3): 
 
ν = 3063 (m), 3030 (m), 2861 (w), 2795 (s), 1496 (s), 1453 (m), 1362 (w), 1286 (s), 
1256 (m), 1209 (m), 1105 (vw), 1027 (m), 910 (s), 883 (s), 739 (w), 699 (w), 653 (s), 
611 (s), 571 (s), 528 (s), 465 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 231 (0.6) [M+( 81Br)+H], 230 (0.8) [M+( 80Br)+H], 229 (1.4) [M+ (79Br)+H], 153 
(13), 152 (0.1), 151 (13), 93 (1), 92 (16), 91 (100). 
 
Elemental Analysis: 
 
C10H13OBr (229.11): C, 52.42; H, 5.72. found: C, 52.53; H, 5.75. 
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(R,R)-4-[3-(Benzyloxy)propyl]-2,2-dimethyl-1,3-dioxan-5-on-RAMP-hydrazone 
(48) 
C22H34O4N2, Mw = 390.52 
 
NN
OCH3
O O
H3C CH3
O
 
 
Yield:   Not measured (crude product directly used in the next step) 
de:   > 98% (1H NMR, 13C NMR, GC) 
 
GC:   Decomposition 
Optical rotation: [α]D25 = - 69.30 (c = 2.10 in acetone) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 7.20-7.38 (m, 5H; Ar-H), 4.50 (s, 2H; CH2OPh), 4.34 (m, 1H; CH), 4.11 (dd, 
3J(H,H) = 15.7, 1.9 Hz, 1H; OCHH), 3.95 (d, 3J(H,H) = 17.0 Hz, 1H; OCHH),  3.19-
3.53 (m, 8H; CH2OCH2Ph, NCH, CH2OCH3, OCH3), 3.02 (m, 1H; NCHH), 2.38 (m, 
1H; NCHH), 1.56-2.10 (m, 8H; CHCH2CH2, CHCH2CH2, NCH2CH2, NCH2CH2CH2), 
1.40 (s, 3H; C(CH3)), 1.36 (s, 3H; C(CH3)) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 162.5 (C=N), 138.7 (Ar-C), 128.7, 127.6, 127.5 (5C, Ar-CH), 100.2 (C(CH3)2), 
75.7 (CH2OCH3), 72.9 (OCH2Ph), 70.6 (CH), 70.3 (OCH2), 66.6 (CHCH2OCH3), 59.8 
(CH2OCH2Ph), 59.2 (OCH3), 55.6 (NCH2), 28.6 (CHCH2CH2), 26.8 (NCH2CH2CH2), 
25.5 (CHCH2CH2), 24.2 (C(CH3)), 23.9 (C(CH3)), 22.8 (NCH2CH2) ppm. 
 
IR (CHCl3): 
 
ν = 3087 (m), 3063 (m), 3030 (w), 2983 (vw), 2936 (vw), 2857 (vw), 2727 (w), 1748 
(w), 1454 (vw), 1380 (vw), 1372 (vw), 1225 (vw), 1161 (vw), 1101 (vw), 1075 (vw), 
1015 (vw), 989 (w), 855 (m) cm-1. 
 
MS (EI, 70 eV): 
 
m/z [%] = 390 (4) [M+], 346 (13), 345 (58), 332 (21), 287 (49), 226 (11), 155 (13), 98 
(94), 91 (100), 71 (37), 70 (66). 
 
Elemental Analysis: 
 
C22H34N2O4 (390.25): calcd C 67.72, H 8.78, N 7.19; found C 67.38, H 8.55, N 6.49. 
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HR-MS: C22H34N2O4 [M+]:  
 
calcd  390.2518 
found 390.2516 
 
 
 
(R)-(+)-4-[3-(Benzyloxy)propyl]-2,2-dimethyl-1,3-dioxan-5-one (49) 
C16H22O4, Mw = 278.34 
 
O O
H3C CH3
O
O
 
 
A dry, argon flushed, 500 mL Schlenk round-bottom flask, equipped with a magnetic 
stirring bar, was filled with RAMP-hydrazone (R)-28 (4.879 g, 20.0 mmol, 1.0 equiv) 
and anhydrous THF (80 mL). Then, tBuLi (14.90 mL, 15% in n-pentane, 22.0 mmol, 
1.1 equiv) was added dropwise by syringe at _78°C. After stirring for 2 h at this 
temperature, the mixture was cooled to _100°C and 3-(benzyloxy)-1-bromopropane 
47 (5.548 g, 22.0 mmol, 1.1 equiv), dissolved in anhydrous THF (4 mL) was added 
slowly. After further stirring for 2 h at _100°C, the mixture was allowed to warm up to 
RT over 15 h. The mixture was quenched with pH 7 buffer solution (4 mL) and diluted 
with Et2O (80 mL). The organic layer was washed with pH 7 buffer solution (20 mL) 
and brine (2x 20 mL). The combinated organic layers were dried (MgSO4) and 
concentrated under reduced pressure. A solution of the resulting crude hydrazone in 
Et2O (100 mL) was vigorously stirred at RT with a saturated aqueous solution of 
oxalic acid (CO2H)2 (80 mL) over 20 h (TLC control). The aqueous layer was 
separated, extracted with Et2O and the organic extracts were combined, washed with 
brine (40 mL), dried (MgSO4) and concentrated under reduced pressure. The crude 
product was purified by flash chromatography on silica gel (n-pentane/Et2O 80:20) to 
afford (R)-49 as a colourless liquid. 
 
Yield:   m = 4.596 g  16.51 mmol, 82% (over 2 steps) 
ee:   99% (GC on chiral stationary phase) 
 
GC:   Rf = 14.0 min CP-Sil-8, 80-10-300 
Optical rotation: [α]D23 = + 150.96 (c = 1.02 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 7.25-7.34 (m, 5H; Ar-H), 4.50 (s, 2H; CH2Ph), 4.24 (ddd, 3J(H,H) = 8.4, 4.2, 1.5 
Hz, 1H; CHCH2), 4.24 (dd, 3J(H,H) = 17.1, 1.5 Hz, 1H; C(O)CHHO),  3.97 (d, 3J(H,H) 
= 17.1 Hz, 1H; C(O)CHHO), 3.49 (td, 3J(H,H) = 6.4, 1.2 Hz, 2H; CH2OCH2), 1.93-2.03 
(m, 1H; CHCHH), 1.68-1.83 (m, 2H; CH2CH2CH2), 1.57-1.65 (m, 1H; CHCHH), 1.42 
(s, 6H; C(CH3)2) ppm. 
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13C NMR (75 MHz, CDCl3): 
 
δ = 209.6 (CO), 138.5 (Ar-C), 128.4, 127.7, 127.6 (5C, Ar-CH), 100.8 (C(CH3)2), 74.4 
(CH), 72.9 (OCH2Ph), 69.9 (C(O)CH2O), 66.6 (CH2CH2CH2), 25.4 (CHCH2), 25.3 
(CH2CH2CH2), 24.0 (C(CH3)), 23.6 (C(CH3)) ppm. 
 
IR (CHCl3): 
 
ν = 3853 (s), 3745 (s), 3674 (s), 3649 (s), 3623 (s), 3471 (s), 3063 (s), 3030 (m), 
2987 (w), 2936 (w), 2860 (w), 2361 (w), 2335 (m), 1746 (vw), 1651 (s), 1559 (s), 
1498 (s), 1453 (m), 1376 (w), 1225 (vw), 1176 (m), 1104 (vw), 1018 (s), 887 (s), 850 
(s), 740 (w), 700 (w), 608 (s), 539 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 279 (2.6) [M++H], 261 (20), 221 (66), 203 (71), 172 (7), 171 (69), 129 (10), 
114 (7), 113 (41), 91 (100), 71 (14). 
 
MS (EI, 70 eV): 
 
m/z [%] = 278 (2.7) [M+], 160 (15), 114 (13), 107 (28), 92 (18), 91 (100), 87 (11), 72 
(53), 71 (34). 
 
Elemental Analysis: 
 
C16H22O4 (278.34): calcd C 69.04, H 7.97; found C 68.81, H 7.96. 
 
 
 
(4R,6R)-(+)-4-[3-(Benzyloxy)propyl]-6-[(R)-hydroxy(phenyl)methyl]-2,2-dimethyl-
1,3-dioxan-5-one (50) 
C23H28O5, Mw = 384.47 
 
O O
H3C CH3
O
O
HO
 
 
To a stirred solution of dicyclopentylborane chloride Cy2BCl (10.70 mL, 10.7 mmol, 
1.5 equiv) in Et2O (70 mL) at _78°C, was added triethylamine Et3N (1.70 mL, 12.1 
mmol, 1.7 equiv) via syringe followed, 10 min later, by a solution of ketone 49 (1.983 
g, 7.1 mmol, 1.0 equiv) in Et2O (15 mL), via syringe. Stirring was continued for a 
further 30 min at _78°C, before the mixture was warmed up to 0°C for 1 h. The 
resulting suspension was recooled to _78°C before a solution of freshly distilled 
benzaldehyde PhCHO (1.10 mL, 10.7 mmol, 1.5 equiv) in Et2O (20 mL) was added 
dropwise via syringe. The stirring was continued for 1 h at _78°C before the flask was 
sealed and placed in a freezer (_24°C) for 20 h. The mixture was quenched with pH 7 
buffer solution (140 mL) and extracted with Et2O (280 mL). The combined organic 
extracts were concentrated under reduced pressure, taken up in pH 7 buffer solution 
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(43 mL) and MeOH (43 mL) and cooled to 0°C before aqueous hydrogen peroxide 
H2O2 (22 mL, 30%, 0.03 equiv) was added dropwise. The mixture was warmed to RT 
for 2 h, poured into pH 7 buffer solution (140 mL) and extracted with CH2Cl2 (560 
mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated 
under reduced pressure. The crude product was purified by flash chromatography on 
silica gel (n-pentane/Et2O 70:30) to afford 50 as a pale yellow oil contaminated by a 
trace of benzaldehyde. 
 
Yield:   m = 1.856 g  4.83 mmol, 68% 
de:   > 98% (1H NMR, 13C NMR) 
 
GC:   Decomposition 
Optical rotation: [α]D23 = + 76.02 (c = 1.05 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.23-7.37 (m, 10H; Ar-H), 4.86 (d, 3J(H,H) = 7.1 Hz, 1H; PhCH(OH)), 4.46 (d, 
3J(H,H) = 1.6 Hz, 2H; CH2Ph),  4.29 (dd, 3J(H,H) = 7.1, 1.4 Hz, 1H; C(O)CHCH(OH)), 
4.09 (ddd, 3J(H,H) = 8.2, 4.1, 1.4 Hz, 1H; CHCH2), 3.76 (s, 1H; OH), 3.43 (td, 3J(H,H) 
= 6.3, 1.6 Hz, 2H; CH2OCH2), 1.87-1.97 (m, 1H; CHCHH), 1.66-1.75 (m, 2H; 
CH2CH2CH2), 1.56-1.65 (m, 1H; CHCHH), 1.30 (s, 3H; C(CH3)), 1.21 (s, 3H; C(CH3)) 
ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 212.1 (CO), 139.2, 138.2 (2C, Ar-C), 128.1, 127.7, 127.7, 127.4, 127.3, 127.0 
(10C, Ar-CH), 101.2 (C(CH3)2), 75.8 (PhCH(OH)), 74.1 (CHCH2), 72.7 (OCH2Ph), 
72.6 (C(O)CHCH(OH)), 69.6 (CH2CH2CH2), 25.5 (CHCH2), 25.2 (CH2CH2CH2), 23.6 
(C(CH3)), 23.5 (C(CH3)) ppm. 
 
IR (CHCl3): 
 
ν = 3854 (s), 3745 (s), 3474 (w, br), 3031 (w), 2986 (w), 2930 (vw), 2861 (vw), 2360 
(w), 1875 (s), 1796 (s), 1737 (vw), 1555 (s), 1497 (m), 1453 (w), 1378 (w), 1226 (vw), 
1171 (m), 1104 (vw), 900 (m), 747 (w), 700 (w) 615 (s), 519 (s) cm-1. 
 
MS (CI, isobutane): 
 
m/z [%] = 385 (1.4) [M++H], 367 (25), 309 (22), 305 (13), 262 (4), 261 (26), 221 (25), 
171 (13), 107 (100), 91 (7), 71 (23), 69 (17), 61 (18). 
 
MS (EI, 70 eV): 
 
m/z [%] = 326 (12) [M+-(CH3)2CO], 220 (23), 193 (13), 148 (12), 147 (22), 131 (12), 
120 (22), 107 (20), 105 (15), 92 (26), 91 (100), 77 (11), 71 (25), 59 (17). 
 
HR-MS: C20H22O4 [M+ -(CH3)2CO]:  
 
calcd  326.1518 
found 326.1518 
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(4R,5R,6R)-(+)-4-[3-(Benzyloxy)propyl]-6-[(R)-hydroxy(phenyl)methyl]-2,2-
dimethyl-1,3-dioxan-5-ol (51) 
C23H30O5, Mw = 386.48 
 
O O
H3C CH3
OH
O
OH
 
 
Reduction with L-Selectride®: 
 
To a stirred solution of aldol 50 (393 mg, 1.0 mmol, 1.0 equiv) in absolute THF (10 
mL) at _78°C was added L-Selectride® (1.50 mL, 1.0 M in THF, 1.5 mmol, 1.5 equiv) 
dropwise via syringe. The stirring was continued for 3 h at this temperature before the 
reaction was quenched with aqueous NH4Cl solution (5 mL). The mixture was poured 
into aqueous NH4Cl solution (10 mL) and extracted with Et2O (20 mL). The aqueous 
portion was diluted with H2O (20 mL) and extracted with Et2O (3x 20 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure to give the crude product as a yellow liquid. Purification by flash 
chromatography on silica gel (n-pentane/Et2O 50:50) gave diol product 51 as a 
colourless oil. 
 
Yield:   m = 382 mg  0.99 mmol, 97% 
de:   > 96% (1H NMR, 13C NMR, HPLC) 
 
Reduction with catecholborane: 
 
To a stirred solution of aldol 50 (397 mg, 1.0 mmol, 1.0 equiv) in absolute THF (8 mL) 
at _10°C was added catecholborane (5.20 mL, 1.0 M in THF, 5.2 mmol, 5.0 equiv) 
dropwise via syringe. The stirring was continued for 3 h at this temperature before the 
reaction was quenched with MeOH (4 mL) and aqueous sodium potassium tartrate 
tetrahydrate NaKC4H4O6 solution (4 mL). The stirring was continued for 2 h at RT and 
the mixture was extracted with Et2O (20 mL). The aqueous portion was diluted with 
H2O (10 mL) and extracted with Et2O (3x 20 mL). The combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure to give the 
crude product as a yellow liquid. Purification by flash chromatography on silica gel (n-
pentane/Et2O 50:50) gave diol product 51 as a colourless oil. 
 
 
Yield:   m = 363 mg  0.94 mmol, 91% 
de:   > 96% (1H NMR, 13C NMR, HPLC) 
 
GC:   Rf = 17.9 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D25 = - 2.95 (c = 1.10 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.23-7.39 (m, 10H; Ar-H), 4.86 (d, 3J(H,H) = 9.6 Hz, 1H; PhCH(OH)), 4.59 (s, 2H; 
CH2Ph), 4.10-4.16 (m, 2H; CH(OH)CHCH(OH), CHCH2), 3.47-3.54 (m, 3H; 
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CH(OH)CHCH(OH), CH2OCH2), 1.47-1.87 (m, 4H; CH2CH2CH2, CHCH2), 1.31 (s, 
3H; C(CH3)), 1.11 (s, 3H; C(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 139.7, 138.4 (2C, Ar-C), 128.1, 127.8, 127.6, 127.4, 127.3, 126.0 (10C, Ar-CH), 
101.0 (C(CH3)2), 76.2 (CHCH(OH)CH), 72.7 (OCH2Ph), 71.7 (PhCH(OH)), 71.1 
(CH(OH)CHCH(OH)), 70.4 (CHCH2), 70.0 (CH2CH2CH2), 26.1 (CHCH2), 25.5 
(C(CH3)), 25.4 (C(CH3)), 24.9 (CH2CH2CH2) ppm. 
 
IR (CHCl3): 
 
ν = 3205 (s), 3088 (s), 3064 (m), 3032 (m), 2930 (vw), 2865 (vw), 2737 (s), 1718 (s), 
1604 (s), 1496 (m), 1455 (w), 1380 (vw), 1312 (m), 1270 (w), 1204 (vw), 1139 (w), 
1103 (w), 1027 (m), 894 (m), 740 (w), 699 (w) 618 (s), 556 (s), 516 (s), 467 (s) cm-1. 
 
MS (CI, isobutane): 
 
m/z [%] = 387 (9.0) [M++H], 377 (20), 329 (9), 294 (16), 293 (72), 287 (28), 261 (8), 
179 (10), 107 (9), 71 (9). 
 
MS (EI, 70 eV): 
 
m/z [%] = 301 (9), 287 (8), 261 (25), 217 (10), 216 (51), 215 (54), 214 (12), 203 (10), 
197 (20), 179 (23), 113 (10), 105 (10), 92 (10), 91 (100), 71 (78). 
 
Elemental Analysis: 
 
C23H30O5 (386.48): calcd C 71.48, H 7.82; found C 71.53, H 7.55. 
 
 
 
(4R,5S,6R)-(+)-4-[3-(Benzyloxy)propyl]-6-[(R)-hydroxy(phenyl)methyl]-2,2-
dimethyl-1,3-dioxan-5-ol (52) 
C23H30O5, Mw = 386.48 
 
O O
H3C CH3
OH
O
OH
 
 
To a stirred solution of aldol product 50 (430 mg, 1.12 mmol, 1.0 equiv) in a mixture 
CH3CO2H (4 mL)/CH3CN (4 mL), at _40°C, was added 
tetramethylammoniumtriacetoxyborhydride Me4NBH(OAc)3 (1.471 g, 5.59 mmol, 5.0 
equiv) in one portion. Stirring was continued for a further 30 min at _40°C, before the 
mixture was sealed and placed in a freezer overnight. Then the mixture was warmed 
up to RT and stirred at this temperature for 3 h. The mixture was quenched with 
aqueous NH4Cl solution (10 mL) and diluted with Et2O (20 mL). The aqueous layer 
was separated, extracted with Et2O (3x 20 mL) and the organic extracts were 
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combined, washed with brine (20 mL), dried (MgSO4) and concentrated under 
reduced pressure. The crude product was purified by flash chromatography on silica 
gel (n-pentane/Et2O 50:50) to afford diol 52 as a colourless oil. 
 
Yield:   m = 395 mg  1.02 mmol, 91% 
de:   > 98% (1H NMR, 13C NMR, HPLC) 
 
GC:   Rf = 17.4 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D29 = - 15.71 (c = 1.05 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.23-7.39 (m, 10H; Ar-H), 4.76 (d, 3J(H,H) = 5.8 Hz, 1H; PhCH(OH)), 4.46 (s, 2H; 
CH2Ph), 3.88 (dd, 3J(H,H) = 6.3, 3.6 Hz, 1H; CH(OH)CHCH(OH)), 3.66-3.70 (m, 1H; 
CHCH2), 3.67 (t, 3J(H,H) = 6.3 Hz, 1H; CH(OH)CHCH(OH)), 3.40-3.49 (m, 2H; 
CH2OCH2), 3.12 (s, 1H; OH), 2.08 (s, 1H; OH), 1.68-1.76 (m, 1H; CHCHH), 1.55-1.63 
(m, 3H; CH2CH2CH2, CHCHH), 1.26 (s, 3H; C(CH3)), 1.24 (s, 3H; C(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 139.9, 138.1 (2C, Ar-C), 128.1, 128.1, 127.6, 127.5, 127.3, 126.3 (10C, Ar-CH), 
100.9 (C(CH3)2), 77.4 (CH(OH)CHCH(OH)), 74.6 (PhCH(OH)), 72.8 (OCH2Ph), 71.1 
(CHCH2), 70.4 (CHCH(OH)CH), 70.0 (CH2OCH2Ph), 25.9 (CHCH2), 25.1 
(CH2CH2CH2), 24.3 (C(CH3)), 23.8 (C(CH3)) ppm. 
 
IR (CHCl3): 
 
ν = 3406 (br, m), 2996 (m), 2929 (m), 1495 (s), 1454 (s), 1376 (m), 1224 (w), 1171 
(s), 1091 (w), 903 (s), 757 (vw), 701 (m) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 387 (10.5) [M++H], 369 (18), 329 (44), 294 (22), 293 (100), 261 (18), 237 
(11), 223 (15), 221 (25), 219 (20), 211 (16), 209 (16), 205 (35), 204 (11), 203 (70), 
201 (10), 192 (13), 191 (77), 181 (11), 179 (41), 161 (41), 149 (11), 132 (13), 119 
(23), 101 (42), 91 (98), 71 (50). 
 
MS (EI, 70 eV): 
 
m/z [%] = 279 (6.4) [M+-PhCH(OH)], 221 (11), 179 (33), 150 (13), 132 (22), 131 (18), 
107 (9), 105 (10), 92 (11), 91 (100), 71 (42), 59 (10). 
 
HR-MS: C16H23O4 [M+ -PhCH(OH)]:  
 
calcd  279.1596 
found 279.1595 
 
 
 
Experimental part 
 
104 
(4R,6R)-(+)-4-[3-(Benzyloxy)propyl]-6-[(R)-(acetoxy)(phenyl)methyl]-2,2-
dimethyl-1,3-dioxan-5-one (53) 
C25H30O6, Mw = 426.50 
 
O O
H3C CH3
O
O
O
O
 
 
To a stirred solution of aldol 50 (479 mg, 1.25 mmol, 1.0 equiv) in CH2Cl2 (6 mL) at 
0°C was added sequencially, pyridine (200 µL, 2.49 mmol, 2.0 equiv), 4-
dimethylaminopyridine (DMAP) (8 mg, 0.06 mmol, 0.05 equiv) and freshly distilled 
acetic anhydride (COMe)2O (130 µL, 1.37 mmol, 1.1 equiv) via syringe. The stirring 
was continued for 2 h at this temperature and then for 5 h at RT. The reaction was 
quenched with H2O (10 mL) and diluted with CH2Cl2 (10 mL). The mixture was 
extracted with CH2Cl2 (20 mL). The aqueous portion was diluted with H2O (10 mL) 
and extracted with CH2Cl2 (3x 20 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure to give the crude product 
as a colourless syrup. Purification by flash chromatography on silica gel (n-
pentane/Et2O 80:20) gave the acetyl-protected product 53 as a colourless oil and 
some product of elimination 54. 
 
Yield:   m = 353 mg  0.83 mmol, 66% 
 
GC:   Rf = 12.9 min CP-Sil-8, 160-10-300 
Optical rotation: [α]D25 = + 42.30 (c = 1.15 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.23-7.39 (m, 10H; Ar-H), 6.18 (d, 3J(H,H) = 4.4 Hz, 1H; PhCH(OAc)), 4.56 (dd, 
3J(H,H) = 4.4, 1.1 Hz; 1H, C(O)CHCH(OAc)), 4.44 (d, 3J(H,H) = 2.7 Hz, 2H; 
OCH2Ph), 3.88 (ddd, 3J(H,H) = 8.5, 4.1, 1.1 Hz, 1H; CHCH2), 3.41 (td, 3J(H,H) = 6.3, 
3.0 Hz, 2H; CH2OCH2), 2.08 (s, 3H, C(O)CH3), 1.84-1.95 (m, 1H; CHCHH), 1.49-1.74 
(m, 3H; CHCHH, CH2CH2CH2), 1.37 (s, 3H; C(CH3)), 1.30 (s, 3H; C(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 207.3 (CO), 169.5 (C(O)CH3), 138.2, 135.6 (2C, Ar-C), 128.4, 128.3, 128.2, 
128.1, 128.1, 127.7, 127.4, 127.3 (10C, Ar-CH), 101.2 (C(CH3)2), 75.4 
(C(O)CHCH(OAc)), 74.1 (PhCH(OAc)), 73.3 (CHCH2), 72.7 (OCH2Ph), 69.6 
(CH2OCH2Ph), 25.2 (2C, CH2CH2CH2, CHCH2), 23.8 (C(CH3)), 23.6 (C(CH3)), 21.0 
(C(O)CH3) ppm. 
 
IR (CHCl3): 
 
ν = 2989 (m), 2934 (w), 2862 (w), 1746 (vw), 1494 (s), 1452 (m), 1374 (w), 1233 
(vw), 1173 (m), 1103 (w), 1030 (w), 755 (vw), 700 (m), 609 (s), 555 (s) cm-1. 
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MS (CI, isobutane): 
 
m/z [%] = 427 (1.9) [M++H], 409 (13), 369 (14), 368 (29), 367 (100), 351 (8), 347 (20), 
310 (8), 309 (37), 291 (6), 287 (7), 161 (10), 157 (16), 71 (7). 
 
MS (EI, 70 eV): 
 
m/z [%] = 366 (16.3) [M+- CH3CO2H], 277 (5), 217 (9), 181 (18), 177 (9), 162 (9), 131 
(26), 120 (37), 118 (17), 101 (8), 92 (9), 91 (100), 71 (51). 
 
HR-MS: C23H26O4 [M+ -CH3CO2H]:  
 
calcd  366.1831 
found 366.1831 
 
 
 
(4R,6R)-(+)-4-[3-(Benzyloxy)propyl]-6-(1-phenyl-methyliden)-2,2-dimethyl-1,3-
dioxan-5-one (54) 
C23H26O4, Mw = 366.45 
 
O O
H3C CH3
O
O
 
 
 
Yield:   m = 46 mg  0.13 mmol, 10% 
 
GC:   Rf = 17.0 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D29 = + 12.91 (c = 1.05 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.74 (dd, 3J(H,H) = 7.4, 0.8 Hz, 2H; Ar-H), 7.24-7.37 (m, 8H; Ar-H), 6.70 (s, 1H; 
CH=C), 4.49 (s, 2H; CH2Ph), 4.45 (dd, 3J(H,H) = 7.1, 4.1 Hz, 1H; CHCH2), 3.50 (t, 
3J(H,H) = 6.3 Hz, 2H; CH2OCH2), 1.98-2.08 (m, 1H; CHCHH), 1.74-1.90 (m, 3H; 
CHCHH, CH2CH2CH2), 1.65 (s, 3H; C(CH3)), 1.60 (s, 3H; C(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 193.4 (CO), 145.5, 138.3 (2C, Ar-C), 133.5 (CH=C), 130.4, 128.4, 128.3, 128.1, 
127.4, 127.3 (10C, Ar-CH), 114.3 (CH=C), 100.9 (C(CH3)2), 75.7 (CHCH2), 72.7 
(OCH2Ph), 69.7 (CH2OCH2Ph), 28.4 (CHCH2), 28.2 (C(CH3)), 25.0 (CH2CH2CH2), 
23.4 (C(CH3)) ppm. 
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IR (CHCl3): 
 
ν = 3026 (m), 2932 (w), 2863 (w), 1730 (vw), 1600 (m), 1494 (m), 1452 (m), 1372 
(w), 1268 (w), 1214 (w), 1098 (w), 1032 (m), 920 (s), 754 (vw), 701 (w), 611 (s), 512 
(s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 368 (18), 367 (80.0) [M++H], 366 (46), 337 (12), 309 (38), 291 (42), 263 
(12), 259 (29), 231 (11), 209 (17), 201 (34), 189 (10), 182 (11), 181 (78), 173 (49), 
119 (15), 118 (13), 107 (20), 105 (12), 91 (100), 71 (56). 
 
MS (EI, 70 eV): 
 
m/z [%] = 366 (32) [M+], 181 (33), 118 (35), 105 (8), 92 (9), 91 (100), 90 (18), 71 (58). 
 
HR-MS: C23H26O4 [M+]:  
 
calcd  366.1831 
found 366.1832 
 
 
 
(4R,6R)-(+)-4-[3-(Benzyloxy)propyl]-6-[(R)-(tert-
butyldimethylsilyloxy)(phenyl)methyl]-2,2-dimethyl-1,3-dioxan-5-one (55) 
C29H42O5Si, Mw = 498.73 
 
O O
H3C CH3
O
O
O
Si
 
 
To a stirred solution of hydroxy ketone 50 (397 mg, 1.0 mmol, 1.0 equiv) in CH2Cl2 
(10 mL) at 0°C was added sequencially, 2,6-lutidine (2,6-dimethylpyridine) (360 µL, 
3.0 mmol, 3.0 equiv) and tert-butyldimethylsilyl triflate TBSOTf (360 µL, 1.5 mmol, 1.5 
equiv) dropwise via syringe. The stirring was continued for 3-4 h at RT before the 
reaction was quenched with aqueous NH4Cl solution (10 mL). The mixture was 
poured into aqueous NH4Cl solution (20 mL) and extracted with CH2Cl2 (30 mL). The 
aqueous portion was diluted with H2O (20 mL) and extracted with CH2Cl2 (2x 10 mL). 
The combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure to give the crude product as a colourless syrup. Purification by 
flash chromatography on silica gel (n-pentane/Et2O 90:10) gave the TBS-protected 
product 55 as a colourless oil. 
 
Yield:   m = 463 mg  0.93 mmol, 90% 
 
GC:   Rf = 14.1 min CP-Sil-8, 160-10-300 
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Optical rotation: [α]D23 = + 65.76 (c = 1.05 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.41-7.52 (m, 10H; Ar-H), 5.28 (d, 3J(H,H) = 3.3 Hz, 1H; PhCH(OSi)), 4.65 (s, 2H; 
CH2Ph), 4.56 (dd, 3J(H,H) = 3.3, 1.1 Hz; 1H, C(O)CHCH(OSi)), 4.13 (ddd, 3J(H,H) = 
8.2, 4.1, 1.1 Hz, 1H; CHCH2), 3.62 (t, 3J(H,H) = 6.3 Hz, 2H; CH2OCH2), 2.00-2.09 (m, 
1H; CHCHH), 1.77-1.94 (m, 2H; CH2CH2CH2), 1.64-1.75 (m, 1H; CHCHH), 1.54 (s, 
3H; C(CH3)), 1.52 (s, 3H; C(CH3)), 1.06 (s, 9H; SiC(CH3)3), 0.26 (s, 3H; Si(CH3)), -
0.09 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 207.7 (CO), 140.3, 138.5 (2C, Ar-C), 128.3, 127.6, 127.6, 127.5, 127.3 (10C, Ar-
CH), 101.0 (C(CH3)2), 79.1 (C(O)CHCH(OSi)), 74.1 (2C, CHCH2, PhCH(OSi)), 72.9 
(OCH2Ph), 69.9 (CH2OCH2Ph), 25.7 (3C, SiC(CH3)3), 25.4 (CH2CH2CH2), 25.0 
(CHCH2), 24.2 (C(CH3)), 23.9 (C(CH3)), 18.2 (SiC(CH3)3), -5.0, -4.8 (2C, Si(CH3)2) 
ppm. 
 
IR (CHCl3): 
 
ν = 3901 (s), 3853 (s), 3817 (s), 3801 (s), 3746 (m), 3673 (m), 3649 (s), 3627 (s), 
3588 (s), 3566 (s), 3064 (s), 3032 (s), 2985 (m), 2932 (vw), 2857 (w), 2362 (vw), 
2336 (vw), 1868 (s), 1794 (s), 1747 (w), 1700 (s), 1652 (m), 1617 (s), 1559 (m), 1541 
(m), 1498 (s), 1456 (w), 1376 (w), 1312 (s), 1252 (w), 1225 (w), 1171 (m), 1101 (vw), 
1070 (w), 1028 (s), 943 (s), 907 (s), 877 (s), 838 (w), 779 (w), 738 (m), 700 (w), 669 
(m), 616 (s), 579 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 499 (3.0) [M++H], 481 (4), 441 (1), 425 (10), 423 (1), 383 (9), 367 (16), 309 
(9), 277 (7), 222 (20), 221 (100), 91 (4). 
 
Elemental Analysis: 
 
C29H42O5Si (498.73): calcd C 69.84, H 8.49; found C 69.89, H 8.56. 
 
 
 
(4R,5R,6S)-(-)-4-[3-(Benzyloxy)propyl]-6-[(R)-(tert-
butyldimethylsilyloxy)(phenyl)methyl]-2,2-dimethyl-1,3-dioxan-5-ol (56) 
C29H44O5Si, Mw = 500.74 
 
O O
H3C CH3
OH
O
O
Si
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To a stirred solution of the TBS-protected aldol 55 (1.729 g, 3.5 mmol, 1.0 equiv) in 
absolute THF (35 mL) at _78°C was added L-Selectride® (5.20 mL, 1.0 M in THF, 5.2 
mmol, 1.5 equiv) dropwise via syringe. The stirring was continued for 5 h (TLC 
control) at this temperature before the reaction was quenched with aqueous NH4Cl 
solution (20 mL). The mixture was poured into aqueous NH4Cl solution (30 mL) and 
extracted with Et2O (30 mL). The aqueous portion was diluted with H2O (30 mL) and 
extracted with Et2O (3x 20 mL). The combined organic extracts were dried (MgSO4), 
filtered and concentrated under reduced pressure to give the crude product as a 
yellow liquid. Purification by flash chromatography on silica gel (n-pentane/Et2O 
80:20) gave alcohol product 56 as a colourless oil. 
 
Yield:   m = 1.531 g  3.06 mmol, 88% 
de:   > 96% (HPLC, 1H NMR, 13C NMR) 
 
GC:   Rf = 14.3 min CP-Sil-8, 160-10-300 
Optical rotation: [α]D23 = - 73.20 (c = 1.16 in CHCl3) 
 
1H NMR (500 MHz, CDCl3): 
 
δ = 7.56-7.70 (m, 10H; Ar-H), 5.26 (d, 3J(H,H) = 6.1 Hz, 1H; PhCH(OSi)), 4.80 (s, 2H; 
CH2Ph),  4.10 (ddd, 3J(H,H) = 6.1, 3.0, 1.1 Hz, 1H; C(OH)CHCH(OSi)), 3.79 (t, 
3J(H,H) = 6.9 Hz, 2H; CH2OCH2), 3.99 (d, 3J(H,H) = 4.6 Hz, 1H; OH), 3.96 (dd, 
3J(H,H) = 5.5, 4.6, 3.0 Hz, 1H; CHCH(OH)), 3.88 (dd, 3J(H,H) = 5.5, 1.1 Hz, 1H; 
CHCH2), 1.94-2.11 (m, 3H; CH2CH2CH2, CHCHH), 1.81-1.88 (m, 1H; CHCHH), 1.65 
(s, 3H; C(CH3)), 1.43 (s, 3H; C(CH3)), 1.21 (s, 9H; SiC(CH3)3), 0.41 (s, 3H; Si(CH3)), -
0.16 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 140.9, 138.4 (2C, Ar-C), 128.1, 127.9, 127.4, 127.4, 127.3, 126.5 (10C, Ar-CH), 
100.7 (C(CH3)2), 75.8 (PhCH(OSi)), 75.0 (CHCH2),  73.4 (C(OH)CHCH(OSi)), 73.2 
(CH(OH)), 72.7 (OCH2Ph), 70.1 (CH2OCH2Ph), 30.3 (CHCH2), 25.9 (CH2CH2CH2), 
25.7 (3C, SiC(CH3)3), 24.8 (C(CH3)), 23.8 (C(CH3)), 18.1 (SiC(CH3)3), -5.2, -4.7 (2C, 
Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3901 (s), 3853 (s), 3836 (s), 3801 (s), 3746 (m), 3711 (s), 3673 (m), 3649 (s), 
3627 (s), 3587 (s), 3471 (m), 3064 (s), 3031 (s), 2985 (m), 2932 (vw), 2857 (w), 2362 
(vw), 2336 (vw), 1869 (s), 1844 (s), 1828 (s), 1794 (s), 1772 (s), 1735 (s), 1699 (m), 
1683 (s), 1652 (m), 1617 (s), 1559 (m), 1541 (m), 1498 (s), 1457 (w), 1418 (s), 1377 
(w), 1252 (w), 1226 (w), 1171 (m), 1099 (vw), 1067 (w), 996 (m), 942 (s), 838 (w), 
780 (w), 736 (m), 699 (w), 669 (m), 608 (s), 559 (s), 522 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 501 (4.8) [M++H], 409 (11), 367 (11), 351 (28), 333 (2), 312 (10), 311 (56), 
294 (20), 293 (100), 221 (41), 207 (10), 203 (49), 191 (28), 181 (12), 179 (25), 91 
(20), 71 (18). 
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Elemental Analysis: 
 
C29H44O5Si (500.74): calcd C 69.56, H 8.86; found C 69.31, H 9.17. 
 
 
 
(4R,5S,6S)-(-)-4-[3-(Benzyloxy)propyl]-6-[(R)-(tert-
butyldimethylsilyloxy)(phenyl)methyl]-2,2-dimethyl-1,3-dioxan-5-ol (57) 
C29H44O5Si, Mw = 500.74 
 
O O
H3C CH3
OH
O
O
Si
 
 
To a stirred solution of the TBS-protected aldol 55 (488 mg, 0.98 mmol, 1.0 equiv) in 
absolute MeOH (10 mL) at _78°C was added sodiumborhydride NaBH4 (448 mg, 1.96 
mmol, 2.0 equiv) in one portion. The stirring was continued for 3 h at RT before the 
reaction was concentrated under reduced pressure. The residue was taken in CH2Cl2 
(10 mL) and washed with aqueous NH4Cl solution (10 mL) and H2O (10 mL). The 
aqueous portion was diluted with H2O (20 mL) and extracted with Et2O (3x 20 mL). 
The combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure to give the crude product as a yellow liquid. Purification by flash 
chromatography on silica gel (n-pentane/Et2O 70:30) gave an easy separation 
between alcohol product 57 (165 mg, 33%) and its diastereoisomer 56 (328 mg, 
67%) as colourless oils. 
 
Yield:   m = 493 mg  0.98 mmol, 100% (reduction yield) 
de:   32% (HPLC, 1H NMR, 13C NMR) 
 
GC:   Rf = 14.5 min CP-Sil-8, 160-10-300 
Optical rotation: [α]D29 = - 38.55 (c = 1.05 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.22-7.36 (m, 10H; Ar-H), 4.70 (d, 3J(H,H) = 6.6 Hz, 1H; PhCH(OSi)), 4.49 (s, 2H; 
CH2Ph),  3.95 (ddd, 3J(H,H) = 6.9, 6.6, 3.3 Hz, 1H; CH(OH)), 3.77 (m, 1H; CHCH2), 
3.58 (t, 3J(H,H) = 6.6 Hz, 1H; CH(OH)CHCH(OSi)), 3.49 (t, 3J(H,H) = 6.3 Hz, 2H; 
CH2OCH2), 1.90 (d, 3J(H,H) = 3.3 Hz, 1H; OH), 1.74-1.82 (m, 1H; CHCHH), 1.61-
1.72 (m, 3H; CH2CH2CH2, CHCHH), 1.24 (s, 3H; C(CH3)), 1.12 (s, 3H; C(CH3)), 1.04 
(s, 9H; SiC(CH3)3), 0.06 (s, 3H; Si(CH3)), -0.16 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 141.4, 138.3 (2C, Ar-C), 128.1, 127.8, 127.5, 127.4, 127.3, 126.4 (10C, Ar-CH), 
100.7 (C(CH3)2), 78.6 (C(OH)CHCH(OSi)), 76.6 (PhCH(OSi)), 72.9 (OCH2Ph), 71.1 
(CH(OH)), 70.9 (CHCH2),  70.3 (CH2OCH2Ph), 26.2 (CHCH2), 25.8 (3C, SiC(CH3)3), 
Experimental part 
 
110 
25.2 (CH2CH2CH2), 24.3 (C(CH3)), 23.6 (C(CH3)), 18.1 (SiC(CH3)3), -4.6, -4.9 (2C, 
Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3560 (br, s), 2939 (w), 2862 (w), 1460 (m), 1375 (m), 1226 (w), 1079 (w), 840 
(w), 759 (vw), 699 (m), 618 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 501 (4.4) [M++H], 370 (19), 369 (77), 367 (10), 321 (16), 311 (15), 294 (22), 
293 (100), 279 (21), 277 (14), 261 (28), 249 (29), 222 (10), 221 (55), 207 (11), 203 
(37), 191 (48), 179 (13), 161 (15), 149 (16), 119 (11), 101 (11), 91 (38), 71 (19). 
 
MS (EI, 70 eV): 
 
m/z [%] = 385 (2.0) [M+-CH3], 279 (15), 221 (22), 207 (15), 193 (10), 171 (13), 129 
(8), 115 (10), 92 (8), 91 (100), 75 (19), 73 (14), 71 (19). 
 
HR-MS: C22H27O3Si [M+ -C7H17O2]:  
 
calcd  367.1729 
found 367.1730 
 
 
 
(4R,5R,6S)-(-)-6-[(R)-(tert-Butyldimethylsilyloxy)(phenyl)methyl]-4-[3-
hydroxypropyl]-2,2-dimethyl-1,3-dioxan-5-ol (58) 
C22H38O5Si, Mw = 410.62 
 
O O
H3C CH3
OH
OH
O
Si
 
 
A solution of compound 56 (451 mg, 0.90 mmol, 1.0 equiv) and 10% palladium on 
carbon Pd/C (45 mg, 10% in weight) in EtOAc (11 mL) was stirred overnight at RT 
under nitrogen atmosphere. The reaction was filtered through a short pad of celite, 
eluting with Et2O, and the filtrate was concentrated under reduced pressure to give 
the crude product as a colourless syrup. Purification by flash chromatography on 
silica gel (n-pentane/Et2O 50:50) gave the debenzylated product 58 as a colourless 
oil. 
 
Yield:   m = 328 mg  0.80 mmol, 89% 
 
GC:   Rf = 13.3 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D26 = - 16.32 (c = 1.00 in CHCl3) 
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1H NMR (400 MHz, CDCl3): 
 
δ = 7.29-7.44 (m, 5H; Ar-H), 4.99 (d, 3J(H,H) = 5.8 Hz, 1H; PhCH(OSi)), 3.92 (s, 1H; 
OH), 3.84 (ddd, 3J(H,H) = 6.0, 3.3, 1.1 Hz, 1H; CHCH(OSi)), 3.70 (m, 1H; CH(OH)), 
3.64 (t, 3J(H,H) = 4.7 Hz, 2H; CH2OH), 3.61-3.65 (m, 1H; CHCH2), 2.35 (s, 1H; OH), 
1.77-1.86 (m, 1H; CHCHH), 1.67-1.74 (ddd, 3J(H,H) = 6.3 Hz, 2H; CH2CH2CH2), 
1.53-1.62 (m, 1H; CHCHH), 1.41 (s, 3H; C(CH3)), 1.18 (s, 3H; C(CH3)), 0.94 (s, 9H; 
SiC(CH3)3), 0.14 (s, 3H; Si(CH3)), -0.15 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 140.7 (Ar-C), 127.9, 127.4, 126.5 (5C, Ar-CH), 100.9 (C(CH3)2), 75.8 
(PhCH(OSi)), 75.1 (CHCH2),  73.4 (CHCH(OSi)), 73.2 (CH(OH)), 62.4 (CH2OCH2Ph), 
30.3 (CHCH2), 29.0 (CH2CH2CH2), 25.6 (3C, SiC(CH3)3), 24.7 (C(CH3)), 23.8 
(C(CH3)), 18.1 (SiC(CH3)3), -4.7, -5.2 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3799 (s), 3400 (w), 3064 (s), 3032 (s), 2932 (vw), 2859 (vw), 1494 (s), 1464 (w), 
1379 (w), 1251 (w), 1227 (w), 1169 (m), 1096 (vw), 1066 (w), 995 (s), 945 (s), 839 
(vw), 779 (w), 733 (s), 701 (w), 669 (s), 607 (s), 560 (s), 522 (s) cm-1. 
 
MS (CI, isobutane): 
 
m/z [%] = 411 (26.4) [M++H], 331 (14), 280 (15), 279 (94), 277 (9), 261 (16), 222 (15), 
221 (100), 203 (48), 191 (8), 159 (9). 
 
MS (EI, 70 eV): 
 
m/z [%] = 278 (15), 277 (69), 235 (15), 227 (30), 222 (14), 221 (57), 208 (19), 207 
(100), 206 (12), 205 (27), 203 (36), 195 (26), 194 (16), 193 (86), 189 (27), 185 (14), 
182 (11), 181 (74), 177 (15), 175 (68), 173 (10), 171 (79), 163 (12), 161 (13), 157 
(31), 133 (12), 132 (26), 131 (44), 129 (33), 115 (17), 105 (12), 101 (15), 91 (14), 85 
(10), 75 (46), 73 (25), 71 (23), 59 (13). 
 
HR-MS: C15H21O3Si [M+ -(CH3)2CO –C4H11O]:  
 
calcd  277.1260 
found 277.1259 
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3-((4R,5R,6S)-6-((R)-(tert-Butyldimethylsilyloxy)(phenyl)methyl)-5-hydroxy-2,2-
dimethyl-1,3-dioxan-4-yl)propanal (59) 
C22H36O5Si, Mw = 408.60 
 
O O
H3C CH3
OH
H
O
Si
O
 
 
Solid tetrapropylammonium perruthenate (TPAP) (10 mg, 0.03 mmol, 5 mol%) was 
added in one portion to a stirred mixture of diol 58 (224 mg, 0.55 mmol, 1.0 equiv), N-
methylmorpholine-N-oxide (NMO) (99 mg, 0.82 mmol, 1.5 equiv) and powdered 4Å 
molecular sieves (273 mg, 0.5 g/mmol diol) in absolute CH2Cl2 (2 mL) at RT under 
argon. On completion the reaction mixture was filtered through a short pad of silica, 
eluting with CH2Cl2, and the filtrate was concentrated under reduced pressure to give 
the crude product as a yellow syrup. Purification by flash chromatography on silica 
gel (n-pentane/Et2O (50:50) gave aldehyde 59 as a colourless oil. 
 
Yield:   m = 148 mg  0.36 mmol, 66% 
 
GC:   Rf = 12.7 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D26 = - 20.06 (c = 1.00 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 9.72 (t, 3J(H,H) = 1.9 Hz, 1H; CHO), 7.25-7.40 (m, 5H; Ar-H), 4.95 (d, 3J(H,H) = 
5.5 Hz, 1H; PhCH(OSi)), 3.83 (d, 3J(H,H) = 4.4 Hz, 1H; OH), 3.79 (dd, 3J(H,H) = 5.7, 
3.3 Hz, 1H; CHCH(OSi)), 3.64-3.68 (m, 1H; CH(OH)), 3.53-3.59 (m, 1H; CHCH2), 
2.42-2.56 (m, 2H; CH2CH2), 1.96-2.05 (m, 1H; CHCHH), 1.74-1.84 (m, 1H; CHCHH), 
1.33 (s, 3H; C(CH3)), 1.12 (s, 3H; C(CH3)), 0.90 (s, 9H; SiC(CH3)3), 0.10 (s, 3H; 
Si(CH3)), -0.15 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 201.8 (CHO), 140.6 (Ar-C), 127.9, 127.5, 126.5 (5C, Ar-CH), 100.9 (C(CH3)2), 
76.0 (PhCH(OSi)), 74.4 (CHCH2),  73.3 (CHCH(OSi)), 73.2 (CH(OH)), 40.4 
(CH2CH2), 26.2 (CHCH2), 25.6 (3C, SiC(CH3)3), 24.6 (C(CH3)), 23.7 (C(CH3)), 18.1 
(SiC(CH3)3), -4.7, -5.2 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3475 (m), 3064 (s), 3032 (s), 2986 (w), 2932 (vw), 2857 (w), 2717 (s), 1725 (vw), 
1495 (s), 1465 (m), 1379 (w), 1251 (w), 1226 (w), 1170 (m), 1093 (vw), 1066 (vw), 
998 (m), 944 (s), 838 (vw), 779 (w), 701 (w), 668 (s), 606 (s), 559 (s), 520 (s) cm-1. 
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MS (CI, isobutane): 
 
m/z [%] = 409 (2.3) [M++H], 391 (25) [M++H -H2O], 333 (20), 277 (23), 260 (17), 259 
(100), 220 (9), 219 (63), 201 (11), 157 (6). 
 
MS (EI, 70 eV): 
 
m/z [%] = 293 (15), 276 (12), 275 (56), 235 (10), 222 (11), 221 (51), 207 (42), 205 
(14), 201 (35), 194 (17), 193 (96), 188 (12), 187 (87), 181 (27), 173 (28), 169 (42), 
161 (12), 159 (16), 157 (41), 155 (11), 143 (21), 132 (14), 131 (19), 129 (54), 115 
(18), 107 (18), 105 (13), 103 (23), 99 (21), 91 (23), 77 (10), 75 (100), 73 (49), 69 (14), 
59 (29), 57 (13), 55 (10). 
 
HR-MS: C16H25O3Si [M+ -(CH3)2CO -C3H5O]:  
 
calcd  293.1209 
found 293.1210 
 
 
 
3-((4R,6R)-6-((R)-(tert-Butyldimethylsilyloxy)(phenyl)methyl)-2,2-dimethyl-5-
oxo-1,3-dioxan-4-yl)propanal (60) 
C22H34O5Si, Mw = 406.59 
 
O O
H3C CH3
O
H
O
Si
O
 
 
To a stirred solution of oxalyl chloride COCl2 (100 µL, 1.07 mmol, 1.1 equiv) in 
absolute CH2Cl2 (2.5 mL) at _78°C was added a solution of dimethylsulfoxide 
(CH3)2SO (DMSO) (150 µL, 2.14 mmol, 2.2 equiv) in absolute CH2Cl2 (2.5 mL) 
dropwise via syringe. After 5 minutes of stirring at this temperature, a solution of diol 
58 (400 mg, 0.97 mmol, 1.0 equiv) in absolute CH2Cl2 (4 mL) was added dropwise 
via syringe. The mixture was warmed up to _20°C in 30 min and the stirring was 
continued at this temperature for 15 min before the reaction was quenched with H2O 
(10 mL). The mixture was extracted with CH2Cl2 (20 mL). The aqueous portion was 
diluted with H2O (20 mL) and extracted with Et2O (3x 20 mL). The combined organic 
extracts were dried (Na2SO4), filtered and concentrated under reduced pressure to 
give the crude product as a colourless liquid. Purification by flash chromatography on 
silica gel (n-pentane/Et2O 80:20) gave aldehyde product 60 as a colourless oil. 
 
Yield:   m = 276 mg  0.68 mmol, 70% 
 
GC:   Rf = 10.1 min CP-Sil-8, 140-10-300 
Optical rotation: [α]D29 = + 35.37 (c = 1.10 in CHCl3) 
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1H NMR (400 MHz, CDCl3): 
 
δ = 9.70 (t, 3J(H,H) = 1.6 Hz, 1H; CHO), 7.22-7.34 (m, 5H; Ar-H), 5.09 (d, 3J(H,H) = 
3.3 Hz, 1H; PhCH(OSi)), 3.70 (dd, 3J(H,H) = 3.3, 1.1 Hz, 1H; CHCH(OSi)), 4.01 (ddd, 
3J(H,H) = 8.0, 4.4, 1.1 Hz, 1H; CHCH2), 2.44-2.50 (m, 2H; CH2CH2), 2.05-2.14 (m, 
1H; CHCHH), 1.84 (pent, 3J(H,H) = 7.4 Hz, 1H; CHCHH), 1.46 (s, 3H; C(CH3)), 1.35 
(s, 3H; C(CH3)), 0.82 (s, 9H; SiC(CH3)3), 0.08 (s, 3H; Si(CH3)), -0.09 (s, 3H; Si(CH3)) 
ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 206.7 (C(O)), 201.3 (CHO), 139.9 (Ar-C), 127.5, 127.3, 127.0 (5C, Ar-CH), 101.1 
(C(CH3)2), 79.2 (PhCH(OSi)), 74.1 (CHCH(OSi)), 73.0 (CHCH2),  39.3 (CH2CH2), 
25.7 (3C, SiC(CH3)3), 24.3 (C(CH3)), 23.7 (C(CH3)), 21.1 (CHCH2), 18.2 (SiC(CH3)3), 
-4.8, -5.0 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 2941 (w), 2863 (w), 1718 (vw), 1456 (m), 1383 (m), 1249 (w), 1101 (w), 939 (s), 
843 (w), 761 (vw), 699 (m), 572 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 407 (0.7) [M++H], 307 (10), 233 (10), 222 (19), 221 (100), 201 (15). 
 
MS (EI, 70 eV): 
 
m/z [%] = 365 (2.2), 307 (30), 289 (9), 222 (9), 221 (51), 207 (9), 202 (13), 201 (100), 
185 (11), 173 (12), 155 (28), 131 (10), 105 (10), 103 (9), 85 (9), 75 (32), 73 (30), 59 
(12). 
 
HR-MS: C17H27O3Si [M+ -(CH3)2CO -C2HO]:  
 
calcd  307.1002 
found 307.1002 
 
 
 
3-((4R,5R,6S)-6-((R)-(tert-Butyldimethylsilyloxy)(phenyl)methyl)-5-hydroxy-2,2-
dimethyl-1,3-dioxan-4-yl)propanoic acid (61) 
C22H36O6Si, Mw = 424.60 
 
O O
H3C CH3
OH
OH
O
Si
O
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To a stirred solution of aldehyde 59 (96 mg, 0.23 mmol, 1.0 equiv) in a mixture 
acetone/H2O (1:1) (1.4 mL) at 0°C was added sequentially 2-methyl-2-butene 
(CH3)2C=CH2 (460 µL, 4.32 mmol, 18.4 equiv), monosodiumdihydrogenophosphate 
NaH2PO4 (73 mg, 0.47 mmol, 2.0 equiv) and sodium chlorite NaOCl2 (80%) (67 mg, 
0.59 mmol, 2.5 equiv). The stirring was continued for 4 h at RT before the mixture 
was extracted with EtOAc several times (aqueous phase: H2O), dried (MgSO4) and 
concentrated under reduced pressure to give the crude product as a yellow liquid. 
Purification by flash chromatography on silica gel (n-pentane/Et2O 50:50) gave 
carboxylic acid 61 as a yellow oil. 
 
Yield:   m = 86 mg  0.20 mmol, 86% 
 
GC:   Rf = 14.0 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D25 = - 14.55 (c = 1.00 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 7.26-7.40 (m, 5H; Ar-H), 4.94 (d, 3J(H,H) = 5.9 Hz, 1H; PhCH(OSi)), 3.80 (dd, 
3J(H,H) = 5.9, 3.2 Hz, 1H; CHCH(OSi)), 3.68 (dd, 3J(H,H) = 6.2, 3.2 Hz, 1H; 
CH(OH)), 3.56-3.63 (m, 1H; CHCH2), 2.34-2.53 (m, 2H; CH2CH2), 1.94-2.05 (m, 1H; 
CHCHH), 1.70-1.80 (m, 1H; CHCHH), 1.34 (s, 3H; C(CH3)), 1.11 (s, 3H; C(CH3)), 
0.89 (s, 9H; SiC(CH3)3), 0.09 (s, 3H; Si(CH3)), -0.16 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 178.8 (COOH), 140.9 (Ar-C), 128.1, 127.7, 126.7 (5C, Ar-CH), 101.1 (C(CH3)2), 
75.8 (PhCH(OSi)), 74.3 (CHCH2), 73.5 (CHCH(OSi)), 73.2 (CH(OH)), 30.5 (CH2CH2), 
28.5 (CHCH2), 25.7 (3C, SiC(CH3)3), 24.7 (C(CH3)), 23.7 (C(CH3)), 18.1 (SiC(CH3)3), 
-4.7, -5.2 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3921 (s), 3395 (s), 2934 (w), 1715 (w), 1454 (m), 1381 (w), 1224 (w), 1084 (w), 
843 (m), 759 (vw), 702 (m), 668 (s) cm-1. 
 
MS (CI, isobutane): 
 
m/z [%] = 425 (26.7) [M++H], 294 (18), 293 (100), 291 (9), 275 (8), 236 (12), 235 (78), 
217 (8), 173 (16). 
 
MS (EI, 70 eV): 
 
m/z [%] = 409 (4.0) [M+-CH3], 309 (7), 292 (12), 291 (56) [M+-(CH3)2CO -C3H7O2], 
235 (11), 221 (33), 217 (30), 207 (29), 205 (11), 203 (43), 194 (18), 193 (100), 189 
(42), 186 (11), 185 (81), 181 (21), 173 (13), 171 (10), 157 (29), 145 (22), 143 (28), 
132 (11), 131 (16), 129 (19), 127 (10), 115 (29), 99 (10), 91 (19), 85 (14), 75 (71), 73 
(39), 59 (30), 57 (12), 55 (14). 
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HR-MS: C21H33O6Si [M+ -CH3]:  
 
calcd  409.2046 
found 409.2046 
 
 
 
3-((4R,5R,6S)-6-((R)-(tert-Butyldimethylsilyloxy)(phenyl)methyl)-5-hydroxy-2,2-
dimethyl-1,3-dioxan-4-yl)methylpropanoate (62) 
C23H38O6Si, Mw = 438.63 
 
O O
H3C CH3
OH
OCH3
O
Si
O
 
 
To a stirred solution of carboxylic acid 61 (88 mg, 0.21 mmol, 1.0 equiv) in absolute 
CH2Cl2 (2 mL) at 0°C was added sequentially 4-dimethylaminopyridine (DMAP) (3 
mg, 0.02 mmol, 0.1 equiv) and 1-((3-dimethylamino)-propyl)-3-ethylcarbodiimide 
hydrochloride (EDCL) (45 mg, 0.23 mmol, 1.1 equiv). The stirring was continued for 5 
min at this temperature before the mixture was allowed to warm up to RT. Then 
freshly distilled MeOH (120 µL, 3.10 mmol, 15.0 equiv) was added to the reaction. 
The stirring was continued for 2 h before the mixture was diluted with CH2Cl2 (2 mL) 
and washed with aqueous NH4Cl solution (10 mL) and brine (10 mL). The aqueous 
phase was extracted with EtOAc (3x 10 mL) and the combined organic extracts were 
dried (MgSO4) and concentrated under reduced pressure to give the crude product 
as a yellow liquid. Purification by flash chromatography on silica gel (n-pentane/Et2O 
50:50) gave methyl ester 62 as a yellow oil. 
 
Yield:   m = 55 mg  0.13 mmol, 61% 
 
GC:   Rf = 13.6 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D29 = - 15.22 (c = 1.00 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 7.25-7.39 (m, 5H; Ar-H), 4.95 (d, 3J(H,H) = 5.8 Hz, 1H; PhCH(OSi)), 3.79 (dd, 
3J(H,H) = 6.0, 3.3 Hz, 1H; CHCH(OSi)), 3.71 (d, 3J(H,H) = 4.7 Hz, 1H; CH(OH)), 3.65 
(s, 3H; OCH3), 3.53-3.59 (m, 1H; CHCH2), 2.32-2.49 (m, 2H; CH2CH2), 1.95-2.04 (m, 
1H; CHCHH), 1.72-1.82 (m, 1H; CHCHH), 1.34 (s, 3H; C(CH3)), 1.11 (s, 3H; C(CH3)), 
0.90 (s, 9H; SiC(CH3)3), 0.09 (s, 3H; Si(CH3)), -0.16 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 173.6 (COOCH3), 140.7 (Ar-C), 127.9, 127.4, 126.5 (5C, Ar-CH), 100.8 
(C(CH3)2), 75.7 (PhCH(OSi)), 74.3 (CHCH2), 73.4 (CHCH(OSi)), 73.1 (CH(OH)), 51.4 
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(COOCH3), 30.5 (CH2CH2), 28.7 (CHCH2), 25.6 (3C, SiC(CH3)3), 24.7 (C(CH3)), 23.7 
(C(CH3)), 18.1 (SiC(CH3)3), -4.7, -5.2 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3983 (s), 3488 (s), 2937 (vw), 2860 (w), 1742 (vw), 1461 (m), 1378 (m), 1225 (w), 
1176 (w), 1092 (vw), 1001 (m), 931 (s), 844 (w), 761 (vw), 700 (m), 668 (s), 528 (s) 
cm-1. 
 
MS (CI, isobutane): 
 
m/z [%] = 440 (30), 439 (100.0) [M++H], 408 (24), 407 (81), 349 (26), 308 (11), 307 
(57), 291 (8), 289 (23), 276 (10), 275 (57), 249 (48), 217 (31). 
 
MS (EI, 70 eV): 
 
m/z [%] = 349 (18), 323 (16), 305 (29), 291 (45), 273 (16), 235 (11), 231 (46), 222 
(11), 221 (55), 217 (62), 207 (40), 205 (22), 203 (17), 199 (29), 194 (15), 193 (96), 
187 (11), 186 (14), 185 (100), 181 (22), 177 (21), 173 (10), 171 (17), 161 (18), 159 
(32), 157 (45), 143 (27), 132 (12), 131 (16), 130 (10), 129 (40), 115 (20), 105 (11), 
103 (10), 91 (24), 85 (25), 75 (57), 73 (37), 59 (16), 55 (11). 
 
HR-MS: C22H35O6Si [M+ -CH3]:  
 
calcd  423.2203 
found 423.2202 
 
 
 
(R)-(4S,5R,6R)-(-)-5-(Benzyloxy)-4-[3-(benzyloxy)propyl]-6-[(R)-(tert-
butyldimethylsilyloxy)(phenyl)methyl]-2,2-dimethyl-1,3-dioxan (63) 
C36H50O5Si, Mw = 590.86 
 
O O
H3C CH3
O
O
O
Si
 
 
To a stirred solution of potassium hydride KH (557 mg, 30% in mineral oil, 4.2 mmol, 
3.0 equiv), washed with cyclohexane, in THF (4 mL) at 0°C was added a solution of 
alcohol product 56 (695 mg, 1.4 mmol, 1.0 equiv) in absolute THF (10 mL) dropwise 
via syringe. The stirring was continued for 30 min at this temperature before freshly 
distilled benzyl bromide BnBr (660 µL, 5.6 mmol, 4.0 equiv) was added dropwise via 
syringe. The stirring was continued overnight at RT before the reaction was 
quenched with H2O (30 mL). The mixture was poured into H2O (20 mL) and extracted 
with Et2O (50 mL). The aqueous portion was extracted with Et2O (3x 20 mL). The 
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combined organic extracts were washed with brine (20 mL), dried (MgSO4), filtered 
and concentrated under reduced pressure to give the crude product as a yellow 
liquid. Purification by flash chromatography on silica gel (n-pentane/Et2O 90:10) gave 
the Bn-protected product 63 as a colourless oil. 
 
Yield:   m = 738 mg  1.25 mmol, 90% 
 
GC:   Rf = 18.8 min CP-Sil-8, 160-10-300 
Optical rotation: [α]D22 = - 1.65 (c = 1.01 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.42-7.62 (m, 15H; Ar-H), 5.11 (d, 3J(H,H) = 9.3 Hz, 1H; PhCH(OSi)), 4.91 (d, 
3J(H,H) = 11.8 Hz, 1H; CHOCHHPh), 4.83 (d, 3J(H,H) = 11.8 Hz, 1H; CHOCHHPh), 
4.70 (s, 2H; CH2OCH2Ph), 4.11 (dd, 3J(H,H) = 9.3, 2.2 Hz, 1H; CHCH(OSi)), 3.98 
(dd, 3J(H,H) = 5.0, 3.3 Hz, 1H; CHCH2), 3.96 (dd, 3J(H,H) = 5.0, 2.2 Hz, 1H; 
CHOCH2Ph), 3.64 (t, 3J(H,H) = 6.3 Hz, 2H; CH2OCH2), 1.95-2.02 (m, 1H; 
CH2CHHCH2),  1.77-1.87 (m, 3H; CH2CHHCH2, CHCH2), 1.45 (s, 3H; C(CH3)), 1.08 
(s, 3H; C(CH3)), 1.05 (s, 9H; SiC(CH3)3), 0.18 (s, 3H; Si(CH3)), -0.25 (s, 3H; Si(CH3)) 
ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 142.8, 139.0, 138.6 (3C, Ar-C), 128.3, 128.2, 128.1, 128.0, 127.9, 127.7, 127.6, 
127.5, 127.4, 127.4, 127.4 (15C, Ar-CH), 100.7 (C(CH3)2), 80.7 (CHCH2), 74.8 
((CHCH(OSi)), 73.9 (CHOCH2Ph), 72.9 (CH2OCH2Ph), 72.7 (CHOCH2Ph),  72.4 
(CH(OSi)), 70.0 (CH2OCH2), 31.8 (CHCH2), 26.1 (CH2CH2CH2), 26.1 (3C, 
SiC(CH3)3), 25.0 (C(CH3)), 23.6 (C(CH3)), 18.2 (SiC(CH3)3), -4.7, -4.0 (2C, Si(CH3)2) 
ppm. 
 
IR (CHCl3): 
 
ν = 3064 (s), 3031 (m), 2988 (m), 2930 (w), 2857 (w), 1495 (s), 1456 (m), 1372 (m), 
1249 (w), 1222 (w), 1173 (s), 1093 (vw), 1030 (m), 839 (w), 758 (vw), 699 (w), 668 
(s), 617 (s), 559 (s), 461 (s). 
 
MS (CI, methane): 
 
m/z [%] = 591 (5.0) [M++H], 575 (11), 516 (14), 515 (36), 459 (10), 425 (15), 409 (14), 
407 (11), 402 (12), 401 (42), 383 (36), 367 (13), 351 (24), 319 (12), 317 (13), 301 
(13), 297 (35), 295 (11), 294 (17), 293 (69), 277 (21), 251 (29), 249 (11), 233 (12), 
222 (20), 221 (100), 215 (11), 203 (14), 191 (34), 181 (33), 173 (13), 161 (14), 91 
(52), 71 (13). 
 
Elemental Analysis: 
 
C36H50O5Si (590.86): calcd C 73.18, H 8.53; found C 73.39, H 8.72. 
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(1R,2R,3R,4R)-(-)-3,7-bis(Benzyloxy)-1-phenylheptane-1,2,4-triol (65) 
C27H32O5, Mw = 436.54 
 
OH OH
O
O
HO
 
 
“no Ar” 
To a stirred solution of the Bn-protected product 63 (337 mg, 0.6 mmol, 1.0 equiv) in 
MeOH (6 mL) at RT was added Amberlyst® 15 (685 mg, 200% in weight). The stirring 
was continued for 4 h (TLC control) at this temperature before the reaction was 
filtered through a short pad of celite, eluting with MeOH. The filtrate was concentrated 
under reduced pressure to give the crude product as a pale yellow syrup. 
Then, to a solution of the resulting crude diol in absolute THF (6 mL) at 0°C was 
added n-tetrabutylammonium fluoride (nBu)4NF (TBAF) (1.10 mL, 1.0 M in THF, 1.1 
mmol, 2.0 equiv) dropwise via syringe. The stirring was continued at RT for 14 h 
(TLC control) before the reaction was quenched with H2O (10 mL). The mixture was 
poured into H2O (20 mL) and extracted with EtOAc (30 mL). The aqueous portion 
was extracted with EtOAc (3x 20 mL). The combined organic extracts were washed 
with brine (20 mL), dried (Na2SO4), filtered and concentrated under reduced pressure 
to give the crude product as a yellow syrup. Purification by flash chromatography on 
silica gel (n-pentane/EtOAc 50:50) gave triol product 65 as a colourless solid. 
 
Yield:   m = 228 mg  0.52 mmol, 92% (over 2 steps) 
 
GC:   Decomposition 
Optical rotation: [α]D22 = - 19.15 (c = 1.07 in CHCl3) 
Melting point: Not measured (compound too hygroscopic) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.26-7.37 (m, 15H; Ar-H), 4.82 (d, 3J(H,H) = 6.6 Hz, 1H; PhCH(OH)), 4.69 (d, 
3J(H,H) = 11.3 Hz, 1H; CHOCHHPh), 4.52 (d, 3J(H,H) = 11.3 Hz, 1H; CHOCHHPh), 
4.50 (s, 2H; CH2OCH2Ph), 4.03 (t, 3J(H,H) = 4.9 Hz, 1H; 
CH(OH)CH(OH)CHOCH2Ph), 3.94 (t, 3J(H,H) = 4.4 Hz, 1H; CHOCH2Ph), 3.63 (s, 1H; 
OH), 3.52 (dd, 3J(H,H) = 4.7, 1.9 Hz, 1H; CHCH2), 3.49 (t, 3J(H,H) = 6.3 Hz, 2H; 
CH2OCH2Ph), 3.42 (s, 1H; OH), 3.11 (s, 1H; OH), 1.73-1.81 (m, 1H; CH2CHHCH2),  
1.63-1.71 (m, 2H; CHCHH, CH2CHHCH2), 1.51-1.59 (m, 1H; CHCHH) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 141.4, 137.9, 137.5 (3C, Ar-C), 128.6, 128.4, 128.3, 128.1, 127.8, 127.7, 126.3, 
(15C, Ar-CH), 79.2 (CHCH2), 75.3 (PhCH(OH)), 73.9 (CH(OH)CH(OH)CHOCH2Ph), 
73.1 (CH2OCH2Ph), 72.4 (CHOCH2Ph), 71.8 (CHOCH2Ph), 70.3 (CH2OCH2), 31.2 
(CHCH2), 26.7 (CH2CH2CH2) ppm. 
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IR (CHCl3): 
 
ν = 3406 (w), 3063 (m), 3030 (m), 2925 (w), 2862 (w), 1603 (s), 1495 (m), 1453 (m), 
1362 (s), 1212 (m), 1093 (vw), 755 (vw), 700 (w), 667 (s), 613 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 437 (16) [M++H], 420 (22), 419 (77), 329 (22), 311 (10), 309 (10), 299 (17), 
293 (31), 221 (11), 211 (11), 203 (21), 192 (11), 191 (82), 181 (44), 179 (31), 123 
(15), 119 (17), 107 (33), 101 (27), 92 (11), 91 (100), 71 (38). 
 
Elemental Analysis: 
 
C27H32O5 (436.54): calcd C 74.29, H 7.39; found C 73.95, H 7.37. 
 
 
 
(1R,2R)-(-)-1,5-bis(Benzyloxy)-1-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-dioxolan-4-
yl]pentan-2-ol (67) 
C30H36O5, Mw = 476.60 
 
O OH
O
OO
H3C
CH3  
 
From triol 65: 
 
To a stirred solution of triol 65 (499 mg, 1.1 mmol, 1.0 equiv) in absolute CH2Cl2 (12 
mL) at RT was added 2,2-dimethoxypropane (CH3)2C(OCH3)2 (2,2-DMP) (730 µL, 5.7 
mmol, 5.0 equiv) dropwise via syringe and a catalytic amount of pyridinium p-
toluenesulfonate (PPTS). The stirring was continued for 14 h (TLC control) at this 
temperature before the reaction was quenched with triethylamine Et3N (3 mL). The 
mixture was diluted into CH2Cl2 (30 mL) and concentrated under reduced pressure to 
give the crude product as a yellow syrup. Purification by flash chromatography on 
silica gel (n-pentane/Et2O 50:50) gave separated both acetonides 66 and 67 as 
colourless oils in a respective proportion of 2 to 1. 
 
Yield:   m = 529 mg  1.11 mmol, 97% (acetonidation yield) 
 
From acetonide 66: 
 
To a stirred solution of acetonide 66 (272 mg, 0.6 mmol, 1.0 equiv) in absolute 
acetone (6 mL) at RT under argon was added a catalytic amount of p-toluenesulfonic 
acid (p-TsOH). The stirring was continued for 24 h at this temperature. Then, 2,2-
dimethoxypropane (CH3)2C(OCH3)2 (2,2-DMP) (20 µL, 0.1 mmol, 0.25 equiv) and a 
catalytic amount of pyridinium p-toluenesulfonate (PPTS) were added. The stirring 
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was continued for 1 h before the reaction was quenched with pH 7 buffer solution (2 
mL) and diluted with Et2O (20 mL). The aqueous layer was extracted with Et2O (3x 20 
mL) and the combined organic extracts were washed with brine (20 mL), dried 
(MgSO4) and concentrated under reduced pressure to give a crude mixture of 
acetonides (ratio of 1.6 to 1) as a colourless syrup. Purification by flash 
chromatography on silica gel (n-pentane/Et2O 50:50) gave acetonide 67 as a pale pink 
oil and recovered starting material 66. 
 
Yield:   m = 257 mg  0.54 mmol, 95% (acetonidation yield) 
 
GC:   Rf = 22.1 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D22 = - 123.75 (c = 1.01 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.15-7.28 (m, 15H; Ar-H), 5.17 (d, 3J(H,H) = 6.9 Hz, 1H; PhCH), 4.58 (dd, 3J(H,H) 
= 6.9, 4.1 Hz, 1H; CHCHPh), 4.42 (s, 2H; CH2OCH2Ph), 4.24 (d, 3J(H,H) = 11.3 Hz, 
1H; CHOCHHPh), 3.85 (d, 3J(H,H) = 11.3 Hz, 1H; CHOCHHPh), 3.44 (dd, 3J(H,H) = 
5.7, 4.1 Hz, 1H; CHCH2), 3.39 (td, 3J(H,H) = 5.4, 1.9 Hz, 2H; CH2OCH2Ph), 2.96 (t, 
3J(H,H) = 4.1 Hz, 1H; CHOCH2Ph), 2.77 (d, 3J(H,H) = 6.4 Hz, 1H; OH), 1.65-1.72 (m, 
1H; CH2CHHCH2),  1.59 (s, 3H; C(CH3)), 1.45-1.54 (m, 2H; CHCHH, CH2CHHCH2), 
1.40-1.43 (m, 1H; CHCHH), 1.40 (s, 3H; C(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 138.6, 138.3, 137.7 (3C, Ar-C), 128.4, 128.2, 128.1, 127.7, 127.7, 127.6, 127.5, 
127.3, 127.1 (15C, Ar-CH), 109.2 (C(CH3)2), 79.4 (CHOCH2Ph), 79.3 (PhCHCH), 
79.2 (PhCH), 73.0 (CH2OCH2Ph), 72.1 (CHOCH2Ph), 70.9 (CHCH2), 70.3 
(CH2OCH2), 30.4 (CH2CH2CH2), 26.7 (C(CH3)), 26.5 (CHCH2), 25.4 (C(CH3)) ppm. 
 
IR (CHCl3): 
 
ν = 3428 (w), 3061 (m), 3031 (w), 2928 (vw), 2863 (vw), 1956 (s), 1722 (s), 1602 (s), 
1495 (m), 1454 (w), 1374 (w), 1248 (w), 1217 (w), 1094 (vw), 880 (m), 741 (vw), 701 
(w), 606 (s), 515 (s), 463 (s) cm-1.  
 
MS (CI, methane): 
 
m/z [%] = 477 (1) [M++H], 459 (2), 420 (30), 419 (100), 383 (5), 311 (16), 309 (12), 
299 (25), 293 (38), 281 (3), 203 (23), 192 (13), 191 (99), 181 (44), 179 (50), 119 (24), 
107 (14), 101 (21), 91 (78), 71 (43). 
 
MS (EI, 70 eV): 
 
m/z [%] = 461 (1) [M+-CH3], 298 (5) [M+-C11H14O2], 191 (10), 179 (14), 165 (11), 148 
(15), 147 (13), 134 (15), 133 (19), 132 (13), 119 (13), 92 (9), 91 (100), 71 (7). 
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HR-MS: C19H22O3 [M+-C11H14O2]:  
 
calcd  298.1569 
found 298.1570 
 
 
 
(R)-(4S,5R,6R)-(-)-5-(Benzyloxy)-4-[3-(benzyloxy)propyl]-6-[(R)-
hydroxy(phenyl)methyl]-2,2-dimethyl-1,3-dioxan (66) 
C30H36O5, Mw = 476.60 
 
O O
H3C CH3
O
O
OH
 
 
To a solution of compound 63 (2.095 g, 3.55 mmol, 1.0 equiv) in absolute THF (35 
mL) at 0°C was added n-tetrabutylammonium fluoride (nBu)4NF (TBAF) (7.10 mL, 1.0 
M in THF, 7.09 mmol, 2.0 equiv) dropwise via syringe. The stirring was continued at 
RT for 13 h before the reaction was quenched with H2O (30 mL). The mixture was 
poured into H2O (20 mL) and extracted with Et2O (3 x 20 mL). The combined organic 
extracts were washed with brine (20 mL), dried (MgSO4), filtered and concentrated 
under reduced pressure to give the crude product as a yellow syrup. Purification by 
flash chromatography on silica gel (n-pentane/EtOAc 70:30) gave the alcohol 66 as a 
colourless oil. 
 
Yield:   m = 1.603 mg 3.36 mmol, 95% 
 
GC:   Rf = 22.7 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D23 = - 9.78 (c = 1.03 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.20-7.37 (m, 15H; Ar-H), 4.90 (dd, 3J(H,H) = 7.9, 5.1 Hz, 1H; PhCH(OH)), 4.58 
(d, 3J(H,H) = 11.4 Hz, 1H; CHOCHHPh), 4.51 (d, 3J(H,H) = 11.4 Hz, 1H; 
CHOCHHPh), 4.44 (s, 2H; CH2OCH2Ph), 3.91 (dd, 3J(H,H) =  7.9, 3.5 Hz, 1H; 
CHCH(OH)), 3.72 (td, 3J(H,H) = 6.4, 6.2 Hz, 1H; CHCH2), 3.59 (dd, 3J(H,H) = 6.2, 3.5 
Hz, 1H; CHOCH2Ph), 3.40 (td, 3J(H,H) = 6.2, 1.7 Hz, 2H; CH2OCH2), 2.94 (d, 3J(H,H) 
= 5.1 Hz, 1H; OH), 1.71-1.80 (m, 1H; CH2CHHCH2), 1.55-1.69 (m, 2H; CH2CHHCH2, 
CHCHH), 1.40-1.53 (m, 1H; CHCHH), 1.29 (s, 3H; C(CH3)), 1.02 (s, 3H; C(CH3)) 
ppm. 
 
 13C NMR (100 MHz, CDCl3): 
 
δ = 142.1, 138.4, 138.2 (3C, Ar-C), 128.4, 128.3, 128.0, 127.8, 127.6, 127.5, 127.5, 
127.4, 126.5 (15C, Ar-CH), 100.8 (C(CH3)2), 81.1 (CHOCH2Ph), 73.6 (CHCH(OH)), 
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73.3 (CHOCH2Ph), 72.9 (CHCH2), 72.7 (CH2OCH2Ph), 72.4 (CH(OH)), 69.7 
(CH2OCH2), 30.9 (CHCH2), 25.8 (CH2CH2CH2), 24.6 (C(CH3)), 23.6 (C(CH3)) ppm. 
 
IR (CHCl3): 
 
ν = 3901 (s), 3853 (s), 3837 (s), 3800 (s), 3747 (m), 3709 (s), 3673 (m), 3649 (m), 
3627 (s), 3588 (s), 3566 (s), 3436 (w), 3086 (m), 3063 (w), 3031 (w), 2987 (w), 2931 
(w), 2862 (w), 2362 (vw), 2336 (vw), 2245 (s), 1947 (s), 1870 (s), 1772 (s), 1735 (s), 
1717 (s), 1700 (s), 1652 (m), 1616 (s), 1559 (m), 1541 (m), 1497 (m), 1456 (w), 1375 
(w), 1313 (s), 1220 (w), 1170 (w), 1093 (vw), 910 (w), 736 (vw), 700 (w), 669 (s), 616 
(m), 550 (s), 513  (m) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 477 (1) [M++H], 459 (2), 420 (29), 419 (100), 401 (13), 383 (5), 312 (3), 311 
(11), 294 (9), 293 (41), 205 (18), 203 (15), 191 (26), 181 (14), 149 (11), 91 (19). 
 
MS (EI, 70 eV): 
 
m/z [%] = 310 (3), 260 (3), 219 (2), 204 (4), 177 (10), 149 (13), 148 (35), 133 (11), 
129 (31), 119 (29), 105 (12), 91 (100), 71 (59). 
 
Elemental Analysis: 
 
C30H36O5 (476.60): calcd C 75.60, H 7.61; found C 75.53, H 8.03. 
 
 
 
(1R,2R)-(-)-1,5-bis(Benzyloxy)-1-[(4R,5R)-2,2-diethyl-5-phenyl-1,3-dioxolan-4-
yl]pentan-2-ol (70) 
C32H40O5, Mw = 504.66 
 
OH
O
OO
O
 
 
 
To a stirred solution of triol 65 (78 mg, 0.16 mmol, 1.0 equiv) in absolute CH2Cl2 (5 
mL) at RT was added 3,3-dimethoxypentane (CH3CH2)2C(OCH3)2 (3,3-DMP) (0.8 
mmol, 5.0 equiv) [obtained from the reaction of 3-pentanone (CH3CH2)2CO (91 mg, 
1.00 mmol, 1.0 equiv), trimethylorthoformiate CH(OCH3)3 (111 mg, 1.00 mmol, 1.0 
equiv) and Amberlyst® 15 (2 mg, 2% in weight) overnight at RT] dropwise via syringe 
and a catalytic amount of pyridinium p-toluenesulfonate (PPTS). The stirring was 
continued for 6 h at this temperature before the reaction was quenched with 
triethylamine Et3N (1 mL). The mixture was diluted into CH2Cl2 (10 mL) and 
concentrated under reduced pressure to give the crude product as a yellow syrup. 
Experimental part 
 
124 
Purification by flash chromatography on silica gel (n-pentane/Et2O 50:50) gave 
separated both acetonides 69 and 70 as colourless oils in a respective proportion of 
3 to 2. 
 
Yield:   m = 109 mg  0.16 mmol, 100% (acetonidation yield) 
 
GC:   Rf = 22.2 min CP-Sil-8, 140-10-300 
Optical rotation: [α]D29 = - 26.97 (c = 1.00 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.15-7.28 (m, 15H; Ar-H), 5.17 (d, 3J(H,H) = 7.7 Hz, 1H; PhCH), 4.57 (dd, 3J(H,H) 
= 7.7, 4.5 Hz, 1H; CHCHPh), 4.42 (s, 2H; CH2OCH2Ph), 4.21 (d, 3J(H,H) = 11.1 Hz, 
1H; CHOCHHPh), 3.78 (d, 3J(H,H) = 11.1 Hz, 1H; CHOCHHPh), 3.34-3.42 (m, 3H; 
CHCH2, CH2OCH2Ph), 3.00 (t, 3J(H,H) = 4.1 Hz, 1H; CHOCH2Ph), 2.77 (d, 3J(H,H) = 
6.7 Hz, 1H; OH), 1.88 (q, 3J(H,H) = 7.5 Hz, 2H; C(CH2CH3)), 1.69 (q, 3J(H,H) = 7.5 
Hz, 2H; C(CH2CH3)), 1.41-1.54 (m, 4H; CH2CH2CH2,  CHCH2), 0.96 (t, 3J(H,H) = 7.5 
Hz, 3H; C(CH2CH3)), 0.88 (t, 3J(H,H) = 7.5 Hz, 3H; C(CH2CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 138.7, 138.4, 138.0 (3C, Ar-C), 128.4, 128.2, 128.1, 127.7, 127.6, 127.6, 127.2, 
127.2 (15C, Ar-CH), 113.2 (C(CH3)2), 79.6 (CHOCH2Ph), 79.1 (PhCH), 79.0 
(PhCHCH), 72.9 (CH2OCH2Ph), 72.1 (CHOCH2Ph), 70.7 (CHCH2), 70.2 (CH2OCH2), 
30.3 (CH2CH2CH2), 28.8 (C(CH2CH3)), 27.5 (C(CH2CH3)), 26.3 (CHCH2), 8.8 
(C(CH2CH3)), 8.6 (C(CH2CH3)) ppm. 
 
IR (CHCl3): 
 
ν = 3529 (br, s), 3410 (br, s), 2936 (w), 2873 (w), 1495 (s), 1456 (m), 1359 (s), 1277 
(s), 1215 (m), 1173 (s), 1091 (w), 938 (m), 755 (vw), 701 (w) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 476 (5.1) [M++H-CH3CH2], 475 (16), 420 (18), 419 (61), 311 (13), 309 (16), 
299 (18), 293 (43), 219 (12), 209 (11), 203 (28), 199 (11), 193 (15), 192 (14), 191 
(100), 181 (45), 179 (54), 119 (22), 107 (17), 101 (21), 91 (97), 87 (25), 71 (47), 61 
(10). 
 
MS (EI, 70 eV): 
 
m/z [%] = 475 (7.1) [M+-CH3CH2], 193 (16), 181 (10), 179 (13), 176 (13), 134 (10), 
133 (14), 132 (10), 119 (11), 92 (10), 91 (100), 71 (13). 
 
HR-MS: C30H35O5 [M+ -C2H5]:  
 
calcd  475.2484 
found 475.2485 
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(R)-(4S,5R,6R)-(-)-5-(Benzyloxy)-4-[3-(benzyloxy)propyl]-6-[(R)-
hydroxy(phenyl)methyl]-2,2-diethyl-1,3-dioxan (69) 
C32H40O5, Mw = 504.66 
 
O O
O
O
OH
 
 
GC:   Rf = 22.0 min CP-Sil-8, 140-10-300 
Optical rotation: [α]D29 = - 0.97 (c = 1.00 in CHCl3) 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 7.99-7.14 (m, 15H; Ar-H), 4.67 (dd, 3J(H,H) = 8.2, 4.5 Hz, 1H; PhCH(OH)), 4.41 
(d, 3J(H,H) = 11.6 Hz, 1H; CHOCHHPh), 4.31 (d, 3J(H,H) = 11.6 Hz, 1H; 
CHOCHHPh), 4.23 (s, 2H; CH2OCH2Ph), 3.62 (dd, 3J(H,H) =  8.2, 3.0 Hz, 1H; 
CHCH(OH)), 3.46-3.52 (m, 1H; CHCH2), 3.36 (dd, 3J(H,H) = 5.4, 3.2 Hz, 1H; 
CHOCH2Ph), 3.20 (td, 3J(H,H) = 5.9, 3.2 Hz, 2H; CH2OCH2), 2.26 (d, 3J(H,H) = 4.7 
Hz, 1H; OH), 1.50-1.61 (m, 2H; CH2CH2CH2), 1.33-1.43 (q, 3J(H,H) = 7.4 Hz, 2H; 
C(CH2CH3)), 1.17-1.30 (m, 2H; CHCH2), 1.33-1.43 (q, 3J(H,H) = 7.4 Hz, 2H; 
C(CH2CH3)), 0.49 (t, 3J(H,H) = 7.4 Hz, 3H; C(CH2CH3)), 0.03 (t, 3J(H,H) = 7.4 Hz, 3H; 
C(CH2CH3)) ppm. 
 
 13C NMR (75 MHz, CDCl3): 
 
δ = 142.4, 138.6, 138.3 (3C, Ar-C), 128.6, 128.4, 128.1, 127.9, 127.7, 127.6, 126.7 
(15C, Ar-CH), 104.6 (C(CH3)2), 81.1 (CHOCH2Ph), 73.7 (CHCH(OH)), 73.3 
(CHOCH2Ph), 72.9 (CH2OCH2Ph), 72.8 (CHCH2), 72.5 (CH(OH)), 69.7 (CH2OCH2), 
31.5 (CHCH2), 26.1 (C(CH2CH3)), 26.0 (C(CH2CH3)) 24.7 (CH2CH2CH2), 8.0 
(C(CH2CH3)), 6.9 (C(CH2CH3)) ppm. 
 
IR (CHCl3): 
 
ν = 3572 (s), 3405 (br, m), 3027 (w), 2939 (vw), 1720 (s), 1600 (s), 1456 (w), 1359 
(m), 1274 (s), 1215 (m), 1170 (m), 1088 (vw), 944 (m), 752 (vw), 701 (w), 610 (s), 
468 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 476 (5.1) [M++H-CH3CH2], 475 (15), 420 (17), 419 (60), 311 (15), 309 (20), 
294 (15), 293 (71), 209 (10), 205 (24), 204 (13), 203 (39), 192 (10), 191 (69), 181 
(43), 179 (16), 149 (15), 119 (17), 107 (52), 105 (11), 101 (16), 92 (11), 91 (100), 87 
(42), 85 (14), 79 (14), 71 (25), 61 (19). 
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MS (EI, 70 eV): 
 
m/z [%] = 475 (9.5) [M+-CH3CH2], 240 (10), 191 (10), 181 (11), 149 (25), 105 (17), 92 
(12), 91 (100), 85 (14). 
 
HR-MS: C30H35O5 [M+ -C2H5]:  
 
calcd  475.2484 
found 475.2485 
 
 
 
(1S,2R)-(-)-1,5-bis(Benzyloxy)-2-[(R)-(tert-butyldimethylsilyloxy)]-1-[(4R,5R)-2,2-
dimethyl-5-phenyl-1,3-dioxolan-4-yl]pentan (71) 
C36H50O5Si, Mw = 590.86 
 
O O
O
OO
H3C
CH3 Si
 
 
To a stirred solution of alcohol 67 (163 mg, 0.3 mmol, 1.0 equiv) in CH2Cl2 (5 mL) at 
0°C was added sequencially, 2,6-lutidine (2,6-dimethylpyridine) (120 µL, 1.0 mmol, 
3.0 equiv) and tert-butyldimethylsilyl triflate TBSOTf (120 µL, 0.5 mmol, 1.5 equiv) 
dropwise via syringe. The stirring was continued for 2 h at RT before the reaction was 
quenched with aqueous NH4Cl solution (10 mL). The mixture was poured into 
aqueous NH4Cl solution (10 mL) and extracted with CH2Cl2 (20 mL). The aqueous 
portion was extracted with CH2Cl2 (2x 10 mL) and the combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure to give the 
crude product as a colourless syrup. Purification by flash chromatography on silica 
gel (n-pentane/Et2O 80:20) gave the TBS-protected product 71 as a colourless oil. 
. 
Yield:   m = 200 mg  0.34 mmol, 99% 
 
GC:   Rf = 19.6 min CP-Sil-8, 160-10-300 
Optical rotation: [α]D22 = - 276.26 (c = 1.13 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.45-7.62 (m, 15H; Ar-H), 5.34 (d, 3J(H,H) = 6.9 Hz, 1H; PhCH), 4.81 (d, 3J(H,H) 
= 11.4 Hz, 1H; CHOCHHPh), 4.75 (dd, 3J(H,H) = 6.9, 6.0 Hz, 1H; CHCH(Ph)), 4.73 
(s, 2H; CH2OCH2Ph), 4.37 (d, 3J(H,H) = 11.4 Hz, 1H; CHOCHHPh), 3.77 (dd, 3J(H,H) 
= 7.7, 3.6 Hz, 1H; CHCH2), 3.66 (td, 3J(H,H) = 5.8, 1.1 Hz, 2H; CH2OCH2Ph), 3.54 
(dd, 3J(H,H) = 6.0, 3.6 Hz, 1H; CHOCH2Ph), 1.90 (s, 3H; C(CH3)), 1.73-1.96 (m, 4H; 
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CH2CH2CH2, CHCH2), 1.71 (s, 3H; C(CH3)), 1.08 (s, 9H; SiC(CH3)3), 0.09 (s, 3H; 
Si(CH3)), 0.00 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 139.3, 138.7, 138.7 (3C, Ar-C), 128.5, 128.4, 128.0, 127.9, 127.7, 127.6, 127.5, 
127.5, 127.1 (15C, Ar-CH), 108.8 (C(CH3)2), 81.0 (CHOCH2Ph), 80.2 (CHCH(Ph)), 
79.3 (CHPh), 73.8 (CHOCH2Ph), 73.3 (CHCH2), 72.9 (CH2OCH2Ph), 70.6 
(CH2OCH2Ph), 28.8 (CHCH2), 27.0 (C(CH3)), 26.1 (3C, SiC(CH3)3), 25.8 
(CH2CH2CH2), 25.5 (C(CH3)), 18.2 (SiC(CH3)3), -4.8, -4.2 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3063 (m), 3029 (m), 2933 (vw), 2858 (vw), 1603 (s), 1495 (m), 1458 (w), 1372 
(w), 1253 (w), 1215 (w), 1101 (vw), 921 (s), 880 (m), 836 (w), 754 (vw), 700 (w), 668 
(s), 598 (s), 506 (s). 
 
MS (CI, methane): 
 
m/z [%] = 591 (1.0) [M++H], 533 (21), 499 (3), 426 (12), 425 (33), 414 (15), 413 (47), 
409 (11), 401 (13), 367 (21), 307 (15), 294 (25), 293 (100), 265 (11), 216 (13), 215 
(74), 187 (15), 181 (12), 91 (26). 
 
MS (EI, 70 eV): 
 
m/z [%] = 575 (1.0) [M+-CH3], 367 (27), 294 (13), 293 (55), 265 (14), 235 (12), 201 
(13), 187 (47), 185 (18), 181 (18), 159 (18), 148 (13), 145 (12), 91 (100). 
 
Elemental Analysis: 
 
C36H50O5Si (590.86): calcd C 73.18, H 8.53; found C 72.81, H 8.92. 
 
 
 
(1S,2R)-(-)-2-(tert-Butyldimethylsilyloxy)-1-[(4S,5R)-2,2-dimethyl-5-phenyl-1,3-
dioxolan-4-yl]pentane-1,5-diol (72) 
C22H38O5Si, Mw = 410.62 
 
O O
OH
OHO
H3C
CH3 Si
 
 
A solution of compound 71 (200 mg, 0.3 mmol, 1.0 equiv) and 10% palladium on 
carbon Pd/C (20 mg, 10% in weight) in EtOAc (5 mL) was stirred overnight at RT 
under nitrogen atmosphere. The reaction was filtered through a short pad of celite, 
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eluting with EtOAc, and the filtrate was concentrated under reduced pressure to give 
the crude product as a colourless syrup. Purification by flash chromatography on 
silica gel (n-pentane/EtOAc 50:50) gave the debenzylated product 72 as a colourless 
oil. 
 
Yield:   m = 138 mg  0.34 mmol, 99% 
 
GC:   Rf = 15.9 min CP-Sil-8, 100-10-300 
Optical rotation: [α]D22 = - 171.80 (c = 1.00 in CHCl3) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.35-7.47 (m, 5H; Ar-H), 5.32 (d, 3J(H,H) = 7.4 Hz, 1H; PhCH), 4.62 (dd, 3J(H,H) 
= 7.4, 3.5 Hz, 1H; CHCH(Ph)), 3.59 (t, 3J(H,H) = 6.2 Hz, 2H; CH2OH), 3.49 (dd, 
3J(H,H) = 6.4, 3.7 Hz, 1H; CHCH2), 3.27 (dd, 3J(H,H) = 6.4, 3.5 Hz, 1H; CHCH2), 2.27 
(s, 2H; OH (x2)), 1.75 (s, 3H; C(CH3)), 1.66-1.73 (m, 1H; CHCHH), 1.57 (s, 3H; 
C(CH3)), 1.47-1.54 (m, 3H; CH2CH2CH2, CHCHH),  0.94 (s, 9H; SiC(CH3)3), 0.02 (s, 
3H; Si(CH3)), 0.00 (s, 3H; Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 137.8 (Ar-C), 128.4, 128.1, 127.0 (5C, Ar-CH), 108.5 (C(CH3)2), 79.0 (CHPh), 
77.5 (CHCH(Ph)), 71.4 (CHCH2), 71.3 (CHOH), 62.8 (CH2OH), 28.5 (CHCH2), 27.3 
(CH2CH2CH2), 26.6 (C(CH3)), 25.8 (3C, SiC(CH3)3), 24.4 (C(CH3)), 18.0 (SiC(CH3)3), 
-4.9, -4.5 (2C, Si(CH3)2) ppm. 
 
IR (CHCl3): 
 
ν = 3719 (s), 3434 (w), 2936 (vw), 2861 (w), 2390 (s), 2298 (s), 1723 (s), 1602 (s), 
1464 (m), 1378 (w), 1256 (w), 1215 (w), 1164 (m), 1100 (w), 1050 (vw), 887 (m), 837 
(w), 758 (vw), 701 (m), 668 (s) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 411 (1) [M++H], 353 (2), 335 (14), 319 (13), 317 (24), 277 (16), 217 (14), 
216 (17), 215 (100), 203 (50), 175 (20), 91 (3), 71 (14). 
 
MS (EI, 70 eV): 
 
m/z [%] = 395 (4) [M+-CH3], 278 (14), 277 (62), 215 (13), 207 (30), 203 (15), 176 
(11), 175 (78), 157 (40), 148 (30), 147 (10), 145 (36), 133 (10), 132 (25), 131 (14), 
129 (20), 119 (13), 105 (12), 91 (24), 83 (21), 75 (45), 73 (34), 71 (100). 
 
HR-MS: C21H35O5Si [M+-CH3]:  
 
calcd  395.2254 
found 395.2253 
 
 
 
  Experimental part 
   
  129 
(5R,6S)-(-)-5-(tert-Butyldimethylsilyloxy)-6-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-
dioxolan-4-yl]-tetrahydropyran-2-one (74) 
C22H34O5Si, Mw = 406.59 
 
O O
O
O
H3C
CH3 Si
O
 
 
To a stirred solution of o-iodoxybenzoic acid (IBX) (1.24 g, 2.0 mmol, 2.2 equiv) in 
freshly distilled dimethyl sulfoxide (CH3)2SO (DMSO) (5 mL) at RT was added a 
solution of diol 72 (825 mg, 2.0 mmol, 1.0 equiv) in DMSO (15 mL) dropwise via 
syringe. The stirring was continued for 3 h at this temperature before the reaction 
was quenched with H2O (20 mL) at 0°C. The reaction was filtered through a short 
pad of celite, eluting with Et2O. The aqueous portion was extracted with Et2O (3x 20 
mL). The combined organic extracts were washed with brine (20 mL), dried 
(Na2SO4), filtered and concentrated under reduced pressure to give the crude 
product 73 as a colourless syrup. Then, solid tetrapropylammonium perruthenate 
(TPAP) (36 mg, 0.1 mmol, 5 mol%) was added in one portion to a stirred mixture of 
the crude lactol (1.08 g), N-methylmorpholine-N-oxide (NMO) (364 mg, 3.0 mmol, 1.5 
equiv) and powdered 4Å molecular sieves (1.01 g, 0.5 g/mmol lactol) in CH2Cl2 (4 
mL) at RT under argon. On completion the reaction mixture was filtered through a 
short pad of silica, eluting with EtOAc, and the filtrate was concentrated under 
reduced pressure to give the crude product as a colourless syrup. Purification by 
flash chromatography on silica gel (n-pentane/Et2O 70:30) gave lactone 74 as a 
colourless solid. 
 
Yield:   m = 625 mg  1.54 mmol, 77% (over 2 steps) 
 
GC:   Rf = 12.6 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D23 = - 111.81 (c = 1.02 in CHCl3) 
Melting point: 107-108°C 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.27-7.48 (m, 5H; Ar-H), 5.42 (d, 3J(H,H) = 7.4 Hz, 1H; PhCH),  4.40 (d, 3J(H,H) = 
7.4 Hz, 1H; CHCH(Ph)), 3.87 (td, 3J(H,H) = 6.9, 4.4 Hz, 1H; CHCH2), 3.52 (d, 3J(H,H) 
= 6.6 Hz, 1H; CHOC(O)), 2.43 (ddt, 3J(H,H) = 49.4, 17.6, 6.6 Hz, 2H; CH2CH2C(O)), 
2.03 (m, 1H; CHCHH), 1.67 (dd, 3J(H,H) = 6.9, 6.6 Hz, 1H; CHCHH),  1.62 (s, 3H; 
C(CH3)),  1.47 (s, 3H; C(CH3)), 0.83 (s, 9H; SiC(CH3)3), 0.02 (s, 3H; Si(CH3)), 0.00 (s, 
3H; Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 170.1 (C(O)), 135.6 (Ar-C), 128.1, 127.8, 126.6 (5C, Ar-CH), 109.6 (C(CH3)2), 
80.1 (CHOC(O)), 79.1 (CHPh), 76.7 (CHCH(Ph)), 65.6 (CHCH2), 26.9 (CHCH2), 26.9 
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(CH2CH2C(O)), 26.2 (C(CH3)), 25.6 (3C, SiC(CH3)3), 25.2 (C(CH3)), 17.8 (SiC(CH3)3), 
-5.0, -4.5 (2C, Si(CH3)2) ppm. 
 
IR (KBr): 
ν = 2945 (w), 2361 (w), 2338 (w), 1726 (vw), 1551 (s), 1462 (m), 1379 (w), 1256 (w), 
1213 (w), 1170 (w), 1086 (w), 1015 (w), 919 (m), 840 (m), 780 (m), 699 (s), 538 (m) 
cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 407 (28) [M++H], 391 (11), 350 (24), 349 (100), 333 (11), 292 (12), 291 
(61), 229 (21), 221 (13), 217 (19). 
 
Elemental Analysis: 
 
C22H34O5Si (406.59): calcd C 64.99, H 8.43; found C 64.92, H 8.71. 
 
 
 
(5R,6S)-(-)-5-(tert-Butyldimethylsilyloxy)-6-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-
dioxolan-4-yl]-5,6-dihydropyran-2-one (75) 
C22H32O5Si, Mw = 404.57 
 
O O
O
O
H3C
CH3 Si
O
 
 
To a stirred solution of lithium diisopropylamine (iPr)2NLi (LDA) (1.9 mL, 0.60 mmol, 4.0 
equiv), from a mother solution of LDA [diisopropylamine (iPr)2NH (330 µL), nBuLi (790 
µL) in THF (5 mL)] at _78°C was added dropwise a solution of lactone 74 (62 mg, 0.15 
mmol, 1.0 equiv) in THF (3 mL) over 15 minutes. After 45 minutes of stirring at this 
temperature, a solution of phenylselenium chloride PhSeCl (89 mg, 0.45 mmol, 3.0 
equiv) in THF (3 mL) was slowly added. The stirring was continued for 1 h at _78°C. 
Then, the reaction was warmed up to RT and quenched with aqueous NH4Cl solution (2 
mL). The organic phase was washed with aqueous NH4Cl solution (20 mL) and brine 
(10 mL), dried (Na2SO4), filtered and concentrated under reduced pressure to give the 
crude product as a yellow syrup. The crude α-selenated product (189 mg) was 
dissolved in CH2Cl2 (2 mL) and pyridine (30 µL, 2.2 equiv) was added at 0°C followed 
by a solution of 30% hydrogen peroxide H2O2/H2O (1:1, v/v) (400 µL, 1.5 mmol, 10.0 
equiv). The stirring was continued for 30 minutes at this temperature before the reaction 
was poured into H2O (20 mL) and CH2Cl2 (20 mL). The reaction mixture was washed 
with H2O (20 mL), brine (10 mL), dried (Na2SO4), filtered and concentrated under 
reduced pressure to give the crude product as a brown syrup. Purification by flash 
chromatography on silica gel (n-pentane/Et2O 80:20) gave unsaturated lactone 75 as a 
pale yellow solid and remaining starting material (19 mg, 31%). 
  Experimental part 
   
  131 
Yield:   m = 37 mg  0.09 mmol, 60% (over 2 steps) 
(86% calculated on the recovered starting material) 
 
GC:   Rf = 13.7 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D23 = - 98.41 (c = 1.00 in CHCl3) 
Melting point: 113°C 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.25-7.50 (m, 5H; Ar-H), 6.57 (dd, 3J(H,H) = 9.9, 1.6 Hz, 1H; C(O)CHCH), 5.72 
(dd, 3J(H,H) = 9.9, 2.2 Hz, 1H; C(O)CHCH), 5.44 (d, 3J(H,H) = 7.4 Hz, 1H; PhCH),  
4.56 (td, 3J(H,H) = 9.9, 1.9 Hz, 1H; CHCH=CH), 4.47 (d, 3J(H,H) = 7.4 Hz, 1H; 
CHCH(Ph)), 3.55 (dd, 3J(H,H) = 9.9, 0.8 Hz, 1H; CHOC(O)), 1.67 (s, 3H; C(CH3)),  
1.49 (s, 3H; C(CH3)), 0.90 (s, 9H; SiC(CH3)3), 0.16 (s, 3H; Si(CH3)), 0.12 (s, 3H; 
Si(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 161.9 (C(O)), 149.6 (C(O)CHCH), 135.3 (Ar-C), 128.0, 127.7, 126.6 (5C, Ar-CH), 
119.2 (C(O)CH), 109.7 (C(CH3)2), 79.7 (CHOC(O)), 78.8 (CHPh), 75.3 (CHCH(Ph)), 
63.7 (CHCH=CH), 26.3 (C(CH3)), 25.6 (3C, SiC(CH3)3), 25.5 (C(CH3)), 17.9 
(SiC(CH3)3), -5.1, -4.6 (2C, Si(CH3)2) ppm. 
 
IR (KBr): 
 
ν = 3017 (w), 2933 (vw), 2859 (w), 1739 (vw), 1496 (s), 1465 (m), 1376 (w), 1318 (s), 
1254 (vw), 1218 (vw), 1163 (w), 1106 (vw), 1061 (w), 1008 (m), 974 (m), 917 (m), 
871 (w), 839 (w), 814 (s), 757 (vw), 701 (m), 666 (m), 554 (s), 509 (s), 473 (s). 
 
MS (CI, methane): 
 
m/z [%] = 405 (53) [M++H], 349 (8), 348 (26), 347 (100), 331 (5), 289 (11), 215 (8), 97 
(9), 91 (1). 
 
MS (EI, 70 eV): 
 
m/z [%] = 389 (13) [M+-CH3], 290 (21), 289 (100), 261 (13), 245 (10), 227 (10), 198 
(26), 169 (38), 148 (27), 147 (12), 119 (9), 91 (20), 75 (14), 73 (26). 
 
HR-MS: C21H29O5Si [M+-CH3]:  
 
calcd  389.1784 
found 389.1784 
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(5R,6R)-(-)-6-[(4R,5R)-2,2-Dimethyl-5-phenyl-1,3-dioxolan-4-yl]-5-hydroxy-5,6-
dihydropyran-2-one (76) 
C16H18O5, Mw = 290.31 
 
O OH
O
O
H3C
CH3
O
 
 
To a solution of compound 75 (290 mg, 0.72 mmol, 1.0 equiv) in absolute THF (7 mL) 
at 0°C was added n-tetrabutylammonium fluoride (nBu)4NF (TBAF) (1.4 mL, 1.0 M in 
THF, 1.44 mmol, 2.0 equiv) dropwise via syringe. The stirring was continued at RT 
for 1 h (TLC control) before the reaction was quenched with H2O (10 mL). The 
mixture was poured into H2O (10 mL) and extracted with EtOAc (3x 10 mL). The 
combined organic extracts were washed with brine (10 mL), dried (Na2SO4), filtered 
and concentrated under reduced pressure to give the crude product as a yellow 
syrup. Purification by flash chromatography on silica gel (n-pentane/EtOAc 50:50) 
gave alcohol 76 as a colourless solid. 
 
Yield:   m = 153 mg  0.53 mmol, 74% 
 
GC:   Rf = 13.9 min CP-Sil-8, 100-10-300 
Optical rotation: [α]D23 = - 106.34 (c = 1.01 in CHCl3) 
Melting point: 164°C 
 
1H NMR (300 MHz, CDCl3): 
 
δ = 7.28-7.52 (m, 5H; Ar-H), 6.68 (dd, 3J(H,H) = 9.9, 2.0 Hz, 1H; C(O)CHCH), 5.80 
(dd, 3J(H,H) = 9.9, 2.0 Hz, 1H; C(O)CH), 5.47 (d, 3J(H,H) = 7.3 Hz, 1H; PhCH),  4.61 
(dd, 3J(H,H) = 7.3, 1.1 Hz, 1H; CHCH(Ph)), 4.54 (ddd, 3J(H,H) = 9.3, 7.1, 2.0 Hz, 1H; 
CHCH=CH), 3.68 (dd, 3J(H,H) = 9.3, 1.1 Hz, 1H; CHOC(O)), 2.05 (d, 3J(H,H) = 7.1 
Hz, 1H; OH), 1.67 (s, 3H; C(CH3)), 1.51 (s, 3H; C(CH3)) ppm. 
 
13C NMR (75 MHz, CDCl3): 
 
δ = 161.9 (C(O)), 148.2 (C(O)CHCH), 135.3 (Ar-C), 128.3, 128.1, 126.9 (5C, Ar-CH), 
120.3 (C(O)CH), 110.1 (C(CH3)2), 79.6 (CHOC(O)), 79.1 (CHPh), 76.0 (CHCH(Ph)), 
63.2 (CHCH=CH), 26.3 (C(CH3)), 25.5 (C(CH3)) ppm. 
 
IR (KBr): 
 
ν = 3852 (w), 3744 (vw), 3678 (m), 3621 (m), 3463 (w), 2919 (s), 2361 (vw), 1708 
(w), 1646 (m), 1548 (vw), 1460 (m), 1378 (w), 1227 (w), 1161 (s), 1084 (w), 970 (m), 
904 (m), 808 (m), 743 (m), 673 (w), 559 (m), 510 (s), 464 (s) cm-1.  
 
 
 
  Experimental part 
   
  133 
MS (CI, methane): 
 
m/z [%] = 291 (39) [M++H],  275 (24), 234 (13), 233 (100), 232 (12), 215 (61), 149 
(10), 148 (14), 97 (10), 91 (6). 
 
MS (EI, 70 eV): 
 
m/z [%] = 276 (14), 275 (100) [M+-CH3],  233 (12), 232 (59), 215 (16), 197 (13), 184 
(16), 149 (17), 148 (93), 147 (58), 133 (16), 131 (11), 126 (23), 120 (19), 119 (31), 
105 (15), 101 (20), 100 (41), 97 (22), 91 (29), 90 (30), 89 (12), 85 (16), 84 (31), 77 
(10), 55 (14). 
 
HR-MS: C15H15O5 [M+-CH3]:  
 
calcd  275.0919 
found 275.0920 
 
 
 
(5S,6R)-(-)-6-[(4R,5R)-2,2-Dimethyl-5-phenyl-1,3-dioxolan-4-yl]-5-
methylbenzenesulfonate-5,6-dihydropyran-2-one (77) 
C23H24O7S, Mw = 444.50 
 
O O
O
O
H3C
CH3
O
S
O
O
 
 
To a stirred solution of alcohol 76 (47 mg, 0.16 mmol, 1.0 equiv) in CH2Cl2 (2 mL) at RT 
were added 4-dimethylaminopyridine (DMAP) (60 mg, 0.48 mmol, 3.0 equiv) and p-
toluenesulfonate chloride CH3C6H4SOCl (p-TsCl) (31 mg, 0.16 mmol, 1.0 equiv). Stirring 
continued for 3 h at this temperature before the mixture was poured into H2O (10 mL) 
and extracted with CH2Cl2 (3x 10 mL). The combined organic extracts were washed 
with H2O (10 mL) and brine (10 mL), dried (Na2SO4) and concentrated under reduced 
pressure to give the crude product as a brown syrup. Purification by flash 
chromatography on silica gel (n-pentane/EtOAc 70:30) gave tosylate 77 as colourless 
crystals. 
 
Yield:   m = 68 mg  0.15 mmol, 95% 
 
GC:   Rf = 10.3 min CP-Sil-8, 120-10-300 
Optical rotation: [α]D23 = - 88.90 (c = 1.00 in CHCl3) 
Melting point: 50-51°C 
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1H NMR (400 MHz, CDCl3): 
 
δ = 7.79 (m, 2H; Ar-H), 7.28-7.44 (m, 7H; Ar-H), 6.59 (dd, 3J(H,H) = 9.9, 2.7 Hz, 1H; 
C(O)CHCH), 5.89 (dd, 3J(H,H) = 9.9, 1.6 Hz, 1H; C(O)CH), 5.32 (d, 3J(H,H) = 7.4 Hz, 
1H; PhCH), 5.18 (ddd, 3J(H,H) = 8.2, 2.7, 1.6 Hz, 1H; CH(OTs)), 4.14 (d, 3J(H,H) = 
7.4 Hz, 1H; CHCH(Ph)), 3.81 (d, 3J(H,H) = 8.2 Hz, 1H; CHOC(O)), 2.49 (s, 3H; CH3), 
1.55 (s, 3H; C(CH3)), 1.34 (s, 3H; C(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 160.6 (C(O)), 145.8 (Ar-C), 141.9 (C(O)CHCH), 134.9, 132.6 (2C, Ar-C), 130.2, 
128.3, 128.2, 128.1, 126.7 (9C, Ar-CH), 122.8 (C(O)CH), 110.1 (C(CH3)2), 78.7 
(CHPh), 76.8 (CHOC(O)), 75.9 (CHCH(Ph)), 70.6 (CHCH=CH), 26.0 (C(CH3)), 25.0 
(C(CH3)), 21.8 (CH3) ppm. 
 
IR (CHCl3): 
 
ν = 3853 (w), 3744 (w), 3670 (m), 3620 (m), 3417 (m), 3024 (s), 2925 (m), 2354 (vw), 
1708 (vw), 1548 (w), 1457 (s), 1384 (s), 1250 (m), 1105 (m), 1022 (m), 820 (m), 758 
(m), 679 (w), 564 (m) cm-1. 
 
MS (CI, methane): 
 
m/z [%] = 233 (10) [M++H -(CH3)2CO -OTs] , 232 (33), 173 (17), 172 (40), 155 (11), 
136 (10), 126 (11), 108 (14), 107 (57), 105 (34), 97 (100), 96 (14), 95 (28), 91 (59), 
79 (29), 77 (30), 68 (13), 65 (11). 
 
MS (EI, 70 eV): 
 
m/z [%] = 429 (13) [M+-CH3], 338 (12), 257 (42), 232 (23), 215 (22), 197 (75), 172 
(10), 166 (100), 155 (24), 148 (39), 147 (24), 123 (10), 119 (15), 115 (12), 108 (65), 
107 (26), 105 (21), 97 (84), 95(38), 91 (58), 89 (11), 79 (15), 78 (12), 77 (23), 59 (15), 
51 (11). 
 
HR-MS: C22H21O7S [M+-CH3]:  
 
calcd  429.1008 
No data (compound too unstable) 
 
Elemental Analysis: 
 
C23H24O7S (444.50): calcd C 62.15, H 5.44; No data (compound too unstable). 
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(1S,6S,8R,9R)-(+)-9-Hydroxy-8-phenyl-2,7-dioxa-bicyclo[4.3.0]non-4-en-3-one 
[(+)-altholactone] (8) 
C13H12O4, Mw = 232.23 
 
O
O
O
HO
 
 
“no Ar” 
To a stirred solution of acetonide 77 (64 mg, 0.14 mmol, 1.0 equiv) in MeOH (2 mL) at 
RT was added Amberlyst® 15 (128 mg, 200% in weight). Stirring continued for 2 h at 
this temperature and subsequently the reaction was filtered through a short pad of celite 
and the solids washed with MeOH. The filtrate was concentrated under reduced 
pressure to give the crude product as a yellow syrup. Purification by flash 
chromatography on silica gel (Et2O pure) gave (+)-altholactone (8) as a colourless solid. 
 
Yield:   m = 31 mg  0.13 mmol, 93% 
 
GC:   Rf = 13.6 min CP-Sil-8, 100-10-300 
Optical rotation: [α]D25 = + 104.10 (c = 1.00 in CHCl3) 
[α]D25 = + 177.46 (c = 0.50 in EtOH) 
(Lit.[37],[39]: [α]D20 =  + 188, [α]D25 =  + 184.7, c = 0.50 in EtOH) 
Melting point: 114°C (Lit.[39]: 110°C) 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.27-7.36 (m, 5H; Ar-H), 7.00 (dd, 3J(H,H) = 9.9, 4.9 Hz, 1H; C(O)CHCH), 6.21 
(d, 3J(H,H) = 9.9 Hz, 1H; C(O)CH), 4.92 (dd, 3J(H,H) = 5.2, 2.2 Hz, 1H; CHOC(O)), 
4.74 (d, 3J(H,H) = 5.8 Hz, 1H; CHPh), 4.63 (t, 3J(H,H) = 5.2 Hz, 1H; CHCH=CH), 4.44 
(dd, 3J(H,H) = 5.8, 2.2 Hz, 1H; CH(OH)), 2.55 (s, 1H; OH) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 161.3 (C(O)), 140.3 (C(O)CHCH), 137.9 (Ar-C), 128.5, 128.2, 125.9 (5C, Ar-CH), 
123.4 (C(O)CH), 86.4 (CHOC(O)), 85.9 (CHPh), 83.5 (CH(OH)), 68.1 (CHCH=CH) 
ppm. 
 
IR (CHCl3): 
 
ν = 3763 (s), 3655 (s), 3438 (w), 2926 (vw), 2859 (vw), 2384 (s), 2279 (w), 1724 (vw), 
1456 (m), 1378 (m), 1259 (w), 1088 (vw), 816 (w), 759 (vw), 706 (w), 576 (s), 533 (s) 
cm-1. 
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MS (CI, methane): 
 
m/z [%] = 233 (100) [M++H], 215 (10), 137 (2), 127 (4), 119 (5), 109 (7), 107 (5), 97 
(16), 91 (8), 79 (1). 
 
MS (EI, 70 eV): 
 
m/z [%] = 232 (26) [M+], 126 (10), 107 (27), 97 (100), 95 (27), 91 (10), 79 (13), 77 
(10). 
 
HR-MS: C13H12O4 [M+]:  
 
calcd  232.0735 
found 232.0733 
 
 
 
(5S,6R)-(-)-6-[(4R,5R)-2,2-Dimethyl-5-phenyl-1,3-dioxolan-4-yl]-5-
methylbenzenesulfonate-5,6-tetrahydropyran-2-ol (79) 
C23H28O7S, Mw = 448.53 
 
O O
O
O
H3C
CH3
OH
S
O
O
 
 
To a stirred solution of tosylate 77 (30 mg, 0.07 mmol, 1.0 equiv) in absolute THF (1 
mL) at 0°C was added lithium triethylborohydride LiBHEt3 (Super-Hydride® or 
Calselect®) (74 µL, 1.0 M in THF, 0.07 mmol, 1.1 equiv). Stirring continued for 3 h at this 
temperature before the mixture was quenched with H2O (10 mL) and extracted with 
Et2O (3 x 10 mL). The combined organic extracts were washed with H2O (10 mL) and 
brine (10 mL), dried (MgSO4) and concentrated under reduced pressure to give the 
crude product as a yellow syrup. Purification by flash chromatography on silica gel (n-
pentane/EtOAc 70:30) gave 79 as a colourless solid. 
 
Yield:   m = 8 mg  0.02 mmol, 26% 
 
GC:   Rf = 9.5 min  CP-Sil-8, 120-10-300 
Optical rotation: Not measured 
Melting point: Not measured 
 
1H NMR (400 MHz, CDCl3): 
 
δ = 7.83 (m, 2H; Ar-H), 7.26-7.38 (m, 7H; Ar-H), 5.25 (d, 3J(H,H) = 8.0 Hz, 1H; 
PhCH), 4.78 (d, 3J(H,H) = 1.9 Hz, 1H; CHOCH(OH)), 4.48 (ddd, 3J(H,H) = 5.0, 4.9, 
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1.1 Hz, 1H; CH(OTs)), 4.31 (d, 3J(H,H) = 8.0 Hz, 1H; CHCH(Ph)), 3.32 (d, 3J(H,H) = 
9.6 Hz, 1H; CHOCH(OH)), 2.46 (s, 3H; CH3), 1.90-1.97 (m, 1H; CH2CHHCH(OH)), 
1.79-1.85 (m, 1H; CH2CHHCH(OH)), 1.56-1.59 (m, 2H; CH2CH2CH(OH)), 1.50 (s, 
3H; C(CH3)), 1.26 (s, 3H; C(CH3)) ppm. 
 
13C NMR (100 MHz, CDCl3): 
 
δ = 144.6, 138.0, 134.1 (3C, Ar-C), 129.8, 128.0, 127.5, 127.3, 127.0 (9C, Ar-CH), 
109.1 (C(CH3)2), 90.0 (CH(OH)), 77.9 (CHPh), 76.0 (CHOCH(OH)), 74.9 
(CHCH(Ph)), 66.9 (CH(OTs)), 28.6 (CH(OH)CH2CH2), 26.1 (C(CH3)), 25.0 
(CH(OH)CH2CH2), 24.9 (C(CH3)), 21.7 (CH3) ppm. 
 
IR (CHCl3): 
 
ν = 3772 (s), 3536 (w), 3177 (s), 2929 (vw), 2374 (s), 2336 (s), 1737 (w), 1599 (m), 
1454 (w), 1367 (vw), 1245 (w), 1180 (w), 1064 (w), 967 (vw), 880 (w), 822 (w), 747 
(m), 664 (w), 557 (vw) cm-1. 
MS (CI, isobutane): 
 
m/z [%] = 431 (2.2) [M++H -H2O] , 375 (8) [M++H –H2O -(CH3)2CO], 374 (21), 373 
(100), 220 (8), 219 (63), 201 (24), 171 (6), 157 (12), 148 (5). 
 
MS (EI, 70 eV): 
 
m/z [%] = 448 (3.4) [M+], 433 (3.4) [M+-CH3], 177 (9), 155 (6), 149 (12), 148 (100), 
147 (18), 133 (6), 120 (7), 119 (20), 112 (9), 99 (7), 91 (17). 
 
HR-MS: C23H28O7S [M+]:  
 
calcd  448.1556 
found 448.1554 
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7. Acronyms and abbreviations 
 
 
Ac      acetyl 
Ar      aromatic ring 
Amb.® 15     Amberlyst® 15 
Bn      benzyl 
br      broadly based 
Bu      butyl 
n-BuLi     n-butyllithium 
tert-BuLi (or tBuLi)    tert-butyllithium 
CAN      cerium ammonium trinitrate 
cat.      catalytic amount 
CI      chemical ionisation 
conc.      concentrated 
m-CPBA     m-chloroperoxybenzoic acid 
CSA      chlorosulphonic acid 
d      day(s) 
∆      heating 
DBU      1,8-diazabicyclo[5.4.0]undec-7-ene 
de      diastereoisomeric excess 
DEAD      diethyl azodicarboxylate 
DIBAL-H     diisobutylaluminium hydride 
DMAP     4-dimethylaminopyridine 
DMF      dimethylformamide 
2,2-DMP     2,2-dimethoxypropane 
DMSO     dimethylsulfoxide 
EDCL      1-[(3-dimethylamino)-propyl]-3-ethylcarbodiimide 
hydrochloride 
ee      enantiomeric excess 
EI      electronic impact 
equiv      equivalent 
Et      ethyl 
GC      gas chromatography 
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h      hour(s) 
HF      hydrogen fluoride 
HPLC      high performance liquid chromatography 
HR-MS     high resolution-mass spectroscopy 
IBX      o-iodoxybenzoic acid 
IC50      inhibitory concentration 50% 
Imid      imidazole 
IR      infrared spectroscopy 
LDA      lithium diisopropylamide 
Lit.      literature 
m      multiplet 
Me      methyl 
min      minute(s) 
mol%      catalytic quantity in mol percentage 
MS      mass spectroscopy or molecular sieves 
NBS      N-bromo succinimide 
NMO      N-methylmorpholine-N-oxyde 
NMR      nuclear magnetic resonance 
NOE      nuclear Overhauser effect 
NOESY     nuclear Overhauser effect spectroscopy 
OTf      triflate (= trifluoromethanesulfonate) 
PCC      pyridinium chlorochromate 
PDC      pyridinium dichromate 
PG      protecting group 
Ph      phenyl 
PPTS      pyridinium p-toluene sulfonate 
PTFE      polytetrafluoroethylene (or Teflon®) 
Py      pyridine 
quant.      quantitative 
R      rest 
rac      racemic 
RAMP     (R)-1-amino-2-(methoxymethyl)pyrrolidine 
RMP      (R)-2-(methoxymethyl)pyrrolidine 
RT      room temperature 
Acronyms and abbreviations 
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Rt      retention time 
SAMP      (S)-1-amino-2-(methoxymethyl)pyrrolidine 
SAR      structure-activity relationship 
SMP      (S)-2-(methoxymethyl)pyrrolidine 
T (or Temp.)     temperature 
TBAF      tetra-n-butylammonium fluoride 
TBDPS     tert-butyldiphenylsilyl 
TBDMS (or TBS)    tert-butyldimethylsilyl 
Tf      trifluoromethane sulfonyl 
TFA      trifluoroacetic acid 
THF      tetrahydrofurane 
TLC      thin-layer chromatography 
TMS      trimethylsilyl and tetramethylsilane (NMR) 
TPAP      tetra-n-propylammoniumperruthenate 
Ts      tosyl (= p-toluene sulfonyl) 
UV      ultraviolet 
X      halogen (Cl, Br or I)
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